BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shaheen NJ, Falk GW, Iyer PG, Gerson LB; American College of Gastroenterology. ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus. Am J Gastroenterol. 2016;111:30-50; quiz 51. [PMID: 26526079 DOI: 10.1038/ajg.2015.322] [Cited by in Crossref: 793] [Cited by in F6Publishing: 630] [Article Influence: 113.3] [Reference Citation Analysis]
Number Citing Articles
1 Shi M, Tang J, Cao Z. Nomograms for predicting survival in early-onset esophageal cancer. Expert Review of Gastroenterology & Hepatology 2021;15:437-46. [DOI: 10.1080/17474124.2021.1842194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Zagari RM, Marasco G, Tassi V, Ferretti S, Lugaresi M, Fortunato F, Bazzoli F, Mattioli S. Risk of Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus in Patients With Achalasia: A Long-Term Prospective Cohort Study in Italy. Am J Gastroenterol 2021;116:289-95. [DOI: 10.14309/ajg.0000000000000955] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
3 Falk GW. 2017 David Sun Lecture: Screening and Surveillance of Barrett's Esophagus: Where Are We Now and What Does the Future Hold? Am J Gastroenterol 2019;114:64-70. [PMID: 30361622 DOI: 10.1038/s41395-018-0374-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Shimamura Y, Iwaya Y, Kobayashi R, Rodriguez de Santiago E, Muwanwella N, Raftopoulos S, Mosko JD, May GR, Kandel G, Kortan P, Marcon N, Teshima CW. Clinical and pathological predictors of failure of endoscopic therapy for Barrett's related high-grade dysplasia and early esophageal adenocarcinoma. Surg Endosc 2021;35:5468-79. [PMID: 32989547 DOI: 10.1007/s00464-020-08037-x] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Trindade AJ, Inamdar S, Kothari S, Berkowitz J, McKinley M, Kaul V. Feasibility of liquid nitrogen cryotherapy after failed radiofrequency ablation for Barrett's esophagus. Dig Endosc. 2017;29:680-685. [PMID: 28303613 DOI: 10.1111/den.12869] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
6 Peters Y, Honing J, Kievit W, Kestens C, Pestman W, Nagtegaal ID, van der Post RS, Siersema PD. Incidence of Progression of Persistent Nondysplastic Barrett’s Esophagus to Malignancy. Clinical Gastroenterology and Hepatology 2019;17:869-877.e5. [DOI: 10.1016/j.cgh.2018.08.033] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 5.7] [Reference Citation Analysis]
7 Savarino E, Villanacci V. Barrett's esophagus detection: Multiple biopsies are useful, even better if you have an "X" on your map. Dig Liver Dis 2016;48:1041-2. [PMID: 27352982 DOI: 10.1016/j.dld.2016.06.008] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
8 Maev IV, Barkalova EV, Andreev DN, Ovsepian MA, Movtaeva PR, Zayratyants OV. Complex assessment of esophageal acidification and motor function in patients with Barrett's esophagus on antisecretory therapy. Terapevticheskii arkhiv 2022;93:1463-9. [DOI: 10.26442/00403660.2021.12.201278] [Reference Citation Analysis]
9 Elsheaita A, El-Bially MA, Shamseya MM, Ahmed SS, Madkour MA, Shamseya AM, Nouh HH. Seattle protocol vs narrow band imaging guided biopsy in screening of Barrett's esophagus in gastroesophageal reflux disease patients. Medicine (Baltimore) 2020;99:e19261. [PMID: 32080134 DOI: 10.1097/MD.0000000000019261] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Struyvenberg M, Kahn A, Fleischer D, Swager AF, Bouma B, Ganguly EK, Konda V, Lightdale CJ, Pleskow D, Sethi A, Smith M, Trindade AJ, Wallace MB, Wang K, Wolfsen HC, Tearney GJ, Curvers WL, Leggett CL, Bergman JJ. Expert assessment on volumetric laser endomicroscopy full scans in Barrett's esophagus patients with or without high grade dysplasia or early cancer. Endoscopy 2021;53:218-25. [PMID: 32515006 DOI: 10.1055/a-1194-0397] [Reference Citation Analysis]
11 Stein E, Sloan J, Sonu I, Kathpalia P, Jodorkovsky D. GERD for the nongastroenterologist: successful evaluation, management, and lifestyle-based symptom control. Ann N Y Acad Sci 2020;1482:106-12. [PMID: 32944973 DOI: 10.1111/nyas.14496] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Lv J, Liu J, Guo L, Zhang J, Cheng Y, Chen C, Zhao H, Wang J. Bioinformatic analyses of microRNA-targeted genes and microarray-identified genes correlated with Barrett's esophagus. Cell Cycle 2018;17:792-800. [PMID: 29417867 DOI: 10.1080/15384101.2018.1431597] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
13 Yusuf A, Fitzgerald RC. Screening for Barrett's Oesophagus: Are We Ready for it? Curr Treat Options Gastroenterol 2021;:1-16. [PMID: 33746508 DOI: 10.1007/s11938-021-00342-1] [Reference Citation Analysis]
14 Klaver E, van der Wel M, Duits L, Pouw R, Seldenrijk K, Offerhaus J, Visser M, Ten Kate F, Biermann K, Brosens L, Doukas M, Huysentruyt C, Karrenbeld A, Kats-Ugurlu G, van der Laan J, van Lijnschoten I, Moll F, Ooms A, Tijssen J, Meijer S, Bergman J. Performance of gastrointestinal pathologists within a national digital review panel for Barrett's oesophagus in the Netherlands: results of 80 prospective biopsy reviews. J Clin Pathol 2021;74:48-52. [PMID: 32467320 DOI: 10.1136/jclinpath-2020-206511] [Reference Citation Analysis]
15 Kohli DR, Schubert ML, Zfass AM, Shah TU. Performance characteristics of optical coherence tomography in assessment of Barrett's esophagus and esophageal cancer: systematic review. Dis Esophagus. 2017;30:1-8. [PMID: 28881898 DOI: 10.1093/dote/dox049] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
16 Solomon SS, Kothari S, Smallfield GB, Inamdar S, Stein P, Rodriguez VA, Sima AP, Bittner K, Zfass AM, Kaul V, Trindade AJ. Liquid Nitrogen Spray Cryotherapy is Associated With Less Postprocedural Pain Than Radiofrequency Ablation in Barrett's Esophagus: A Multicenter Prospective Study. J Clin Gastroenterol 2019;53:e84-90. [PMID: 29351156 DOI: 10.1097/MCG.0000000000000999] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
17 Labenz J. [Barrett's esophagus]. Internist (Berl) 2016;57:1079-92. [PMID: 27757487 DOI: 10.1007/s00108-016-0152-5] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
18 Erichsen R, Horvath-Puho E, Lund JL, Dellon ES, Shaheen NJ, Pedersen L, Davey Smith G, Sørensen HT. Mortality and cardiovascular diseases risk in patients with Barrett's oesophagus: a population-based nationwide cohort study. Aliment Pharmacol Ther 2017;45:973-82. [PMID: 28139003 DOI: 10.1111/apt.13962] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
19 Konda VJA, Spechler SJ. Endoscopic eradication therapy and the test of time. Gastrointest Endosc 2018;87:85-7. [PMID: 29241865 DOI: 10.1016/j.gie.2017.07.033] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
20 Marginean EC, Dhanpat J. Pathologic assessment of endoscopic resection specimens with superficial carcinoma of the esophagus: current practice and practical issues. Ann N Y Acad Sci 2020;1482:130-45. [PMID: 32875588 DOI: 10.1111/nyas.14455] [Reference Citation Analysis]
21 Schmidt M, Hackett RJ, Baker AM, McDonald SAC, Quante M, Graham TA. Evolutionary dynamics in Barrett oesophagus: implications for surveillance, risk stratification and therapy. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34728819 DOI: 10.1038/s41575-021-00531-4] [Reference Citation Analysis]
22 Roark R, Sydor M, Chatila AT, Umar S, Guerra R, Bilal M, Guturu P. Management of gastroesophageal reflux disease. Dis Mon 2020;66:100849. [PMID: 30798984 DOI: 10.1016/j.disamonth.2019.02.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
23 Zerbib F, Bredenoord AJ, Fass R, Kahrilas PJ, Roman S, Savarino E, Sifrim D, Vaezi M, Yadlapati R, Gyawali C. ESNM/ANMS consensus paper: Diagnosis and management of refractory gastro‐esophageal reflux disease. Neurogastroenterology & Motility 2021;33. [DOI: 10.1111/nmo.14075] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
24 Li J, Chen XL, Shaker A, Oshima T, Shan J, Miwa H, Feng C, Zhang J. Contribution of immunomodulators to gastroesophageal reflux disease and its complications: stromal cells, interleukin 4, and adiponectin. Ann N Y Acad Sci 2016;1380:183-94. [PMID: 27441783 DOI: 10.1111/nyas.13157] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
25 Lin PH, Hsieh JG, Yu HC, Jeng JH, Hsu CL, Chen CH, Wu PC. Risk Prediction of Barrett's Esophagus in a Taiwanese Health Examination Center Based on Regression Models. Int J Environ Res Public Health 2021;18:5332. [PMID: 34067792 DOI: 10.3390/ijerph18105332] [Reference Citation Analysis]
26 Kahn A, Al-qaisi M, Kommineni VT, Callaway JK, Boroff ES, Burdick GE, Lam-himlin DM, Temkit M, Vela MF, Ramirez FC. Longitudinal outcomes of radiofrequency ablation versus surveillance endoscopy for Barrett's esophagus with low-grade dysplasia. Diseases of the Esophagus 2017;31. [DOI: 10.1093/dote/dox120] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
27 Levine MS, Carucci LR. Esophageal abnormalities in gastroesophageal reflux disease. Abdom Radiol 2018;43:1284-93. [DOI: 10.1007/s00261-017-1412-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
28 Smith MS, Cash B, Konda V, Trindade AJ, Gordon S, DeMeester S, Joshi V, Diehl D, Ganguly E, Mashimo H, Singh S, Jobe B, McKinley M, Wallace M, Komatsu Y, Thakkar S, Schnoll-Sussman F, Sharaiha R, Kahaleh M, Tarnasky P, Wolfsen H, Hawes R, Lipham J, Khara H, Pleskow D, Navaneethan U, Kedia P, Hasan M, Sethi A, Samarasena J, Siddiqui UD, Gress F, Rodriguez R, Lee C, Gonda T, Waxman I, Hyder S, Poneros J, Sharzehi K, Di Palma JA, Sejpal DV, Oh D, Hagen J, Rothstein R, Sawhney M, Berzin T, Malik Z, Chang K. Volumetric laser endomicroscopy and its application to Barrett's esophagus: results from a 1,000 patient registry. Dis Esophagus 2019;32:doz029. [PMID: 31037293 DOI: 10.1093/dote/doz029] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
29 Sawas T, Azad N, Killcoyne S, Iyer PG, Wang KK, Fitzgerald RC, Katzka DA. Comparison of Phenotypes and Risk Factors for Esophageal Adenocarcinoma at Present vs Prior Decades. Clin Gastroenterol Hepatol 2020;18:2710-2716.e1. [PMID: 31712077 DOI: 10.1016/j.cgh.2019.11.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Dugalic P, Djuranovic S, Pavlovic-Markovic A, Dugalic V, Tomasevic R, Gluvic Z, Obradovic M, Bajic V, Isenovic ER. Proton Pump Inhibitors and Radiofrequency Ablation for Treatment of Barrett's Esophagus. Mini Rev Med Chem 2020;20:975-87. [PMID: 31644405 DOI: 10.2174/1389557519666191015203636] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
31 Peitz U, Vieth M, Evert M, Arand J, Roessner A, Malfertheiner P. The prevalence of gastric heterotopia of the proximal esophagus is underestimated, but preneoplasia is rare - correlation with Barrett's esophagus. BMC Gastroenterol. 2017;17:87. [PMID: 28701149 DOI: 10.1186/s12876-017-0644-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 4.4] [Reference Citation Analysis]
32 Waters KM, Salimian KJ, Voltaggio L, Montgomery EA. Refined Criteria for Separating Low-grade Dysplasia and Nondysplastic Barrett Esophagus Reduce Equivocal Diagnoses and Improve Prediction of Patient Outcome: A 10-Year Review. American Journal of Surgical Pathology 2018;42:1723-9. [DOI: 10.1097/pas.0000000000001162] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.8] [Reference Citation Analysis]
33 Rubenstein JH, McConnell D, Waljee AK, Metko V, Nofz K, Khodadost M, Jiang L, Raghunathan T. Validation and Comparison of Tools for Selecting Individuals to Screen for Barrett's Esophagus and Early Neoplasia. Gastroenterology 2020;158:2082-92. [PMID: 32119928 DOI: 10.1053/j.gastro.2020.02.037] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
34 Raman V, Jawitz OK, Voigt SL, Yang CJ, Harpole DH, D'Amico TA, Hartwig MG. The effect of age on survival after endoscopic resection versus surgery for T1a esophageal cancer. J Thorac Cardiovasc Surg 2020;160:295-302.e3. [PMID: 31928824 DOI: 10.1016/j.jtcvs.2019.11.050] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
35 Filiberti RA, Fontana V, De Ceglie A, Blanchi S, Lacchin T, De Matthaeis M, Ignomirelli O, Cappiello R, Rosa A, D'Onofrio V, Iaquinto G, Conio M. Dietary Habits and Risk of Esophagitis and Barrett's Esophagus: A Multicenter Italian Case-Control Study. Dig Dis Sci 2021;66:3448-60. [PMID: 33073332 DOI: 10.1007/s10620-020-06658-9] [Reference Citation Analysis]
36 Graham DY, Tan MC. No Barrett's-No Cancer: A Proposed New Paradigm for Prevention of Esophageal Adenocarcinoma. J Clin Gastroenterol 2020;54:136-43. [PMID: 31851107 DOI: 10.1097/MCG.0000000000001298] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
37 Syed T, Doshi A, Guleria S, Syed S, Shah T. Artificial Intelligence and Its Role in Identifying Esophageal Neoplasia. Dig Dis Sci 2020;65:3448-55. [PMID: 33057945 DOI: 10.1007/s10620-020-06643-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Cardoso J, Mesquita M, Dias Pereira A, Bettencourt-Dias M, Chaves P, Pereira-Leal JB. CYR61 and TAZ Upregulation and Focal Epithelial to Mesenchymal Transition May Be Early Predictors of Barrett's Esophagus Malignant Progression. PLoS One 2016;11:e0161967. [PMID: 27583562 DOI: 10.1371/journal.pone.0161967] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
39 Klamt AL, Neyeloff JL, Santos LM, Mazzini GDS, Campos VJ, Gurski RR. Echoendoscopy in Preoperative Evaluation of Esophageal Adenocarcinoma and Gastroesophageal Junction: Systematic Review and Meta-analysis. Ultrasound Med Biol 2021;47:1657-69. [PMID: 33896677 DOI: 10.1016/j.ultrasmedbio.2021.03.013] [Reference Citation Analysis]
40 Singer ME, Smith MS. Wide Area Transepithelial Sampling with Computer-Assisted Analysis (WATS3D) Is Cost-Effective in Barrett's Esophagus Screening. Dig Dis Sci 2021;66:1572-9. [PMID: 32578042 DOI: 10.1007/s10620-020-06412-1] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
41 Suresh Kumar VC, Harne P, Patthipati VS, Subedi A, Masood U, Sharma A, Goyal F, Aggarwal N, Sapkota B. Wide-area transepithelial sampling in adjunct to forceps biopsy increases the absolute detection rates of Barrett's oesophagus and oesophageal dysplasia: a meta-analysis and systematic review. BMJ Open Gastroenterol 2020;7:e000494. [PMID: 32928869 DOI: 10.1136/bmjgast-2020-000494] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Husain NS, El-Serag HB. Chemoprevention of Barrett's oesophagus: a step closer with PPIs and aspirin. Nat Rev Clin Oncol 2018;15:728-30. [PMID: 30237519 DOI: 10.1038/s41571-018-0096-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
43 Ashrafi D, Memon B, Memon MA. Management of oesophageal intramucosal carcinoma. BMJ Case Rep 2018;2018:bcr-2018-224893. [PMID: 30217797 DOI: 10.1136/bcr-2018-224893] [Reference Citation Analysis]
44 Ali S, Bailey A, Ash S, Haghighat M, Leedham SJ, Lu X, East JE, Rittscher J, Braden B; TGU Investigators. A Pilot Study on Automatic Three-Dimensional Quantification of Barrett's Esophagus for Risk Stratification and Therapy Monitoring. Gastroenterology 2021;161:865-878.e8. [PMID: 34116029 DOI: 10.1053/j.gastro.2021.05.059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
45 Agha YH, Taleb A, Srinivasan S, Tofteland N, Salyers W. Screening for Barrett's Esophagus in Patients with Cirrhosis Using WATS3D. Kans J Med 2021;14:206-8. [PMID: 34367492 DOI: 10.17161/kjm.vol1415074] [Reference Citation Analysis]
46 Usui G, Shinozaki T, Jinno T, Fujibayashi K, Morikawa T, Gunji T, Matsuhashi N. Relationship between time-varying status of reflux esophagitis and Helicobacter pylori and progression to long-segment Barrett's esophagus: time-dependent Cox proportional-hazards analysis. BMC Gastroenterol 2020;20:270. [PMID: 32799812 DOI: 10.1186/s12876-020-01418-5] [Reference Citation Analysis]
47 Bruno G, Zaccari P, Rocco G, Scalese G, Panetta C, Porowska B, Pontone S, Severi C. Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified. World J Gastroenterol 2019; 25(22): 2706-2719 [PMID: 31235994 DOI: 10.3748/wjg.v25.i22.2706] [Cited by in CrossRef: 55] [Cited by in F6Publishing: 42] [Article Influence: 18.3] [Reference Citation Analysis]
48 Kollar M, Krajciova J, Prefertusova L, Sticova E, Maluskova J, Vackova Z, Martinek J. Probe-based confocal laser endomicroscopy versus biopsies in the diagnostics of oesophageal and gastric lesions: A prospective, pathologist-blinded study. United European Gastroenterol J 2020;8:436-43. [PMID: 32213027 DOI: 10.1177/2050640620904865] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Sawas T, Zamani SA, Killcoyne S, Dullea A, Wang KK, Iyer PG, Fitzgerald RC, Katzka DA. Limitations of Heartburn and Other Societies' Criteria in Barrett's Screening for Detecting De Novo Esophageal Adenocarcinoma. Clin Gastroenterol Hepatol 2021:S1542-3565(21)01152-6. [PMID: 34757196 DOI: 10.1016/j.cgh.2021.10.039] [Reference Citation Analysis]
50 Holmberg D, Ness-Jensen E, Mattsson F, Lagergren J. Adherence to clinical guidelines for Barrett's esophagus. Scand J Gastroenterol. 2019;54:945-952. [PMID: 31314608 DOI: 10.1080/00365521.2019.1641740] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
51 Bibbò S, Ianiro G, Ricci R, Arciuolo D, Petruzziello L, Spada C, Larghi A, Riccioni ME, Gasbarrini A, Costamagna G, Cammarota G. Barrett's oesophagus and associated dysplasia are not equally distributed within the esophageal circumference. Digestive and Liver Disease 2016;48:1043-7. [DOI: 10.1016/j.dld.2016.06.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
52 Marshall C, Mounzer R, Hall M, Simon V, Centeno B, Dennis K, Dhillon J, Fan F, Khazai L, Klapman J, Komanduri S, Lin X, Lu D, Mehrotra S, Muthusamy VR, Nayar R, Paintal A, Rao J, Sams S, Shah J, Watson R, Rastogi A, Wani S. Suboptimal Agreement Among Cytopathologists in Diagnosis of Malignancy Based on Endoscopic Ultrasound Needle Aspirates of Solid Pancreatic Lesions: A Validation Study. Clin Gastroenterol Hepatol. 2018;16:1114-1122.e2. [PMID: 28911946 DOI: 10.1016/j.cgh.2017.09.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
53 Visrodia K, Zakko L, Wang KK. Radiofrequency Ablation of Barrett's Esophagus: Efficacy, Complications, and Durability. Gastrointest Endosc Clin N Am 2017;27:491-501. [PMID: 28577770 DOI: 10.1016/j.giec.2017.03.003] [Cited by in Crossref: 5] [Article Influence: 1.0] [Reference Citation Analysis]
54 Seewald S, Ang TL, Pouw RE, Bannwart F, Bergman JJ. Management of Early-Stage Adenocarcinoma of the Esophagus: Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection. Dig Dis Sci 2018;63:2146-54. [PMID: 29934725 DOI: 10.1007/s10620-018-5158-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
55 Agha YH, Srinivasan S, Hyder J, Wuthnow C, Taleb A, Tofteland N, Kilgore W, Salyers W. WATS3D versus forceps biopsy in screening for Barrett's esophagus: experience in community endoscopy centers. Ann Gastroenterol 2021;34:164-8. [PMID: 33654354 DOI: 10.20524/aog.2020.0564] [Reference Citation Analysis]
56 Bhat I, Pleskow DK. Is Endoscopic Submucosal Dissection of Early Esophageal Cancer Ready for Prime Time? Clin Gastroenterol Hepatol 2019;17:30-1. [PMID: 30055265 DOI: 10.1016/j.cgh.2018.07.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
57 Kamboj AK, Leggett CL. Barrett's esophagus indefinite for dysplasia carries a definite risk of neoplasia. Gastrointest Endosc 2021;94:271-2. [PMID: 33975711 DOI: 10.1016/j.gie.2021.03.019] [Reference Citation Analysis]
58 Krause J, Rösch T, Steurer S, Clauditz T, Sehner S, Schumacher U, Neuhaus H, Messmann H, Schumacher B, Probst A, Schachschal G, Ehlken H, Vieth M, Schmitz R. Quantitative analysis of submucosal excision depth in endoscopic resection for early Barrett's cancer. Endoscopy 2021. [PMID: 34856621 DOI: 10.1055/a-1659-3514] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Ishimura N, Yuki M, Yuki T, Komazawa Y, Kushiyama Y, Fujishiro H, Ishihara S, Kinoshita Y. Inter-institutional variations regarding Barrett's esophagus diagnosis. Esophagus 2019;16:71-6. [PMID: 30056606 DOI: 10.1007/s10388-018-0631-y] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
60 Bresalier RS. Chemoprevention of Barrett’s Esophagus and Esophageal Adenocarcinoma. Dig Dis Sci 2018;63:2155-62. [DOI: 10.1007/s10620-018-5149-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
61 Gotink AW, Ten Kate FJ, Doukas M, Wijnhoven BP, Bruno MJ, Looijenga LH, Koch AD, Biermann K. Do pathologists agree with each other on the histological assessment of pT1b oesophageal adenocarcinoma? United European Gastroenterol J 2019;7:261-9. [PMID: 31080611 DOI: 10.1177/2050640618817693] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
62 Shah AK, Joshi V, Hartel G, Barbour AP, Hill MM. To BE or not to BE: non-invasive screening for Barrett's esophagus, dysplasia and adenocarcinoma. Transl Gastroenterol Hepatol 2019;4:31. [PMID: 31231698 DOI: 10.21037/tgh.2019.04.08] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
63 Curtius K, Rubenstein JH, Chak A, Inadomi JM. Computational modelling suggests that Barrett's oesophagus may be the precursor of all oesophageal adenocarcinomas. Gut 2020:gutjnl-2020-321598. [PMID: 33234525 DOI: 10.1136/gutjnl-2020-321598] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
64 Raphael KL, Stewart M, Sejpal DV, Cheung M, Whitson MJ, Han D, Benias PC, Lee C, Miller LS, Trindade AJ. Adjunctive Yield of Wide-Area Transepithelial Sampling for Dysplasia Detection After Advanced Imaging and Random Biopsies in Barrett's Esophagus. Clin Transl Gastroenterol 2019;10:e00107. [PMID: 31833863 DOI: 10.14309/ctg.0000000000000107] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
65 Shah SC, McKinley M, Gupta S, Peek RM Jr, Martinez ME, Gomez SL. Population-Based Analysis of Differences in Gastric Cancer Incidence Among Races and Ethnicities in Individuals Age 50 Years and Older. Gastroenterology 2020;159:1705-1714.e2. [PMID: 32771406 DOI: 10.1053/j.gastro.2020.07.049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
66 van Zanten SV. Chronic GERD and risk of esophageal adenocarcinoma: Should we screen with gastroscopy? CMAJ 2020;192:E781-2. [PMID: 32631910 DOI: 10.1503/cmaj.200697] [Reference Citation Analysis]
67 Tsai T, Leggett CL, Trindade AJ. Optical coherence tomography in gastroenterology: a review and future outlook. J Biomed Opt 2017;22:1. [DOI: 10.1117/1.jbo.22.12.121716] [Cited by in Crossref: 29] [Cited by in F6Publishing: 11] [Article Influence: 5.8] [Reference Citation Analysis]
68 Lv J, Guo L, Wang JH, Yan YZ, Zhang J, Wang YY, Yu Y, Huang YF, Zhao HP. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett’s esophagus. World J Gastroenterol 2019; 25(2): 233-244 [PMID: 30670912 DOI: 10.3748/wjg.v25.i2.233] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
69 Shafa S, Shaheen NJ. How I Approach It: Care of the Post-Ablation Barrett's Esophagus Patient. Am J Gastroenterol 2017;112:1487-90. [PMID: 28925988 DOI: 10.1038/ajg.2017.291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
70 Sharma P, Shaheen NJ, Katzka D, Bergman JJGHM. AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review.Gastroenterology. 2020;158:760-769. [PMID: 31730766 DOI: 10.1053/j.gastro.2019.09.051] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 14.0] [Reference Citation Analysis]
71 Wani S, Qumseya B, Sultan S, Agrawal D, Chandrasekhara V, Harnke B, Kothari S, Mccarter M, Shaukat A, Wang A, Yang J, Dewitt J. Endoscopic eradication therapy for patients with Barrett’s esophagus–associated dysplasia and intramucosal cancer. Gastrointestinal Endoscopy 2018;87:907-931.e9. [DOI: 10.1016/j.gie.2017.10.011] [Cited by in Crossref: 59] [Cited by in F6Publishing: 39] [Article Influence: 14.8] [Reference Citation Analysis]
72 Mittal SK, Abdo J, Adrien MP, Bayu BA, Kline JR, Sullivan MM, Agrawal DK. Current state of prognostication, therapy and prospective innovations for Barrett's-related esophageal adenocarcinoma: a literature review. J Gastrointest Oncol 2021;12:1197-214. [PMID: 34532080 DOI: 10.21037/jgo-21-117] [Reference Citation Analysis]
73 Critchley-Thorne RJ, Davison JM, Prichard JW, Reese LM, Zhang Y, Repa K, Li J, Diehl DL, Jhala NC, Ginsberg GG, DeMarshall M, Foxwell T, Jobe BA, Zaidi AH, Duits LC, Bergman JJ, Rustgi A, Falk GW. A Tissue Systems Pathology Test Detects Abnormalities Associated with Prevalent High-Grade Dysplasia and Esophageal Cancer in Barrett's Esophagus. Cancer Epidemiol Biomarkers Prev 2017;26:240-8. [PMID: 27729357 DOI: 10.1158/1055-9965.EPI-16-0640] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 3.2] [Reference Citation Analysis]
74 Kahn A, Kamboj AK, Muppa P, Sawas T, Lutzke LS, Buras MR, Golafshar MA, Katzka DA, Iyer PG, Smyrk TC, Wang KK, Leggett CL. Staging of T1 esophageal adenocarcinoma with volumetric laser endomicroscopy: a feasibility study.Endosc Int Open. 2019;7:E462-E470. [PMID: 30931378 DOI: 10.1055/a-0838-5326] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
75 Belghazi K, Pouw RE, Bergman JJ. In the expanding arena of endoscopic management for Barrett's neoplasia, how should we fit in endoscopic submucosal dissection? Gastrointest Endosc 2018;87:1394-5. [PMID: 29759155 DOI: 10.1016/j.gie.2018.02.004] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
76 Konda VJA, Souza RF. Barrett’s Esophagus and Esophageal Carcinoma: Can Biomarkers Guide Clinical Practice? Curr Gastroenterol Rep 2019;21. [DOI: 10.1007/s11894-019-0685-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
77 Luigiano C, Iabichino G, Eusebi LH, Arena M, Consolo P, Morace C, Opocher E, Mangiavillano B. Outcomes of Radiofrequency Ablation for Dysplastic Barrett's Esophagus: A Comprehensive Review. Gastroenterol Res Pract. 2016;2016:4249510. [PMID: 28070182 DOI: 10.1155/2016/4249510] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
78 Allen JE, Desai M, Roumans CAM, Vennalaganti S, Vennalaganti P, Bansal A, Falk G, Lieberman D, Sampliner R, Thota P, Vargo J, Gupta N, Moawad F, Bruno M, Kennedy KF, Gaddam S, Young P, Mathur S, Cash B, Spaander M, Sharma P. Low Risk of Progression of Barrett's Esophagus to Neoplasia in Women. J Clin Gastroenterol 2021;55:321-6. [PMID: 32379085 DOI: 10.1097/MCG.0000000000001362] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
79 Amlashi FG, Wang X, Davila RE, Maru DM, Bhutani MS, Lee JH, Weston BR, Mizrak Kaya D, Vassilakopoulou M, Harada K, Blum Murphy MA, Rice DC, Hofstetter WL, Davila M, Nguyen QN, Ajani JA. Barrett's Esophagus after Bimodality Therapy in Patients with Esophageal Adenocarcinoma. Oncology 2018;95:81-90. [PMID: 29843157 DOI: 10.1159/000488489] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
80 Wani S, Gaddam S. Editorial: Best Practices in Surveillance of Barrett's Esophagus. Am J Gastroenterol 2017;112:1056-60. [PMID: 28725066 DOI: 10.1038/ajg.2017.117] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
81 Barret M, Pioche M, Terris B, Ponchon T, Cholet F, Zerbib F, Chabrun E, Le Rhun M, Coron E, Giovannini M, Caillol F, Laugier R, Jacques J, Legros R, Boustiere C, Rahmi G, Metivier-Cesbron E, Vanbiervliet G, Bauret P, Escourrou J, Branche J, Jilet L, Abdoul H, Kaddour N, Leblanc S, Bensoussan M, Prat F, Chaussade S. Endoscopic radiofrequency ablation or surveillance in patients with Barrett's oesophagus with confirmed low-grade dysplasia: a multicentre randomised trial. Gut 2021;70:1014-22. [PMID: 33685969 DOI: 10.1136/gutjnl-2020-322082] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Salimian KJ, Birkness-Gartman J, Waters KM. The path(ology) from reflux oesophagitis to Barrett oesophagus to oesophageal adenocarcinoma. Pathology 2021:S0031-3025(21)00482-7. [PMID: 34711413 DOI: 10.1016/j.pathol.2021.08.006] [Reference Citation Analysis]
83 Valero M, Robles-Medranda C. Endoscopic ultrasound in oncology: An update of clinical applications in the gastrointestinal tract. World J Gastrointest Endosc 2017; 9(6): 243-254 [PMID: 28690767 DOI: 10.4253/wjge.v9.i6.243] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
84 Lottrup C, Krarup AL, Gregersen H, Ejstrud P, Drewes AM. Esophageal Acid Clearance During Random Swallowing Is Faster in Patients with Barrett's Esophagus Than in Healthy Controls. J Neurogastroenterol Motil 2016;22:630-42. [PMID: 27557545 DOI: 10.5056/jnm16019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
85 Chua T, Fukami N. Upfront endoscopic submucosal dissection for superficial squamous cell carcinoma is superior to upfront surgical therapy. Gastrointest Endosc 2018;88:634-6. [PMID: 30217240 DOI: 10.1016/j.gie.2018.07.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
86 Ooi GJ, Browning A, Hii MW, Read M. Perioperative screening, management, and surveillance of Barrett's esophagus in bariatric surgical patients. Ann N Y Acad Sci 2020;1481:224-35. [PMID: 32794237 DOI: 10.1111/nyas.14441] [Reference Citation Analysis]
87 Bang CS, Lee JJ, Baik GH. Computer-aided diagnosis of esophageal cancer and neoplasms in endoscopic images: a systematic review and meta-analysis of diagnostic test accuracy. Gastrointest Endosc 2021;93:1006-1015.e13. [PMID: 33290771 DOI: 10.1016/j.gie.2020.11.025] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
88 Honing J, Kievit W, Bookelaar J, Peters Y, Iyer PG, Siersema PD. Endosheath ultrathin transnasal endoscopy is a cost-effective method for screening for Barrett's esophagus in patients with GERD symptoms. Gastrointest Endosc 2019;89:712-722.e3. [PMID: 30385112 DOI: 10.1016/j.gie.2018.10.024] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
89 Puchkov KV, Khabarova EV, Tishchenko ES. [Two-stage treatment of Barrett's esophagus]. Khirurgiia (Mosk) 2019;:18-24. [PMID: 31532162 DOI: 10.17116/hirurgia201909118] [Reference Citation Analysis]
90 Panda A, Shin MR, Cheng C, Bajpai M. Barrett's Epithelium to Esophageal Adenocarcinoma: Is There a "Point of No Return"? Front Genet 2021;12:706706. [PMID: 34603373 DOI: 10.3389/fgene.2021.706706] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
91 Scarpignato C, Gatta L, Zullo A, Blandizzi C; SIF-AIGO-FIMMG Group; Italian Society of Pharmacology, the Italian Association of Hospital Gastroenterologists, and the Italian Federation of General Practitioners. Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression. BMC Med. 2016;14:179. [PMID: 27825371 DOI: 10.1186/s12916-016-0718-z] [Cited by in Crossref: 148] [Cited by in F6Publishing: 123] [Article Influence: 24.7] [Reference Citation Analysis]
92 Douville C, Moinova HR, Thota PN, Shaheen NJ, Iyer PG, Canto MI, Wang JS, Dumot JA, Faulx A, Kinzler KW, Papadopoulos N, Vogelstein B, Markowitz SD, Bettegowda C, Willis JE, Chak A. Massively Parallel Sequencing of Esophageal Brushings Enables an Aneuploidy-Based Classification of Patients With Barrett's Esophagus. Gastroenterology 2021;160:2043-2054.e2. [PMID: 33493502 DOI: 10.1053/j.gastro.2021.01.209] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
93 Feczko AF, Louie BE. Endoscopic Resection in the Esophagus. Thorac Surg Clin 2018;28:481-97. [PMID: 30268294 DOI: 10.1016/j.thorsurg.2018.07.006] [Reference Citation Analysis]
94 Rice TW, Patil DT, Blackstone EH. 8th edition AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice. Ann Cardiothorac Surg. 2017;6(2):119-130. [PMID: 28447000 DOI: 10.21037/acs.2017.03.14] [Cited by in Crossref: 186] [Cited by in F6Publishing: 152] [Article Influence: 37.2] [Reference Citation Analysis]
95 Huang J, Liu H, Sun T, Fang JY, Wang J, Xiong H. Omeprazole prevents CDX2 and SOX9 expression by inhibiting hedgehog signaling in Barrett's esophagus cells. Clin Sci (Lond) 2019;133:483-95. [PMID: 30705106 DOI: 10.1042/CS20180828] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
96 Hajelssedig OE, Zorron Cheng Tao Pu L, Thompson JY, Lord A, El Sayed I, Meyer C, Shaukat Ali F, Abdulazeem HM, Kheir AO, Siepmann T, Singh R. Diagnostic accuracy of narrow-band imaging endoscopy with targeted biopsies compared with standard endoscopy with random biopsies in patients with Barrett's esophagus: A systematic review and meta-analysis. J Gastroenterol Hepatol 2021. [PMID: 34121232 DOI: 10.1111/jgh.15577] [Reference Citation Analysis]
97 Tang Y, Anandasabapathy S, Richards-Kortum R. Advances in optical gastrointestinal endoscopy: a technical review. Mol Oncol 2021;15:2580-99. [PMID: 32915503 DOI: 10.1002/1878-0261.12792] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
98 D'Souza SM, Houston K, Keenan L, Yoo BS, Parekh PJ, Johnson DA. Role of microbial dysbiosis in the pathogenesis of esophageal mucosal disease: A paradigm shift from acid to bacteria? World J Gastroenterol 2021; 27(18): 2054-2072 [PMID: 34025064 DOI: 10.3748/wjg.v27.i18.2054] [Reference Citation Analysis]
99 Cotton CC, Haidry R, Thrift AP, Lovat L, Shaheen NJ. Development of Evidence-Based Surveillance Intervals After Radiofrequency Ablation of Barrett's Esophagus. Gastroenterology 2018;155:316-326.e6. [PMID: 29655833 DOI: 10.1053/j.gastro.2018.04.011] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
100 Peleg N, Schmilovitz-Weiss H, Shamah S, Schwartz A, Dotan I, Sapoznikov B. Neutrophil to lymphocyte ratio and risk of neoplastic progression in patients with Barrett's esophagus. Endoscopy 2021;53:774-81. [PMID: 33075822 DOI: 10.1055/a-1292-8747] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
101 Braghetto I, Csendes A. FAILURE AFTER FUNDOPLICATION: RE-FUNDOPLICATION? IS THERE A ROOM FOR GASTRECTOMY? IN WHICH CLINICAL SCENARIES? Arq Bras Cir Dig 2019;32:e1440. [PMID: 31460600 DOI: 10.1590/0102-672020190001e1440] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
102 Joo MK, Park JJ, Chun HJ. Additional Benefits of Routine Drugs on Gastrointestinal Cancer: Statins, Metformin, and Proton Pump Inhibitors. Dig Dis 2018;36:1-14. [PMID: 28881340 DOI: 10.1159/000480149] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
103 Toon C, Allanson B, Leslie C, Acott N, Mirzai B, Raftopoulos S, Kumarasinghe MP. Patterns of p53 immunoreactivity in non-neoplastic and neoplastic Barrett's mucosa of the oesophagus: in-depth evaluation in endoscopic mucosal resections. Pathology 2019;51:253-60. [DOI: 10.1016/j.pathol.2018.12.415] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
104 Struyvenberg MR, de Groof AJ, Fonollà R, van der Sommen F, de With PHN, Schoon EJ, Weusten BLAM, Leggett CL, Kahn A, Trindade AJ, Ganguly EK, Konda VJA, Lightdale CJ, Pleskow DK, Sethi A, Smith MS, Wallace MB, Wolfsen HC, Tearney GJ, Meijer SL, Vieth M, Pouw RE, Curvers WL, Bergman JJ. Prospective development and validation of a volumetric laser endomicroscopy computer algorithm for detection of Barrett's neoplasia. Gastrointest Endosc 2021;93:871-9. [PMID: 32735947 DOI: 10.1016/j.gie.2020.07.052] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
105 Omidvari AH, Ali A, Hazelton WD, Kroep S, Lee M, Naber SK, Lauren BN, Ostvar S, Richmond E, Kong CY, Rubenstein JH, Lansdorp-Vogelaar I, Luebeck G, Hur C, Inadomi J. Optimizing Management of Patients With Barrett's Esophagus and Low-Grade or No Dysplasia Based on Comparative Modeling. Clin Gastroenterol Hepatol 2020;18:1961-9. [PMID: 31816445 DOI: 10.1016/j.cgh.2019.11.058] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
106 Fecteau RE, Kong J, Kresak A, Brock W, Song Y, Fujioka H, Elston R, Willis JE, Lynch JP, Markowitz SD, Guda K, Chak A. Association Between Germline Mutation in VSIG10L and Familial Barrett Neoplasia. JAMA Oncol 2016;2:1333-9. [PMID: 27467440 DOI: 10.1001/jamaoncol.2016.2054] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
107 Alkhayyat M, Kumar P, Sanaka KO, Thota PN. Chemoprevention in Barrett's esophagus and esophageal adenocarcinoma. Therap Adv Gastroenterol 2021;14:17562848211033730. [PMID: 34434254 DOI: 10.1177/17562848211033730] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
108 Kurtom S, Kaplan BJ. Esophagus and Gastrointestinal Junction Tumors. Surg Clin North Am 2020;100:507-21. [PMID: 32402297 DOI: 10.1016/j.suc.2020.02.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
109 Feuerstein JD, Bilal M, Berzin TM, Calderwood AH, Guturu P, Juncadella AC, Ketwaroo G, Mishkin DS, Perdue DG, Sekhon S, Sengupta N, Singh S, Pleskow DK, Sawhney MS. Triage of General Gastrointestinal Endoscopic Procedures During the COVID-19 Pandemic: Results From a National Delphi Consensus Panel. Tech Innov Gastrointest Endosc 2021;23:113-21. [PMID: 33521705 DOI: 10.1016/j.tige.2020.12.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
110 Sami SS, Iyer PG, Pophali P, Halland M, di Pietro M, Ortiz-Fernandez-Sordo J, White JR, Johnson M, Guha IN, Fitzgerald RC, Ragunath K. Acceptability, Accuracy, and Safety of Disposable Transnasal Capsule Endoscopy for Barrett's Esophagus Screening. Clin Gastroenterol Hepatol. 2019;17:638-646.e1. [PMID: 30081223 DOI: 10.1016/j.cgh.2018.07.019] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
111 Que J, Garman KS, Souza RF, Spechler SJ. Pathogenesis and Cells of Origin of Barrett's Esophagus. Gastroenterology 2019;157:349-364.e1. [PMID: 31082367 DOI: 10.1053/j.gastro.2019.03.072] [Cited by in Crossref: 50] [Cited by in F6Publishing: 38] [Article Influence: 16.7] [Reference Citation Analysis]
112 Eluri S, Shaheen NJ. Measuring Quality in Barrett’s Endoscopy. Clinical Gastroenterology and Hepatology 2021;19:889-91. [DOI: 10.1016/j.cgh.2020.09.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
113 Tan MC, Murrey-Ittmann J, Nguyen T, Ketwaroo GA, El-Serag HB, Thrift AP. Risk Profiles for Barrett's Esophagus Differ between New and Prevalent, and Long- and Short-Segment Cases. PLoS One 2016;11:e0169250. [PMID: 28036381 DOI: 10.1371/journal.pone.0169250] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
114 Bhandari P, Longcroft-Wheaton G, Libanio D, Pimentel-Nunes P, Albeniz E, Pioche M, Sidhu R, Spada C, Anderloni A, Repici A, Haidry R, Barthet M, Neumann H, Antonelli G, Testoni A, Ponchon T, Siersema PD, Fuccio L, Hassan C, Dinis-Ribeiro M. Revising the European Society of Gastrointestinal Endoscopy (ESGE) research priorities: a research progress update. Endoscopy 2021;53:535-54. [PMID: 33822332 DOI: 10.1055/a-1397-3005] [Reference Citation Analysis]
115 Pulido JV, Guleria S, Ehsan L, Shah T, Syed S, Brown DE. SCREENING FOR BARRETT'S ESOPHAGUS WITH PROBE-BASED CONFOCAL LASER ENDOMICROSCOPY VIDEOS. Proc IEEE Int Symp Biomed Imaging 2020;2020:1659-63. [PMID: 34040694 DOI: 10.1109/isbi45749.2020.9098630] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
116 Schlottmann F, Dreifuss NH, Patti MG. Obesity and esophageal cancer: GERD, Barrett´s esophagus, and molecular carcinogenic pathways. Expert Review of Gastroenterology & Hepatology 2020;14:425-33. [DOI: 10.1080/17474124.2020.1764348] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
117 Ahmed Y, Othman M. EMR/ESD: Techniques, Complications, and Evidence. Curr Gastroenterol Rep 2020;22:39. [PMID: 32542462 DOI: 10.1007/s11894-020-00777-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
118 Siddique SM, May FP. Race-Based Clinical Recommendations in Gastroenterology. Gastroenterology 2021:S0016-5085(21)04050-6. [PMID: 34890599 DOI: 10.1053/j.gastro.2021.12.234] [Reference Citation Analysis]
119 FalcÃo AM, Nasi A, Szachnowicz S, Santa-Cruz F, Seguro FCBC, Sena BF, Duarte A, Sallum RA, Cecconello I. Does the nissen fundoplication procedure improve esophageal dysmotility in patients with barrett's esophagus? Rev Col Bras Cir 2020;47:e20202637. [PMID: 33263652 DOI: 10.1590/0100-6991e-20202637] [Reference Citation Analysis]
120 Yang D, Othman M, Draganov PV. Endoscopic Mucosal Resection vs Endoscopic Submucosal Dissection For Barrett's Esophagus and Colorectal Neoplasia. Clin Gastroenterol Hepatol. 2019;17:1019-1028. [PMID: 30267866 DOI: 10.1016/j.cgh.2018.09.030] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 6.5] [Reference Citation Analysis]
121 Hussein M, Sehgal V, Sami S, Bassett P, Sweis R, Graham D, Telese A, Morris D, Rodriguez-Justo M, Jansen M, Novelli M, Banks M, Lovat LB, Haidry R. The natural history of low-grade dysplasia in Barrett's esophagus and risk factors for progression. JGH Open 2021;5:1019-25. [PMID: 34584970 DOI: 10.1002/jgh3.12625] [Reference Citation Analysis]
122 Holme Ø, Løberg M. Methodological considerations for surveillance in GI practice. Best Pract Res Clin Gastroenterol 2016;30:867-78. [PMID: 27938782 DOI: 10.1016/j.bpg.2016.10.011] [Reference Citation Analysis]
123 Peter S. Shining a White Light on Barrett's Esophagus: What Does the BING Classification Bring? Dig Dis Sci 2017;62:2612-4. [PMID: 28836070 DOI: 10.1007/s10620-017-4694-8] [Reference Citation Analysis]
124 Smith LP, Yamato JA, Galipeau PC, Paulson TG, Li X, Sanchez CA, Reid BJ, Kuhner MK. Within-patient phylogenetic reconstruction reveals early events in Barrett's Esophagus. Evol Appl 2021;14:399-415. [PMID: 33664784 DOI: 10.1111/eva.13125] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
125 Sehgal V, Ragunath K, Haidry R. Measuring Quality in Barrett's Esophagus: Time to Embrace Quality Indicators. Gastrointest Endosc Clin N Am 2021;31:219-36. [PMID: 33213797 DOI: 10.1016/j.giec.2020.09.006] [Reference Citation Analysis]
126 de Tomás J. Conversion to gastric bypass in patients with Barrett's esophagus after sleeve gastrectomy. Cir Esp (Engl Ed) 2021;99:397-8. [PMID: 33632513 DOI: 10.1016/j.ciresp.2021.01.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
127 Lottrup C, Krarup AL, Gregersen H, Ejstrud P, Drewes AM. Patients with Barrett's esophagus are hypersensitive to acid but hyposensitive to other stimuli compared with healthy controls. Neurogastroenterol Motil 2017;29:e12992. [DOI: 10.1111/nmo.12992] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
128 Beuque M, Martin-Lorenzo M, Balluff B, Woodruff HC, Lucas M, de Bruin DM, van Timmeren JE, Boer OJ, Heeren RM, Meijer SL, Lambin P. Machine learning for grading and prognosis of esophageal dysplasia using mass spectrometry and histological imaging. Comput Biol Med 2021;138:104918. [PMID: 34638018 DOI: 10.1016/j.compbiomed.2021.104918] [Reference Citation Analysis]
129 Jiang Y, Gong Y, Rubenstein JH, Wang TD, Seibel EJ. Toward real-time quantification of fluorescence molecular probes using target/background ratio for guiding biopsy and endoscopic therapy of esophageal neoplasia. J Med Imaging (Bellingham) 2017;4:024502. [PMID: 28560244 DOI: 10.1117/1.JMI.4.2.024502] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
130 Eluri S, Paterson A, Lauren BN, O'Donovan M, Bhandari P, di Pietro M, Lee M, Haidry R, Lovat L, Ragunath K, Hur C, Fitzgerald RC, Shaheen NJ. Utility and Cost-Effectiveness of a Nonendoscopic Approach to Barrett's Esophagus Surveillance After Endoscopic Therapy. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00147-6. [PMID: 33581357 DOI: 10.1016/j.cgh.2021.02.013] [Reference Citation Analysis]
131 Matsuhashi N, Sakai E, Ohata K, Ishimura N, Fujisaki J, Shimizu T, Iijima K, Koike T, Endo T, Kikuchi T, Inayoshi T, Amano Y, Furuta T, Haruma K, Kinoshita Y. Surveillance of patients with long-segment Barrett's esophagus: A multicenter prospective cohort study in Japan. J Gastroenterol Hepatol 2017;32:409-14. [PMID: 27416773 DOI: 10.1111/jgh.13491] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
132 Nobel TB, Curry M, Gennarelli R, Jones DR, Molena D. Higher clinical suspicion is needed for prompt diagnosis of esophageal adenocarcinoma in young patients. J Thorac Cardiovasc Surg 2019:S0022-5223(19)30796-2. [PMID: 31126651 DOI: 10.1016/j.jtcvs.2019.03.095] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
133 Iyer PG. Prediction of progression in Barrett's esophagus: does inflammation hold the key? Endoscopy 2021;53:782-3. [PMID: 34315177 DOI: 10.1055/a-1381-7899] [Reference Citation Analysis]
134 Kahn A, Priyan H, Dierkhising RA, Johnson ML, Lansing RM, Maixner KA, Wolfsen HC, Wallace MB, Ramirez FC, Fleischer DE, Leggett CL, Wang KK, Iyer PG. Outcomes of radiofrequency ablation by manual versus self-sizing circumferential balloon catheters for the treatment of dysplastic Barrett's esophagus: a multicenter comparative cohort study. Gastrointest Endosc 2021;93:880-887.e1. [PMID: 32739482 DOI: 10.1016/j.gie.2020.07.056] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
135 Yao H, Wang L, Li H, Xu S, Bai Z, Wu Y, Chen H, Goyal H, Qi X. Proton pump inhibitors may reduce the risk of high-grade dysplasia and/or esophageal adenocarcinoma in Barrett's esophagus: a systematic review and meta-analysis. Expert Rev Clin Pharmacol 2021;:1-10. [PMID: 34806503 DOI: 10.1080/17512433.2022.2008909] [Reference Citation Analysis]
136 Graham D, Sever N, Magee C, Waddingham W, Banks M, Sweis R, Al-Yousuf H, Mitchison M, Alzoubaidi D, Rodriguez-Justo M, Lovat L, Novelli M, Jansen M, Haidry R. Risk of lymph node metastases in patients with T1b oesophageal adenocarcinoma: A retrospective single centre experience. World J Gastroenterol 2018; 24(41): 4698-4707 [PMID: 30416317 DOI: 10.3748/wjg.v24.i41.4698] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
137 Nachiappan A, Ragunath K, Card T, Kaye P. Diagnosing dysplasia in Barrett's oesophagus still requires Seattle protocol biopsy in the era of modern video endoscopy: results from a tertiary centre Barrett's dysplasia database. Scand J Gastroenterol 2020;55:9-13. [PMID: 31880176 DOI: 10.1080/00365521.2019.1706762] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
138 Yadlapati R, Masihi M, Gyawali CP, Carlson DA, Kahrilas PJ, Nix BD, Jain A, Triggs JR, Vaezi MF, Kia L, Kaizer A, Pandolfino JE. Ambulatory Reflux Monitoring Guides Proton Pump Inhibitor Discontinuation in Patients With Gastroesophageal Reflux Symptoms: A Clinical Trial. Gastroenterology 2021;160:174-182.e1. [PMID: 32949568 DOI: 10.1053/j.gastro.2020.09.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
139 Codipilly DC, Iyer PG. What's next for wide-area transepithelial sampling in Barrett's esophagus management? Gastrointest Endosc 2021:S0016-5107(21)01832-0. [PMID: 34916062 DOI: 10.1016/j.gie.2021.11.013] [Reference Citation Analysis]
140 Pollit V, Graham D, Leonard C, Filby A, McMaster J, Mealing SJ, Lovat LB, Haidry RJ. A cost-effectiveness analysis of endoscopic eradication therapy for management of dysplasia arising in patients with Barrett's oesophagus in the United Kingdom. Curr Med Res Opin 2019;35:805-15. [PMID: 30479169 DOI: 10.1080/03007995.2018.1552407] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
141 Katzka DA, Fitzgerald RC. Time to Challenge Current Strategies for Detection of Barrett's Esophagus and Esophageal Adenocarcinoma. Dig Dis Sci 2020;65:18-21. [PMID: 31754994 DOI: 10.1007/s10620-019-05965-0] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
142 Montgomery EA, Canto MI, Srivastava A. American Registry of Pathology Expert Opinions: Evaluation and reporting of biopsies from the columnar-lined esophagus and gastro-esophageal junction (GEJ). Annals of Diagnostic Pathology 2019;39:111-7. [DOI: 10.1016/j.anndiagpath.2019.02.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
143 Alves JR, Graffunder FP, Rech JVT, Ternes CMP, Koerich-Silva I. DIAGNOSIS, TREATMENT AND FOLLOW-UP OF BARRETT'S ESOPHAGUS: A SYSTEMATIC REVIEW. Arq Gastroenterol 2020;57:289-95. [PMID: 33027480 DOI: 10.1590/S0004-2803.202000000-53] [Reference Citation Analysis]
144 Kumar P, Gordon IO, Thota PN. Post-ablation buried neoplasia in Barrett's esophagus. Scand J Gastroenterol 2021;56:624-8. [PMID: 33764825 DOI: 10.1080/00365521.2021.1896774] [Reference Citation Analysis]
145 Salomao MA, Lam-Himlin D, Pai RK. Substantial Interobserver Agreement in the Diagnosis of Dysplasia in Barrett Esophagus Upon Review of a Patient's Entire Set of Biopsies. Am J Surg Pathol 2018;42:376-81. [PMID: 29135518 DOI: 10.1097/PAS.0000000000000988] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
146 Chwiesko A, Kowal-Bielecka O, Sierakowski S. Perspectives on the interlinked nature of systemic sclerosis and reflux disease. Expert Rev Gastroenterol Hepatol. 2019;13:213-227. [PMID: 30791766 DOI: 10.1080/17474124.2019.1561274] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
147 Braillon A. Screening and Surveillance for Barrett's Esophagus: When Will We Reach the Horizon? Am J Gastroenterol 2016;111:899-900. [PMID: 27249988 DOI: 10.1038/ajg.2016.80] [Reference Citation Analysis]
148 Tsoi EH, Cameron G, Williams R, Desmond P, Taylor A. Factors that predict a poor response to radiofrequency ablation for Barrett's oesophagus with dysplasia. ANZ J Surg 2020;90:272-6. [PMID: 31970858 DOI: 10.1111/ans.15687] [Reference Citation Analysis]
149 van de Ven SEM, Spaander MCW, Pouw RE, Tang TJ, Houben MHMG, Schoon EJ, de Jonge PJF, Bruno MJ, Koch AD. Favorable effect of endoscopic reassessment of clinically staged T2 esophageal adenocarcinoma: a multicenter prospective cohort study. Endoscopy 2021. [PMID: 33530109 DOI: 10.1055/a-1380-8899] [Reference Citation Analysis]
150 Enslin S, Kaul V. Barrett's Esophagus Management in the Elderly: Principles and Best Practice. Curr Gastroenterol Rep 2020;22:37. [PMID: 32542508 DOI: 10.1007/s11894-020-00774-2] [Reference Citation Analysis]
151 Krishnamoorthi R, Lewis JT, Krishna M, Crews NJ, Johnson ML, Dierkhising RA, Ginos BF, Wang KK, Wolfsen HC, Fleischer DE, Ramirez FC, Buttar NS, Katzka DA, Iyer PG. Predictors of Progression in Barrett’s Esophagus with Low-Grade Dysplasia: Results from a Multicenter Prospective BE Registry. American Journal of Gastroenterology 2017;112:867-73. [DOI: 10.1038/ajg.2017.84] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
152 Trindade AJ, Leggett CL, Chang KJ. Volumetric laser endomicroscopy in the management of Barrett's esophagus. Curr Opin Gastroenterol. 2017;33:254-260. [PMID: 28402993 DOI: 10.1097/mog.0000000000000366] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
153 Muñoz-Largacha JA, Fernando HC, Litle VR. Optimizing the diagnosis and therapy of Barrett's esophagus. J Thorac Dis 2017;9:S146-53. [PMID: 28446978 DOI: 10.21037/jtd.2017.01.58] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
154 Nogales O, Caballero-marcos A, Clemente-sánchez A, García-lledó J, Pérez-carazo L, Merino B, Carbonell C, López-ibáñez M, González-asanza C. Usefulness of Non-magnifying Narrow Band Imaging in EVIS EXERA III Video Systems and High-Definition Endoscopes to Diagnose Dysplasia in Barrett’s Esophagus Using the Barrett International NBI Group (BING) Classification. Dig Dis Sci 2017;62:2840-6. [DOI: 10.1007/s10620-017-4581-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
155 Spechler SJ. Screening for Barrett's oesophagus: are we looking for the right thing? Gut 2020:gutjnl-2020-323378. [PMID: 33239343 DOI: 10.1136/gutjnl-2020-323378] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
156 Srinivasan S, Sharma P. Real-world data for endoscopic therapy in LGD: not looking so good. Gut 2021:gutjnl-2021-324544. [PMID: 34330785 DOI: 10.1136/gutjnl-2021-324544] [Reference Citation Analysis]
157 Wani S, Rubenstein JH, Vieth M, Bergman J. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association. Gastroenterology 2016;151:822-35. [PMID: 27702561 DOI: 10.1053/j.gastro.2016.09.040] [Cited by in Crossref: 77] [Cited by in F6Publishing: 65] [Article Influence: 12.8] [Reference Citation Analysis]
158 Mashimo H, Gordon SR, Singh SK. Advanced endoscopic imaging for detecting and guiding therapy of early neoplasias of the esophagus. Ann N Y Acad Sci 2020;1482:61-76. [PMID: 33184872 DOI: 10.1111/nyas.14523] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
159 Sanghi V, Thota PN. Barrett's esophagus: novel strategies for screening and surveillance. Ther Adv Chronic Dis 2019;10:2040622319837851. [PMID: 30937155 DOI: 10.1177/2040622319837851] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
160 Frei NF, Konté K, Duits LC, Klaver E, Ten Kate FJ, Offerhaus GJ, Meijer SL, Visser M, Seldenrijk CA, Schoon EJ, Weusten BLAM, Schenk BE, Mallant-Hent RC, Bergman JJ, Pouw RE. The SpaTemp cohort: 168 nondysplastic Barrett's esophagus surveillance patients with and without progression to early neoplasia to evaluate the distribution of biomarkers over space and time. Dis Esophagus 2021;34:doaa095. [PMID: 32944737 DOI: 10.1093/dote/doaa095] [Reference Citation Analysis]
161 Wallner B, Björ O, Andreasson A, Vieth M, Schmidt PT, Hellström PM, Forsberg A, Talley NJ, Agreus L. Z-line alterations and gastroesophageal reflux: an endoscopic population-based prospective cohort study. Scand J Gastroenterol 2019;54:1065-9. [PMID: 31453726 DOI: 10.1080/00365521.2019.1656775] [Reference Citation Analysis]
162 Choi WT, Tsai JH, Rabinovitch PS, Small T, Huang D, Mattis AN, Kakar S. Diagnosis and risk stratification of Barrett's dysplasia by flow cytometric DNA analysis of paraffin-embedded tissue. Gut 2018;67:1229-38. [PMID: 28642331 DOI: 10.1136/gutjnl-2017-313815] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
163 Krishnamoorthi R, Ramos GP, Crews N, Johnson M, Dierkhising R, Shi Q, Ginos B, Wang K, Katzka D, Buttar N, Iyer PG. Persistence of Nondysplastic Barrett's Esophagus Is Not Protective Against Progression to Adenocarcinoma. Clin Gastroenterol Hepatol 2017;15:950-2. [PMID: 28238955 DOI: 10.1016/j.cgh.2017.02.019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
164 Ichihara S, Uedo N, Gotoda T. Considering the esophagogastric junction as a ‘zone’. Digestive Endoscopy 2017;29:3-10. [DOI: 10.1111/den.12792] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
165 Anilkumar M, Alkhayyat M, Grewal US, Sanaka MR, Thota PN. Higher risk of neoplastic progression of Barrett's esophagus in patients with systemic sclerosis. Gastroenterol Rep (Oxf) 2021;9:595-6. [PMID: 34925857 DOI: 10.1093/gastro/goaa096] [Reference Citation Analysis]
166 Medina AL, Troendle DM, Park JY, Thaker A, Dunbar KB, Cheng E. Eosinophilic esophagitis, Barrett's esophagus and esophageal neoplasms in the pediatric patient: a narrative review. Transl Gastroenterol Hepatol 2021;6:32. [PMID: 34423153 DOI: 10.21037/tgh-20-223] [Reference Citation Analysis]
167 Pouw RE, Klaver E, Phoa KN, van Vilsteren FG, Weusten BL, Bisschops R, Schoon EJ, Pech O, Manner H, Ragunath K, Fernández-Sordo JO, Fullarton G, Di Pietro M, Januszewicz W, O'Toole D, Bergman JJ. Radiofrequency ablation for low-grade dysplasia in Barrett's esophagus: long-term outcome of a randomized trial. Gastrointest Endosc 2020;92:569-74. [PMID: 32217112 DOI: 10.1016/j.gie.2020.03.3756] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
168 Reddy CA, Tavakkoli A, Chen VL, Korsnes S, Bedi AO, Carrott PW, Chang AC, Lagisetty KH, Kwon RS, Elmunzer BJ, Orringer MB, Piraka C, Prabhu A, Reddy RM, Wamsteker E, Rubenstein JH. Long-Term Quality of Life Following Endoscopic Therapy Compared to Esophagectomy for Neoplastic Barrett's Esophagus. Dig Dis Sci 2021;66:1580-7. [PMID: 32519141 DOI: 10.1007/s10620-020-06377-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
169 Suzuki L, Ten Kate FJC, Gotink AW, Stoop H, Doukas M, Nieboer D, Spaander MCW, van Lanschot JJB, van Wijnhoven BPL, Koch AD, Bruno MJ, Looijenga LHJ, Biermann K. Olfactomedin 4 (OLFM4) expression is associated with nodal metastases in esophageal adenocarcinoma. PLoS One 2019;14:e0219494. [PMID: 31283789 DOI: 10.1371/journal.pone.0219494] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
170 Wani S, Han S, Kushnir V, Early D, Mullady D, Hammad H, Brauer B, Thaker A, Simon V, Ezekwe E, Hollander T, Wood M, Rastogi A, Edmundowicz S, Muthusamy VR, Komanduri S. Recurrence Is Rare Following Complete Eradication of Intestinal Metaplasia in Patients With Barrett's Esophagus and Peaks at 18 Months. Clin Gastroenterol Hepatol 2020;18:2609-2617.e2. [PMID: 31982610 DOI: 10.1016/j.cgh.2020.01.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
171 Harrison M, Allen JE, Gorrepati VS, López-jamar JME, Sharma P. Management of Barrett's esophagus with low-grade dysplasia. Diseases of the Esophagus 2018;31. [DOI: 10.1093/dote/doy004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
172 Inadomi JM, Saxena N. Screening and Surveillance for Barrett’s Esophagus: Is It Cost-Effective? Dig Dis Sci 2018;63:2094-104. [DOI: 10.1007/s10620-018-5148-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
173 Iwaya Y, Shimamura Y, Goda K, Rodríguez de Santiago E, Coneys JG, Mosko JD, Kandel G, Kortan P, May G, Marcon N, Teshima C. Clinical characteristics of young patients with early Barrett’s neoplasia. World J Gastroenterol 2019; 25(24): 3069-3078 [PMID: 31293342 DOI: 10.3748/wjg.v25.i24.3069] [Cited by in CrossRef: 1] [Article Influence: 0.3] [Reference Citation Analysis]
174 Shah Gilani SN, Bass GA, Kharytaniuk N, Downes MR, Caffrey EF, Tobbia I, Walsh TN. Gastroesophageal Mucosal Injury after Cholecystectomy: An Indication for Surveillance? J Am Coll Surg 2017;224:319-26. [PMID: 27993699 DOI: 10.1016/j.jamcollsurg.2016.12.003] [Reference Citation Analysis]
175 Qumseya BJ, Bukannan A, Gendy S, Ahemd Y, Sultan S, Bain P, Gross SA, Iyer P, Wani S. Systematic review and meta-analysis of prevalence and risk factors for Barrett's esophagus.Gastrointest Endosc. 2019;90:707-717.e1. [PMID: 31152737 DOI: 10.1016/j.gie.2019.05.030] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
176 Li N, Jin SZ. Artificial intelligence and early esophageal cancer. Artif Intell Gastrointest Endosc 2021; 2(5): 198-210 [DOI: 10.37126/aige.v2.i5.198] [Reference Citation Analysis]
177 Fitzgerald RC, Corley DA. Will a Proton Pump Inhibitor and an Aspirin Keep the Doctor Away for Patients With Barrett's Esophagus? Gastroenterology 2019;156:1228-31. [PMID: 30849313 DOI: 10.1053/j.gastro.2019.03.001] [Reference Citation Analysis]
178 Xie Y, Shi L, He X, Luo Y. Gastrointestinal cancers in China, the USA, and Europe. Gastroenterol Rep (Oxf) 2021;9:91-104. [PMID: 34026216 DOI: 10.1093/gastro/goab010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
179 Bowman CJ, Zhang R, Balitzer D, Wang D, Rabinovitch PS, Kővári BP, Mattis AN, Kakar S, Lauwers GY, Choi WT. Persistent or recurrent Barrett's neoplasia after an endoscopic therapy session is associated with DNA content abnormality and can be detected by DNA flow cytometric analysis of paraffin-embedded tissue. Mod Pathol 2021. [PMID: 34108638 DOI: 10.1038/s41379-021-00832-8] [Reference Citation Analysis]
180 Stephanie M, Nour H, de Sá Inês M, Shanker K, Kevin K, Mario DR, Prateek S. Gender differences in Barrett's esophagus and progression of disease: a systematic review and meta-analysis. Dis Esophagus 2021:doab075. [PMID: 34761256 DOI: 10.1093/dote/doab075] [Reference Citation Analysis]
181 Krishnamoorthi R, Singh S, Ragunathan K, Visrodia K, Wang KK, Katzka DA, Iyer PG. Factors Associated With Progression of Barrett’s Esophagus: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology 2018;16:1046-1055.e8. [DOI: 10.1016/j.cgh.2017.11.044] [Cited by in Crossref: 39] [Cited by in F6Publishing: 28] [Article Influence: 9.8] [Reference Citation Analysis]
182 Xiao YL, Zhou LY, Hou XH, Li YQ, Zou DW, Chen MH; Chinese Society of Gastroenterology. Chinese expert consensus on gastroesophageal reflux disease in 2020. J Dig Dis 2021;22:376-89. [PMID: 34105263 DOI: 10.1111/1751-2980.13028] [Reference Citation Analysis]
183 Hamade N, Sharma P. Ablation Therapy for Barrett's Esophagus: New Rules for Changing Times. Curr Gastroenterol Rep 2017;19:48. [PMID: 28819902 DOI: 10.1007/s11894-017-0589-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
184 Cattelan L, Ghazawi FM, Le M, Lagacé F, Savin E, Zubarev A, Gantchev J, Tomaszewski M, Sasseville D, Waschke K, Litvinov IV. Epidemiologic trends and geographic distribution of esophageal cancer in Canada: A national population-based study. Cancer Med 2020;9:401-17. [PMID: 31715645 DOI: 10.1002/cam4.2700] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
185 Sullivan R, Mulki R, Peter S. The role of ablation in the treatment of dysplastic Barrett's esophagus. Ther Adv Gastrointest Endosc 2021;14:26317745211049967. [PMID: 34708203 DOI: 10.1177/26317745211049967] [Reference Citation Analysis]
186 Cummings D, Wong J, Palm R, Hoffe S, Almhanna K, Vignesh S. Epidemiology, Diagnosis, Staging and Multimodal Therapy of Esophageal and Gastric Tumors. Cancers (Basel) 2021;13:582. [PMID: 33540736 DOI: 10.3390/cancers13030582] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
187 Iyer PG. Endoscopic submucosal dissection in endotherapy for Barrett's esophagus-related dysplasia and neoplasia: An essential or optional technique? Gastrointest Endosc 2017;86:623-5. [PMID: 28917342 DOI: 10.1016/j.gie.2017.03.006] [Reference Citation Analysis]
188 Brimhall B, Wani S. Current Endoscopic Approaches for the Treatment of Barrett Esophagus. Journal of Clinical Gastroenterology 2017;51:2-11. [DOI: 10.1097/mcg.0000000000000742] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
189 Goonawardena J, Ward S. Effect of Roux-en-Y gastric bypass on Barrett’s esophagus: a systematic review. Surgery for Obesity and Related Diseases 2021;17:221-30. [DOI: 10.1016/j.soard.2020.09.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
190 van der Wel MJ, Duits LC, Klaver E, Pouw RE, Seldenrijk CA, Offerhaus G, Visser M, Ten Kate F, Tijssen JG, Bergman J, Meijer SL. Development of benchmark quality criteria for assessing whole-endoscopy Barrett's esophagus biopsy cases. United European Gastroenterol J 2018;6:830-7. [PMID: 30023060 DOI: 10.1177/2050640618764710] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
191 Iyer PG, Taylor WR, Johnson ML, Lansing RL, Maixner KA, Hemminger LL, Cayer FK, Yab TC, Devens ME, Slettedahl SW, Broderick BT, Mahoney DW, McGlinch MC, Berger CK, Foote PH, Giakomopoulos M, Allawi H, Smyrk TC, Wang KK, Katzka DA, Wolfsen HC, Burke JA, Ahlquist DA, Kisiel JB. Accurate Nonendoscopic Detection of Barrett's Esophagus by Methylated DNA Markers: A Multisite Case Control Study. Am J Gastroenterol 2020;115:1201-9. [PMID: 32558685 DOI: 10.14309/ajg.0000000000000656] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
192 Curtius K, Dewanji A, Hazelton WD, Rubenstein JH, Luebeck GE. Optimal Timing for Cancer Screening and Adaptive Surveillance Using Mathematical Modeling. Cancer Res 2021;81:1123-34. [PMID: 33293425 DOI: 10.1158/0008-5472.CAN-20-0335] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
193 Tabatabaiefar MA, Moridnia A. Gastrointestinal Cancers. In: Mehdipour P, editor. Cancer Genetics and Psychotherapy. Cham: Springer International Publishing; 2017. pp. 589-625. [DOI: 10.1007/978-3-319-64550-6_12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
194 Dong J, Levine DM, Buas MF, Zhang R, Onstad L, Fitzgerald RC, Corley DA, Shaheen NJ, Lagergren J, Hardie LJ, Reid BJ, Iyer PG, Risch HA, Caldas C, Caldas I, Pharoah PD, Liu G, Gammon MD, Chow WH, Bernstein L, Bird NC, Ye W, Wu AH, Anderson LA, MacGregor S, Whiteman DC, Vaughan TL, Thrift AP; Stomach and Oesophageal Cancer Study (SOCS) Consortium. Interactions Between Genetic Variants and Environmental Factors Affect Risk of Esophageal Adenocarcinoma and Barrett's Esophagus. Clin Gastroenterol Hepatol 2018;16:1598-1606.e4. [PMID: 29551738 DOI: 10.1016/j.cgh.2018.03.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
195 Duits LC, van der Wel MJ, Cotton CC, Phoa KN, ten Kate FJ, Seldenrijk CA, Offerhaus GJA, Visser M, Meijer SL, Mallant-hent RC, Krishnadath KK, Pouw RE, Tijssen JG, Shaheen NJ, Bergman JJ. Patients With Barrett’s Esophagus and Confirmed Persistent Low-Grade Dysplasia Are at Increased Risk for Progression to Neoplasia. Gastroenterology 2017;152:993-1001.e1. [DOI: 10.1053/j.gastro.2016.12.008] [Cited by in Crossref: 59] [Cited by in F6Publishing: 47] [Article Influence: 11.8] [Reference Citation Analysis]
196 Wu H, Minamide T, Yano T. Role of photodynamic therapy in the treatment of esophageal cancer. Dig Endosc 2019;31:508-16. [PMID: 30667112 DOI: 10.1111/den.13353] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 9.7] [Reference Citation Analysis]
197 Richter JE. Editorial: maybe our 'Barrett's recommendation speech' should change? Aliment Pharmacol Ther 2017;45:1266-7. [PMID: 28370045 DOI: 10.1111/apt.14001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
198 Bonavina L, Fisichella PM, Gavini S, Lee YY, Tatum RP. Clinical course of gastroesophageal reflux disease and impact of treatment in symptomatic young patients. Ann N Y Acad Sci 2020;1481:117-26. [PMID: 32266986 DOI: 10.1111/nyas.14350] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
199 Iriarte F, Su S, Petrov RV, Bakhos CT, Abbas AE. Surgical Management of Early Esophageal Cancer. Surg Clin North Am 2021;101:427-41. [PMID: 34048763 DOI: 10.1016/j.suc.2021.03.005] [Reference Citation Analysis]
200 Hashimoto R, Requa J, Dao T, Ninh A, Tran E, Mai D, Lugo M, El-Hage Chehade N, Chang KJ, Karnes WE, Samarasena JB. Artificial intelligence using convolutional neural networks for real-time detection of early esophageal neoplasia in Barrett's esophagus (with video). Gastrointest Endosc. 2020;91:1264-1271.e1. [PMID: 31930967 DOI: 10.1016/j.gie.2019.12.049] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 23.0] [Reference Citation Analysis]
201 Iyer PG, Kaul V. Barrett Esophagus. Mayo Clinic Proceedings 2019;94:1888-901. [DOI: 10.1016/j.mayocp.2019.01.032] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
202 Elkassem S. Gastroesophageal Reflux Disease, Esophagitis, and Barrett's Esophagus 3 to 4 Years Post Sleeve Gastrectomy. Obes Surg 2021;31:5148-55. [PMID: 34599728 DOI: 10.1007/s11695-021-05688-0] [Reference Citation Analysis]
203 da Veiga T, Chandler JH, Lloyd P, Pittiglio G, Wilkinson NJ, Hoshiar AK, Harris RA, Valdastri P. Challenges of continuum robots in clinical context: a review. Prog Biomed Eng 2020;2:032003. [DOI: 10.1088/2516-1091/ab9f41] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
204 Omae M, Hagström H, Ndegwa N, Vieth M, Wang N, Vujasinovic M, Baldaque-Silva F. Wide-field endoscopic submucosal dissection for the treatment of Barrett's esophagus neoplasia. Endosc Int Open 2021;9:E727-34. [PMID: 33937514 DOI: 10.1055/a-1386-3668] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
205 Phillips R, Januszewicz W, Pilonis ND, O'Donovan M, Sawas T, Katzka DA, Fitzgerald RC, di Pietro M. The risk of neoplasia in patients with Barrett's esophagus indefinite for dysplasia: a multicenter cohort study. Gastrointest Endosc 2021;94:263-270.e2. [PMID: 33548281 DOI: 10.1016/j.gie.2021.01.042] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
206 Struyvenberg MR, de Groof AJ, Kahn A, Weusten BLAM, Fleischer DE, Ganguly EK, Konda VJA, Lightdale CJ, Pleskow DK, Sethi A, Smith MS, Trindade AJ, Wallace MB, Wolfsen HC, Tearney GJ, Meijer SL, Leggett CL, Bergman JJGHM, Curvers WL. Multicenter study on the diagnostic performance of multiframe volumetric laser endomicroscopy targets for Barrett's esophagus neoplasia with histopathology correlation. Dis Esophagus 2020;33:doaa062. [PMID: 32607539 DOI: 10.1093/dote/doaa062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
207 Klavan H, Russell MB, Macklin J, Lee E, Aslanian HR, Muniraj T. Barrett's esophagus: A comprehensive review for the internist. Dis Mon 2018;64:471-87. [PMID: 29880269 DOI: 10.1016/j.disamonth.2018.04.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
208 Colvin SD, Zarzour JG, Morgan DE, Callaway JP, Corey BL, Grams J, Galgano SJ. Same day barium esophagography and high-resolution manometry during the COVID-19 pandemic. Abdom Radiol (NY) 2021. [PMID: 34687322 DOI: 10.1007/s00261-021-03322-2] [Reference Citation Analysis]
209 Dhaliwal L, Codipilly DC, Gandhi P, Johnson ML, Lansing R, Wang KK, Leggett CL, Katzka DA, Iyer PG. Neoplasia Detection Rate in Barrett's Esophagus and Its Impact on Missed Dysplasia: Results from a Large Population-Based Database. Clin Gastroenterol Hepatol 2021;19:922-929.e1. [PMID: 32707339 DOI: 10.1016/j.cgh.2020.07.034] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
210 Kunze B, Wein F, Fang HY, Anand A, Baumeister T, Strangmann J, Gerland S, Ingermann J, Münch NS, Wiethaler M, Sahm V, Hidalgo-Sastre A, Lange S, Lightdale CJ, Bokhari A, Falk GW, Friedman RA, Ginsberg GG, Iyer PG, Jin Z, Nakagawa H, Shawber CJ, Nguyen T, Raab WJ, Dalerba P, Rustgi AK, Sepulveda AR, Wang KK, Schmid RM, Wang TC, Abrams JA, Quante M. Notch Signaling Mediates Differentiation in Barrett's Esophagus and Promotes Progression to Adenocarcinoma. Gastroenterology 2020;159:575-90. [PMID: 32325086 DOI: 10.1053/j.gastro.2020.04.033] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
211 Li S, Chung DC, Mullen JT. Screening high-risk populations for esophageal and gastric cancer. J Surg Oncol. 2019;120:831-846. [PMID: 31373005 DOI: 10.1002/jso.25656] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
212 Nguyen TH, Thrift AP, George R, Rosen DG, El-Serag HB, Ketwaroo GA. Prevalence and Predictors of Missed Dysplasia on Index Barrett's Esophagus Diagnosing Endoscopy in a Veteran Population. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00396-7. [PMID: 33839273 DOI: 10.1016/j.cgh.2021.04.008] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
213 Chen CC, Hsu YC, Lee CT, Hsu CC, Tai CM, Wang WL, Tseng CH, Hsu CT, Lin JT, Chang CY. Central Obesity and H. pylori Infection Influence Risk of Barrett's Esophagus in an Asian Population. PLoS One 2016;11:e0167815. [PMID: 27936223 DOI: 10.1371/journal.pone.0167815] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
214 Karamchandani DM, Gonzalez RS, Westerhoff M, Westbrook LM, Panarelli NC, Al-Nuaimi M, King T, Arnold CA. Measuring depth of invasion of submucosa - invasive adenocarcinoma in oesophageal endoscopic specimens: how good are we?☆. Histopathology 2021. [PMID: 34519098 DOI: 10.1111/his.14566] [Reference Citation Analysis]
215 Schlottmann F, Patti MG. Current Concepts in Treatment of Barrett's Esophagus With and Without Dysplasia. J Gastrointest Surg 2017;21:1354-60. [PMID: 28353175 DOI: 10.1007/s11605-017-3371-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
216 Vaughan TL, Onstad L, Dai JY. Interactive decision support for esophageal adenocarcinoma screening and surveillance. BMC Gastroenterol 2019;19:109. [PMID: 31248371 DOI: 10.1186/s12876-019-1022-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
217 Jiang K, Lauwers GY. The dawn of a new era: performance measurement for the pathologic diagnosis of Barrett's esophagus-associated dysplasia. Gastrointest Endosc 2018;88:816-7. [PMID: 30309491 DOI: 10.1016/j.gie.2018.09.013] [Reference Citation Analysis]
218 Lee SW, Lien HC, Chang CS, Ko CW, Tung CF, Yeh HZ. Health-related quality of life of subjects with Barrett's esophagus in a Chinese population. PLoS One 2017;12:e0190201. [PMID: 29267355 DOI: 10.1371/journal.pone.0190201] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
219 Chang K, Jackson CS, Vega KJ. Barrett's Esophagus: Diagnosis, Management, and Key Updates. Gastroenterol Clin North Am 2021;50:751-68. [PMID: 34717869 DOI: 10.1016/j.gtc.2021.08.009] [Reference Citation Analysis]
220 Saracco M, Savarino V, Bodini G, Saracco GM, Pellicano R. Gastroesophageal reflux disease: key messages for clinicians. Minerva Gastroenterol (Torino) 2021;67:390-403. [PMID: 33103406 DOI: 10.23736/S1121-421X.20.02783-X] [Reference Citation Analysis]
221 Waterhouse DJ, Fitzpatrick CRM, di Pietro M, Bohndiek SE. Emerging optical methods for endoscopic surveillance of Barrett's oesophagus. The Lancet Gastroenterology & Hepatology 2018;3:349-62. [DOI: 10.1016/s2468-1253(18)30030-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
222 Otaki F, Iyer PG. Gastroesophageal Reflux Disease and Barrett Esophagus in the Elderly. Clin Geriatr Med 2021;37:17-29. [PMID: 33213770 DOI: 10.1016/j.cger.2020.08.003] [Reference Citation Analysis]
223 Dam AN, Klapman J. A narrative review of Barrett's esophagus in 2020, molecular and clinical update.Ann Transl Med. 2020;8:1107. [PMID: 33145326 DOI: 10.21037/atm-20-4406] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
224 Genere JR, Visrodia K, Zakko L, Hoefnagel SJM, Wang KK. Spray cryotherapy versus continued radiofrequency ablation in persistent Barrett’s esophagus. Diseases of the Esophagus 2022. [DOI: 10.1093/dote/doab084] [Reference Citation Analysis]
225 Paterson AL, Gehrung M, Fitzgerald RC, O'Donovan M. Role of TFF3 as an adjunct in the diagnosis of Barrett's esophagus using a minimally invasive esophageal sampling device-The CytospongeTM. Diagn Cytopathol 2020;48:253-64. [PMID: 31814330 DOI: 10.1002/dc.24354] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
226 Killcoyne S, Gregson E, Wedge DC, Woodcock DJ, Eldridge MD, de la Rue R, Miremadi A, Abbas S, Blasko A, Kosmidou C, Januszewicz W, Jenkins AV, Gerstung M, Fitzgerald RC. Genomic copy number predicts esophageal cancer years before transformation. Nat Med 2020;26:1726-32. [PMID: 32895572 DOI: 10.1038/s41591-020-1033-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 12.0] [Reference Citation Analysis]
227 Nguyen T, Thrift AP, Yu X, Duan Z, El-Serag HB. The Annual Risk of Esophageal Adenocarcinoma Does Not Decrease Over Time in Patients With Barrett's Esophagus. Am J Gastroenterol 2017;112:1049-55. [PMID: 28244499 DOI: 10.1038/ajg.2017.18] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
228 Bolckmans R, Roriz-silva R, Mazzini GS, Altieri MS, Docimo S, Campos GM. Long-Term Implications of GERD After Sleeve Gastrectomy. Curr Surg Rep 2021;9. [DOI: 10.1007/s40137-021-00284-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
229 Otaki F, Iyer PG. Point-Counterpoint: Screening and Surveillance for Barrett's Esophagus, Is It Worthwhile? Dig Dis Sci 2018;63:2081-93. [PMID: 29713986 DOI: 10.1007/s10620-018-5065-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
230 Kwon MJ, Kang HS, Kim HT, Choo JW, Lee BH, Hong SE, Park KH, Jung DM, Lim H, Soh JS, Moon SH, Kim JH, Park HR, Min SK, Seo JW, Choe JY. Treatment for gastric ‘indefinite for neoplasm/dysplasia’ lesions based on predictive factors. World J Gastroenterol 2019; 25(4): 469-484 [PMID: 30700943 DOI: 10.3748/wjg.v25.i4.469] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
231 Kunzmann AT, Thrift AP, Johnston BT, Mcmanus DT, Gavin AT, Turkington RC, Coleman HG. External validation of a model to determine risk of progression of Barrett’s oesophagus to neoplasia. Aliment Pharmacol Ther 2019;49:1274-81. [DOI: 10.1111/apt.15235] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
232 Alshelleh M, Inamdar S, McKinley M, Stewart M, Novak JS, Greenberg RE, Sultan K, Devito B, Cheung M, Cerulli MA, Miller LS, Sejpal DV, Vegesna AK, Trindade AJ. Incremental yield of dysplasia detection in Barrett's esophagus using volumetric laser endomicroscopy with and without laser marking compared with a standardized random biopsy protocol. Gastrointest Endosc. 2018;88:35-42. [PMID: 29410080 DOI: 10.1016/j.gie.2018.01.032] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
233 Struyvenberg MR, de Groof AJ, van der Putten J, van der Sommen F, Baldaque-Silva F, Omae M, Pouw R, Bisschops R, Vieth M, Schoon EJ, Curvers WL, de With PH, Bergman JJ. A computer-assisted algorithm for narrow-band imaging-based tissue characterization in Barrett's esophagus. Gastrointest Endosc. 2021;93:89-98. [PMID: 32504696 DOI: 10.1016/j.gie.2020.05.050] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
234 Sonnenberg A, Turner KO, Spechler SJ, Genta RM. The influence of Helicobacter pylori on the ethnic distribution of Barrett's metaplasia. Aliment Pharmacol Ther 2017;45:283-90. [PMID: 27862104 DOI: 10.1111/apt.13854] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
235 Kew GS, Soh AYS, Lee YY, Gotoda T, Li YQ, Zhang Y, Chan YH, Siah KTH, Tong D, Law SYK, Ruszkiewicz A, Tseng PH, Lee YC, Chang CY, Quach DT, Kusano C, Bhatia S, Wu JCY, Singh R, Sharma P, Ho KY. Multinational survey on the preferred approach to management of Barrett’s esophagus in the Asia-Pacific region. World J Gastrointest Oncol 2021; 13(4): 279-294 [PMID: 33889279 DOI: 10.4251/wjgo.v13.i4.279] [Reference Citation Analysis]
236 Loomans-Kropp HA, Richmond E. Undetected Barrett's esophagus: how do we improve early detection? Oncotarget 2021;12:2418-20. [PMID: 34853662 DOI: 10.18632/oncotarget.28005] [Reference Citation Analysis]
237 Shah T, Lippman R, Kohli D, Mutha P, Solomon S, Zfass A. Accuracy of probe-based confocal laser endomicroscopy (pCLE) compared to random biopsies during endoscopic surveillance of Barrett's esophagus. Endosc Int Open 2018;6:E414-20. [PMID: 29607393 DOI: 10.1055/s-0043-124868] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
238 Abdo J, Wichman CS, Dietz NE, Ciborowski P, Fleegel J, Mittal SK, Agrawal DK. Discovery of Novel and Clinically Relevant Markers in Formalin-Fixed Paraffin-Embedded Esophageal Cancer Specimen. Front Oncol 2018;8:157. [PMID: 29868478 DOI: 10.3389/fonc.2018.00157] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
239 Hamade N, Desai M, Thoguluva Chandrasekar V, Chalhoub J, Patel M, Duvvuri A, Gorrepati VS, Jegadeesan R, Choudhary A, Sathyamurthy A, Rai T, Gupta N, Sharma P. Efficacy of cryotherapy as first line therapy in patients with Barrett's neoplasia: a systematic review and pooled analysis. Dis Esophagus 2019;32:doz040. [PMID: 31076753 DOI: 10.1093/dote/doz040] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
240 Huang LM, Yang WJ, Huang ZY, Tang CW, Li J. Artificial intelligence technique in detection of early esophageal cancer. World J Gastroenterol 2020; 26(39): 5959-5969 [PMID: 33132647 DOI: 10.3748/wjg.v26.i39.5959] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
241 Martelli MG, Duckworth LV, Draganov PV. Endoscopic Submucosal Dissection Is Superior to Endoscopic Mucosal Resection for Histologic Evaluation of Barrett's Esophagus and Barrett's-Related Neoplasia. Am J Gastroenterol 2016;111:902-3. [PMID: 27249992 DOI: 10.1038/ajg.2016.124] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
242 Mohan BP, Krishnamoorthi R, Ponnada S, Shakhatreh M, Jayaraj M, Garg R, Law J, Larsen M, Irani S, Ross A, Adler DG. Liquid Nitrogen Spray Cryotherapy in Treatment of Barrett's Esophagus, where do we stand? A Systematic Review and Meta-Analysis. Dis Esophagus 2019;32:doy130. [PMID: 30715267 DOI: 10.1093/dote/doy130] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
243 Canto MI, Montgomery E. Wide-area transepithelial sampling with 3-dimensional cytology: Does it detect more dysplasia or yield more hype? Gastrointest Endosc 2018;87:356-9. [PMID: 29406925 DOI: 10.1016/j.gie.2017.11.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
244 Hamade N, Weng G, Desai M, Chandrasekar VT, Dasari C, Kennedy K, Sharma P. Significant decline in the prevalence of Barrett's esophagus among patients with gastroesophageal reflux disease. Dis Esophagus 2021;34:doaa131. [PMID: 33458760 DOI: 10.1093/dote/doaa131] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
245 Thota PN, Chak A. Is Mass Screening for Barrett's Esophagus a Myth or Reality? Clin Gastroenterol Hepatol 2019;17:610-2. [PMID: 30267863 DOI: 10.1016/j.cgh.2018.09.026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
246 Yang D, Zou F, Xiong S, Forde JJ, Wang Y, Draganov PV. Endoscopic submucosal dissection for early Barrett's neoplasia: a meta-analysis. Gastrointest Endosc. 2018;87:1383-1393. [PMID: 28993137 DOI: 10.1016/j.gie.2017.09.038] [Cited by in Crossref: 44] [Cited by in F6Publishing: 32] [Article Influence: 8.8] [Reference Citation Analysis]
247 Iyer PG, Taylor WR, Slettedahl SW, Lansing RL, Hemminger LL, Cayer FK, Mahoney DW, Giakoumopoulos M, Allawi HT, Wu TT, Wang KK, Wolfsen HC, Antpack E, Kisiel JB. Validation of a methylated DNA marker panel for the nonendoscopic detection of Barrett's esophagus in a multisite case-control study. Gastrointest Endosc 2021;94:498-505. [PMID: 33857451 DOI: 10.1016/j.gie.2021.03.937] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
248 Codipilly DC, Iyer PG. Novel Screening Tests for Barrett's Esophagus. Curr Gastroenterol Rep 2019;21:42. [PMID: 31346777 DOI: 10.1007/s11894-019-0710-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
249 Tan WK, Sharma AN, Chak A, Fitzgerald RC. Progress in Screening for Barrett's Esophagus: Beyond Standard Upper Endoscopy. Gastrointest Endosc Clin N Am 2021;31:43-58. [PMID: 33213799 DOI: 10.1016/j.giec.2020.08.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
250 Then EO, Lopez M, Saleem S, Gayam V, Sunkara T, Culliford A, Gaduputi V. Esophageal Cancer: An Updated Surveillance Epidemiology and End Results Database Analysis. World J Oncol 2020;11:55-64. [PMID: 32284773 DOI: 10.14740/wjon1254] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 17.5] [Reference Citation Analysis]
251 Eluri S, Shaheen NJ. Endoscopic Eradication Therapy in Barrett's Esophagus. Tech Gastrointest Endosc. 2017;19:137-142. [PMID: 29269998 DOI: 10.1016/j.tgie.2017.06.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
252 Mohy-ud-din N, Krill TS, Shah AR, Chatila AT, Singh S, Bilal M, Parupudi S. Barrett's esophagus: What do we need to know? Disease-a-Month 2020;66:100850. [DOI: 10.1016/j.disamonth.2019.02.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
253 di Pietro M, Canto MI, Fitzgerald RC. Endoscopic Management of Early Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus: Screening, Diagnosis, and Therapy. Gastroenterology. 2018;154:421-436. [PMID: 28778650 DOI: 10.1053/j.gastro.2017.07.041] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 12.8] [Reference Citation Analysis]
254 Tofani CJ, Gandhi K, Spataro J, Yoo J, Murphy M, Mohan N, Daitch Z, Shah A, Janowski R, Huntley C, Dabbish N, Keith S, Coben R, Cohen S, Kastenberg D, Infantolino A. Esophageal adenocarcinoma in a first-degree relative increases risk for esophageal adenocarcinoma in patients with Barrett's esophagus. United European Gastroenterol J 2019;7:225-9. [PMID: 31080607 DOI: 10.1177/2050640618817098] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
255 Kamboj AK, Kahn A, Wolfsen HC, Trindade AJ, Ganguly EK, Otaki F, Chan D, Zakko L, Visrodia K, Lutzke L, Wang KK, Leggett CL. Volumetric laser endomicroscopy interpretation and feature analysis in dysplastic Barrett's esophagus: Barrett's Esophagus Endomicroscopy. Journal of Gastroenterology and Hepatology 2018;33:1761-5. [DOI: 10.1111/jgh.14153] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
256 Sali R, Moradinasab N, Guleria S, Ehsan L, Fernandes P, Shah TU, Syed S, Brown DE. Deep Learning for Whole-Slide Tissue Histopathology Classification: A Comparative Study in the Identification of Dysplastic and Non-Dysplastic Barrett's Esophagus. J Pers Med. 2020;10. [PMID: 32977465 DOI: 10.3390/jpm10040141] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
257 Li J, Xu J, Zheng Y, Gao Y, He S, Li H, Zou K, Li N, Tian J, Chen W, He J. Esophageal cancer: Epidemiology, risk factors and screening. Chin J Cancer Res 2021;33:535-47. [PMID: 34815628 DOI: 10.21147/j.issn.1000-9604.2021.05.01] [Reference Citation Analysis]
258 Voltaggio L, Cimino-Mathews A, Bishop JA, Argani P, Cuda JD, Epstein JI, Hruban RH, Netto GJ, Stoler MH, Taube JM, Vang R, Westra WH, Montgomery EA. Current concepts in the diagnosis and pathobiology of intraepithelial neoplasia: A review by organ system. CA Cancer J Clin 2016;66:408-36. [PMID: 27270763 DOI: 10.3322/caac.21350] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
259 Shetler KP, Bikhtii S, Triadafilopoulos G. Ineffective esophageal motility: clinical, manometric, and outcome characteristics in patients with and without abnormal esophageal acid exposure. Diseases of the Esophagus 2017;30:1-8. [DOI: 10.1093/dote/dox012] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
260 Ben-Eltriki M, Green CJ, Maclure M, Musini V, Bassett KL, Wright JM. Do proton pump inhibitors increase mortality? A systematic review and in-depth analysis of the evidence. Pharmacol Res Perspect 2020;8:e00651. [PMID: 32996701 DOI: 10.1002/prp2.651] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
261 Wen H, Liu T, Liu H, Teng JH, Li SB. An improved surgical procedure to establish a gastroesophageal reflux model with a high incidence of Barrett's esophagus in rats. Exp Ther Med 2018;16:3863-8. [PMID: 30344662 DOI: 10.3892/etm.2018.6712] [Reference Citation Analysis]
262 Agarwal S, Alshelleh M, Scott J, Dhaliwal L, Codipilly DC, Dierkhising R, Leggett CL, Wang KK, Otaki FA, Trindade AJ, Iyer PG. Comparative outcomes of radiofrequency ablation and cryoballoon ablation in dysplastic Barrett's esophagus: a propensity score-matched cohort study. Gastrointest Endosc 2021:S0016-5107(21)01694-1. [PMID: 34624303 DOI: 10.1016/j.gie.2021.09.037] [Reference Citation Analysis]
263 Thrumurthy SG, Chaudry MA, Thrumurthy SSD, Mughal M. Oesophageal cancer: risks, prevention, and diagnosis. BMJ. 2019;366:l4373. [PMID: 31289038 DOI: 10.1136/bmj.l4373] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
264 Goldstone RN, Hasan SR, Drury S, Darragh TM, van Zante A, Goldstone SE. A trial of radiofrequency ablation for anal intraepithelial neoplasia. Int J Colorectal Dis 2017;32:357-65. [DOI: 10.1007/s00384-016-2679-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
265 Turner KO, Genta RM, Sonnenberg A. The Meaning of Incidental Goblet Cells at the Gastroesophageal Junction. Dig Dis Sci 2021;66:1588-92. [PMID: 32495255 DOI: 10.1007/s10620-020-06357-5] [Reference Citation Analysis]
266 Alsop BR, Sharma P. Esophageal Cancer. Gastroenterol Clin North Am. 2016;45:399-412. [PMID: 27546839 DOI: 10.1016/j.gtc.2016.04.001] [Cited by in Crossref: 67] [Cited by in F6Publishing: 66] [Article Influence: 13.4] [Reference Citation Analysis]
267 Chen YH, Yu HC, Lin KH, Lin HS, Hsu PI. Prevalence and risk factors for Barrett’s esophagus in Taiwan. World J Gastroenterol 2019; 25(25): 3231-3241 [PMID: 31333314 DOI: 10.3748/wjg.v25.i25.3231] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
268 Moinova HR, LaFramboise T, Lutterbaugh JD, Chandar AK, Dumot J, Faulx A, Brock W, De la Cruz Cabrera O, Guda K, Barnholtz-Sloan JS, Iyer PG, Canto MI, Wang JS, Shaheen NJ, Thota PN, Willis JE, Chak A, Markowitz SD. Identifying DNA methylation biomarkers for non-endoscopic detection of Barrett's esophagus. Sci Transl Med 2018;10:eaao5848. [PMID: 29343623 DOI: 10.1126/scitranslmed.aao5848] [Cited by in Crossref: 61] [Cited by in F6Publishing: 51] [Article Influence: 20.3] [Reference Citation Analysis]
269 Brown CS, Lapin B, Goldstein JL, Linn JG, Talamonti MS, Carbray J, Ujiki MB. Predicting Progression in Barrett's Esophagus: Development and Validation of the Barrett's Esophagus Assessment of Risk Score (BEAR Score). Annals of Surgery 2018;267:716-20. [DOI: 10.1097/sla.0000000000002179] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
270 Richardson C, Colavita P, Dunst C, Bagnato J, Billing P, Birkenhagen K, Buckley F, Buitrago W, Burnette J, Leggett P, McCollister H, Stewart K, Wang T, Zfass A, Severson P. Real-time diagnosis of Barrett's esophagus: a prospective, multicenter study comparing confocal laser endomicroscopy with conventional histology for the identification of intestinal metaplasia in new users. Surg Endosc 2019;33:1585-91. [PMID: 30203202 DOI: 10.1007/s00464-018-6420-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
271 . UEG Week 2018 Poster Presentations. United European Gastroenterol j 2018;6. [DOI: 10.1177/2050640618792819] [Cited by in Crossref: 16] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
272 Spiceland CM, Elmunzer BJ, Paros S, Roof L, McVey M, Hawes R, Hoffman BJ, Elias PS. Salvage cryotherapy in patients undergoing endoscopic eradication therapy for complicated Barrett's esophagus. Endosc Int Open. 2019;7:E904-E911. [PMID: 31281876 DOI: 10.1055/a-0902-4587] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
273 O’byrne LM, Witherspoon J, Verhage RJJ, O’brien M, Muldoon C, Ryan C, Buckley M, Murphy T, Reynolds R, Patchett S, Kay E, Azam H, Robb W, Arumugasamy M, Mathuna PM, Leyden J, Gargan S, Doherty G, Sheahan K, Collins C, Nath A, O’sullivan J, Donohoe CL, Ravi N, O’toole D, Reynolds JV. Barrett’s Registry Collaboration of academic centers in Ireland reveals high progression rate of low-grade dysplasia and low risk from nondysplastic Barrett’s esophagus: report of the RIBBON network. Diseases of the Esophagus 2020;33:doaa009. [DOI: 10.1093/dote/doaa009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
274 Marino KA, Sullivan JL, Weksler B. Esophagectomy versus endoscopic resection for patients with early-stage esophageal adenocarcinoma: A National Cancer Database propensity-matched study. J Thorac Cardiovasc Surg 2018;155:2211-2218.e1. [PMID: 29455958 DOI: 10.1016/j.jtcvs.2017.11.111] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
275 Kroupa R, Katinova I, Pavlik T, Kunovsky L, Prochazka V, Borilova Linhartova P, Packova B, Kala Z, Dolina J. Incidence trends of esophageal cancer in the Czech Republic by histological subtype and stage and prescription rate of acid suppressing drugs. Cancer Epidemiol 2020;69:101853. [PMID: 33161372 DOI: 10.1016/j.canep.2020.101853] [Reference Citation Analysis]
276 van der Wel MJ, Klaver E, Duits LC, Pouw RE, Seldenrijk CA, Offerhaus G, Visser M, Ten Kate F, Biermann K, Brosens L, Doukas M, Huysentruyt C, Karrenbeld A, Kats-Ugurlu G, van der Laan JS, van Lijnschoten G, Moll F, Ooms A, Tijssen JG, Bergman J, Meijer SL. Adherence to pre-set benchmark quality criteria to qualify as expert assessor of dysplasia in Barrett's esophagus biopsies - towards digital review of Barrett's esophagus. United European Gastroenterol J 2019;7:889-96. [PMID: 31428413 DOI: 10.1177/2050640619853441] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
277 Ghaus S, Neumann H, Muhammad H, Tontini GE, Ishaq S. Diagnosis and Surveillance of Barrett’s Esophagus: Addressing the Transatlantic Divide. Dig Dis Sci 2016;61:2185-93. [DOI: 10.1007/s10620-016-4138-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
278 Pan W, Li X, Wang W, Zhou L, Wu J, Ren T, Liu C, Lv M, Su S, Tang Y. Identification of Barrett's esophagus in endoscopic images using deep learning. BMC Gastroenterol 2021;21:479. [PMID: 34920705 DOI: 10.1186/s12876-021-02055-2] [Reference Citation Analysis]
279 Raphael KL, Trindade AJ. Management of Barrett’s esophagus with dysplasia refractory to radiofrequency ablation. World J Gastroenterol 2020; 26(17): 2030-2039 [PMID: 32536772 DOI: 10.3748/wjg.v26.i17.2030] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
280 Hoefnagel SJM, Mostafavi N, Timmer MR, Lau CT, Meijer SL, Wang KK, Krishnadath KK. A genomic biomarker-based model for cancer risk stratification of non-dysplastic Barrett's esophagus patients after extended follow up; results from Dutch surveillance cohorts. PLoS One 2020;15:e0231419. [PMID: 32282835 DOI: 10.1371/journal.pone.0231419] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
281 Bartel MJ, Wallace TM, Gomez-Esquivel RD, Raimondo M, Wolfsen HC, Woodward TA, Wallace MB. Role of EUS in patients with suspected Barrett's esophagus with high-grade dysplasia or early esophageal adenocarcinoma: impact on endoscopic therapy. Gastrointest Endosc. 2017;86:292-298. [PMID: 27889544 DOI: 10.1016/j.gie.2016.11.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
282 Fassan M, Realdon S, Cascione L, Hahne JC, Munari G, Guzzardo V, Arcidiacono D, Lampis A, Brignola S, Dal Santo L, Agostini M, Bracon C, Maddalo G, Scarpa M, Farinati F, Zaninotto G, Valeri N, Rugge M. Circulating microRNA expression profiling revealed miR-92a-3p as a novel biomarker of Barrett's carcinogenesis. Pathol Res Pract 2020;216:152907. [PMID: 32131978 DOI: 10.1016/j.prp.2020.152907] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
283 Pouw RE, Bergman JJ. Safety Signal for the Simple Double Ablation Regimen When Using the Barrx 360 Express Radiofrequency Ablation Balloon Catheter. Gastroenterology 2017;153:614. [DOI: 10.1053/j.gastro.2017.05.058] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
284 Niclauss N, Chevallay M, Frossard JL, Mönig SP. [Surgical strategy for early stage carcinoma of the esophagus]. Chirurg 2018;89:339-46. [PMID: 29392342 DOI: 10.1007/s00104-018-0589-2] [Reference Citation Analysis]
285 Britton J, Chatten K, Riley T, Keld RR, Hamdy S, McLaughlin J, Ang Y. Dedicated service improves the accuracy of Barrett's oesophagus surveillance: a prospective comparative cohort study. Frontline Gastroenterol 2019;10:128-34. [PMID: 31205652 DOI: 10.1136/flgastro-2018-101019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
286 Alsayid M, Melson J. Will magnet-assisted capsule endoscopy become a viable screening tool for Barrett's esophagus and esophageal varices? Gastrointestinal Endoscopy 2020;91:782-4. [DOI: 10.1016/j.gie.2019.12.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
287 Duvvuri A, Desai M, Vennelaganti S, Higbee A, Gorrepati VS, Dasari C, Chandrasekar VT, Vennalaganti P, Kohli D, Sathyamurthy A, Rai T, Sharma P. Diagnostic accuracy of a novel third generation esophageal capsule as a non-invasive detection method for Barrett's esophagus: A pilot study. J Gastroenterol Hepatol 2021;36:1222-5. [PMID: 32996655 DOI: 10.1111/jgh.15283] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
288 Sawas T, Alsawas M, Bazerbachi F, Iyer PG, Wang KK, Murad MH, Katzka DA. Persistent intestinal metaplasia after endoscopic eradication therapy of neoplastic Barrett’s esophagus increases the risk of dysplasia recurrence: meta-analysis. Gastrointestinal Endoscopy 2019;89:913-925.e6. [DOI: 10.1016/j.gie.2018.11.035] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
289 Nayna L, Emma W, Vani K. Radiofrequency ablation for low-grade dysplasia in Barrett's esophagus. Current Opinion in Gastroenterology 2016;32:294-301. [DOI: 10.1097/mog.0000000000000277] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
290 Britton J, Taxiarchi P, Martin G, Willert R, Horne M, Hamdy S, McLaughlin J, Ang Y. Comparative quantitative survey of patient experience in Barrett's oesophagus and other gastrointestinal disorders. BMJ Open Gastroenterol 2020;7:e000357. [PMID: 32337055 DOI: 10.1136/bmjgast-2019-000357] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
291 Mosko JD, Pleskow D. Evaluation of NinePoint Medical's Nvision VLE device for gastrointestinal applications. Expert Rev Med Devices 2017;14:495-503. [PMID: 28617072 DOI: 10.1080/17434440.2017.1343142] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
292 Guleria S, Shah TU, Pulido JV, Fasullo M, Ehsan L, Lippman R, Sali R, Mutha P, Cheng L, Brown DE, Syed S. Deep learning systems detect dysplasia with human-like accuracy using histopathology and probe-based confocal laser endomicroscopy. Sci Rep 2021;11:5086. [PMID: 33658592 DOI: 10.1038/s41598-021-84510-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
293 Ma M, Shroff S, Feldman M, DeMarshall M, Price C, Tierney A, Falk GW. Risk of malignant progression in Barrett's esophagus indefinite for dysplasia. Dis Esophagus 2017;30:1-5. [PMID: 28184470 DOI: 10.1093/dote/dow025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
294 Lynch KL. Is Obesity Associated with Barrett’s Esophagus and Esophageal Adenocarcinoma? Gastroenterology Clinics of North America 2016;45:615-24. [DOI: 10.1016/j.gtc.2016.07.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
295 Cummings LC, Thota PN, Willis JE, Chen Y, Cooper GS, Furey N, Bednarchik B, Alashkar BM, Dumot J, Faulx AL, Fink SP, Kresak AM, Abusneineh B, Barnholtz-Sloan J, Leahy P, Veigl ML, Chak A, Markowitz SD. A nonrandomized trial of vitamin D supplementation for Barrett's esophagus. PLoS One 2017;12:e0184928. [PMID: 28922414 DOI: 10.1371/journal.pone.0184928] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
296 Wishahy AMK, Seleim H, Qinawy M, Mohamed W, Mansour O, Abdullateef KS, Elkadi R, Raslan H, Arafa A, Yassin T. Short-term Effects of Mitomycin C Infiltration for Caustic Oesophageal Strictures in Children. J Pediatr Gastroenterol Nutr 2019;69:673-7. [PMID: 31436706 DOI: 10.1097/MPG.0000000000002466] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
297 Sami SS, Iyer PG. Recent Advances in Screening for Barrett's Esophagus. Curr Treat Options Gastroenterol 2018;16:1-14. [PMID: 29330747 DOI: 10.1007/s11938-018-0166-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
298 Ehlken H, Schmitz R, Riethdorf S, Riethdorf L, Krause J, Karstens KF, Schrader J, Viol F, Giannou A, Sterlacci W, Vieth M, Clauditz T, Kähler C, Mann O, Izbicki JR, Huber S, Pantel K, Rösch T. Possible tumour cell reimplantation during curative endoscopic therapy of superficial Barrett's carcinoma. Gut 2021:gutjnl-2020-322723. [PMID: 33441377 DOI: 10.1136/gutjnl-2020-322723] [Reference Citation Analysis]
299 Januszewicz W, Subhash VV, Waldock W, Fernando DI, Bartalucci G, Chettouh H, Miremadi A, O'Donovan M, Fitzgerald RC, di Pietro M. The utility of a methylation panel in the assessment of clinical response to radiofrequency ablation for Barrett's esophagus. EBioMedicine 2020;58:102877. [PMID: 32707444 DOI: 10.1016/j.ebiom.2020.102877] [Reference Citation Analysis]
300 Soh YSA, Lee YY, Gotoda T, Sharma P, Ho KY;  Asian Barrett's Consortium. Challenges to diagnostic standardization of Barrett's esophagus in Asia. Dig Endosc. 2019;31:609-618. [PMID: 30892742 DOI: 10.1111/den.13402] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
301 Maley CC, Aktipis A, Graham TA, Sottoriva A, Boddy AM, Janiszewska M, Silva AS, Gerlinger M, Yuan Y, Pienta KJ, Anderson KS, Gatenby R, Swanton C, Posada D, Wu CI, Schiffman JD, Hwang ES, Polyak K, Anderson ARA, Brown JS, Greaves M, Shibata D. Classifying the evolutionary and ecological features of neoplasms. Nat Rev Cancer 2017;17:605-19. [PMID: 28912577 DOI: 10.1038/nrc.2017.69] [Cited by in Crossref: 195] [Cited by in F6Publishing: 153] [Article Influence: 39.0] [Reference Citation Analysis]
302 Tozburun S. Superficial photothermal laser ablation of ex vivo sheep esophagus using a cone-shaped optical fiber tip. J Biophotonics 2020;13:e201960116. [PMID: 32134552 DOI: 10.1002/jbio.201960116] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
303 Dam AN, Lauwers GY. A new step for volumetric laser endomicroscopy: entering the therapeutic realm of endoscopic mucosal resection. Gastrointest Endosc 2019;89:709-11. [PMID: 30902199 DOI: 10.1016/j.gie.2018.12.020] [Reference Citation Analysis]
304 Triadafilopoulos G, Tandon A, Shetler KP, Clarke J. Clinical and pH study characteristics in reflux patients with and without ineffective oesophageal motility (IEM). BMJ Open Gastroenterol 2016;3:e000126. [PMID: 28074151 DOI: 10.1136/bmjgast-2016-000126] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
305 Kia L, Komanduri S. Care of the Postablation Patient. Gastrointestinal Endoscopy Clinics of North America 2017;27:515-29. [DOI: 10.1016/j.giec.2017.02.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
306 Yang D, Coman RM, Kahaleh M, Waxman I, Wang AY, Sethi A, Shah AR, Draganov PV. Endoscopic submucosal dissection for Barrett's early neoplasia: a multicenter study in the United States. Gastrointest Endosc 2017;86:600-7. [PMID: 27688205 DOI: 10.1016/j.gie.2016.09.023] [Cited by in Crossref: 51] [Cited by in F6Publishing: 33] [Article Influence: 8.5] [Reference Citation Analysis]
307 Knabe M, Beyna T, Rösch T, Bergman J, Manner H, May A, Schachschal G, Neuhaus H, Kandler J, Weusten B, Pech O, Faiss S, Anders M, Vieth M, Sehner S, Bisschops R, Bhandari P, Ell C, Ehlken H. Hybrid APC in Combination With Resection for the Endoscopic Treatment of Neoplastic Barrett's Esophagus: A Prospective, Multicenter Study. Am J Gastroenterol 2021. [PMID: 34845994 DOI: 10.14309/ajg.0000000000001539] [Reference Citation Analysis]
308 Masuda A, Fujita T, Murakami M, Yamazaki Y, Kobayashi M, Terao S, Sanuki T, Okada A, Adachi M, Shiomi H, Arisaka Y, Kutsumi H, Umegaki E, Azuma T. Influence of hiatal hernia and male sex on the relationship between alcohol intake and occurrence of Barrett's esophagus. PLoS One 2018;13:e0192951. [PMID: 29447244 DOI: 10.1371/journal.pone.0192951] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
309 Guerrero Garcia Hall M, Wenner J, Öberg S. The normal squamocolumnar junction is circumferentially even and minimal irregularities are manifestations of gastroesophageal acid reflux. Scandinavian Journal of Gastroenterology 2017;52:270-5. [DOI: 10.1080/00365521.2016.1249402] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
310 Shah AK, Hartel G, Brown I, Winterford C, Na R, Cao KL, Spicer BA, Dunstone MA, Phillips WA, Lord RV, Barbour AP, Watson DI, Joshi V, Whiteman DC, Hill MM. Evaluation of Serum Glycoprotein Biomarker Candidates for Detection of Esophageal Adenocarcinoma and Surveillance of Barrett's Esophagus. Mol Cell Proteomics 2018;17:2324-34. [PMID: 30097534 DOI: 10.1074/mcp.RA118.000734] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
311 Bergman JJ, de Groof AJ, Pech O, Ragunath K, Armstrong D, Mostafavi N, Lundell L, Dent J, Vieth M, Tytgat G, Sharma P. An Interactive Web-Based Educational Tool Improves Detection and Delineation of Barrett’s Esophagus–Related Neoplasia. Gastroenterology 2019;156:1299-1308.e3. [DOI: 10.1053/j.gastro.2018.12.021] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
312 Trindade AJ, Zhang J, Hauschild J, Leggett CL, Iyer PG. Impact of COVID-19 on the diagnosis and therapy for Barrett's esophagus and esophageal cancer in the United States. Gastroenterology 2021:S0016-5085(21)03796-3. [PMID: 34808138 DOI: 10.1053/j.gastro.2021.11.020] [Reference Citation Analysis]
313 Filby A, Taylor M, Lipman G, Lovat L, Haidry R. Cost–effectiveness analysis of endoscopic eradication therapy for treatment of high-grade dysplasia in Barrett’s esophagus. Journal of Comparative Effectiveness Research 2017;6:425-36. [DOI: 10.2217/cer-2016-0089] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
314 Gora MJ, Simmons LH, Quénéhervé L, Grant CN, Carruth RW, Lu W, Tiernan A, Dong J, Walker-Corkery B, Soomro A, Rosenberg M, Metlay JP, Tearney GJ. Tethered capsule endomicroscopy: from bench to bedside at a primary care practice.J Biomed Opt. 2016;21:104001. [PMID: 27689919 DOI: 10.1117/1.Jbo.21.10.104001] [Cited by in Crossref: 29] [Cited by in F6Publishing: 11] [Article Influence: 4.8] [Reference Citation Analysis]
315 Leclercq P, Bisschops R. Optimizing Outcomes with Radiofrequency Ablation of Barrett's Esophagus: Candidates, Efficacy and Durability. Gastrointest Endosc Clin N Am 2021;31:131-54. [PMID: 33213792 DOI: 10.1016/j.giec.2020.09.004] [Reference Citation Analysis]
316 Rajendra S, Sharma P. Barrett Esophagus and Intramucosal Esophageal Adenocarcinoma. Hematol Oncol Clin North Am 2017;31:409-26. [PMID: 28501084 DOI: 10.1016/j.hoc.2017.01.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
317 van Munster SN, Frederiks CN, Nieuwenhuis EA, Alvarez Herrero L, Bogte A, Alkhalaf A, Schenk BE, Schoon EJ, Curvers WL, Koch AD, van de Ven SEM, de Jonge PJF, Tang TJ, Nagengast WB, Peters FTM, Westerhof J, Houben MHMG, Bergman JJGHM, Pouw RE, Weusten BLAM. Incidence and outcomes of poor healing and poor squamous regeneration after radiofrequency ablation therapy for early Barrett's neoplasia. Endoscopy 2021. [PMID: 34062597 DOI: 10.1055/a-1521-6318] [Reference Citation Analysis]
318 Emura F, Torres-Rincon R, Calderon-Zapata D, Huertas S, Toro-Calle J. Circumferential endoscopic submucosal dissection for the treatment of ultra-short-segment Barrett's adenocarcinoma with multifocal dysplasia. VideoGIE 2020;5:649-51. [PMID: 33319131 DOI: 10.1016/j.vgie.2020.07.018] [Reference Citation Analysis]
319 Wani S, Muthusamy VR, Shaheen NJ, Yadlapati R, Wilson R, Abrams JA, Bergman J, Chak A, Chang K, Das A, Dumot J, Edmundowicz SA, Eisen G, Falk GW, Fennerty MB, Gerson L, Ginsberg GG, Grande D, Hall M, Harnke B, Inadomi J, Jankowski J, Lightdale CJ, Makker J, Odze RD, Pech O, Sampliner RE, Spechler S, Triadafilopoulos G, Wallace MB, Wang K, Waxman I, Komanduri S. Development of quality indicators for endoscopic eradication therapies in Barrett’s esophagus: the TREAT-BE (Treatment with Resection and Endoscopic Ablation Techniques for Barrett’s Esophagus) Consortium. Gastrointestinal Endoscopy 2017;86:1-17.e3. [DOI: 10.1016/j.gie.2017.03.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
320 Fitzgerald RC, di Pietro M, O'Donovan M, Maroni R, Muldrew B, Debiram-Beecham I, Gehrung M, Offman J, Tripathi M, Smith SG, Aigret B, Walter FM, Rubin G, Sasieni P; BEST3 Trial team. Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial. Lancet 2020;396:333-44. [PMID: 32738955 DOI: 10.1016/S0140-6736(20)31099-0] [Cited by in Crossref: 42] [Cited by in F6Publishing: 20] [Article Influence: 21.0] [Reference Citation Analysis]
321 Correia FP, Lourenço LC. Artificial intelligence application in diagnostic gastrointestinal endoscopy - Deus ex machina? World J Gastroenterol 2021; 27(32): 5351-5361 [PMID: 34539137 DOI: 10.3748/wjg.v27.i32.5351] [Reference Citation Analysis]
322 Duarte-Chavez R, Kim M, Marino D, Kahaleh M. Traction-assisted endoscopic submucosal dissection with submucosal tunneling for Barrett's esophagus nodularity. Endoscopy 2021. [PMID: 34144614 DOI: 10.1055/a-1499-6267] [Reference Citation Analysis]
323 Vennalaganti PR, Kaul V, Wang KK, Falk GW, Shaheen NJ, Infantolino A, Johnson DA, Eisen G, Gerson LB, Smith MS, Iyer PG, Lightdale CJ, Schnoll-Sussman F, Gupta N, Gross SA, Abrams J, Haber GB, Chuttani R, Pleskow DK, Kothari S, Goldblum JR, Zhang Y, Sharma P. Increased detection of Barrett's esophagus-associated neoplasia using wide-area trans-epithelial sampling: a multicenter, prospective, randomized trial. Gastrointest Endosc. 2018;87:348-355. [PMID: 28757316 DOI: 10.1016/j.gie.2017.07.039] [Cited by in Crossref: 52] [Cited by in F6Publishing: 43] [Article Influence: 10.4] [Reference Citation Analysis]
324 Schlottmann F, Patti MG, Shaheen NJ. Endoscopic Treatment of High-Grade Dysplasia and Early Esophageal Cancer. World J Surg 2017;41:1705-11. [DOI: 10.1007/s00268-017-3977-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
325 Cao JS, Lu ZY, Chen MY, Zhang B, Juengpanich S, Hu JH, Li SJ, Topatana W, Zhou XY, Feng X, Shen JL, Liu Y, Cai XJ. Artificial intelligence in gastroenterology and hepatology: Status and challenges. World J Gastroenterol 2021; 27(16): 1664-1690 [PMID: 33967550 DOI: 10.3748/wjg.v27.i16.1664] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
326 di Pietro M, Bertani H, OʼDonovan M, Santos P, Alastal H, Phillips R, Ortiz-Fernández-Sordo J, Iacucci M, Modolell I, Reggiani Bonetti L, Ragunath K, Wernisch L. Development and Validation of Confocal Endomicroscopy Diagnostic Criteria for Low-Grade Dysplasia in Barrett's Esophagus. Clin Transl Gastroenterol 2019;10:e00014. [PMID: 30985335 DOI: 10.14309/ctg.0000000000000014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
327 Abe S, Ishihara R, Takahashi H, Ono H, Fujisaki J, Matsui A, Takahashi A, Goda K, Kawada K, Koike T, Takeuchi M, Tsuji Y, Hirasawa D, Oyama T. Long-term outcomes of endoscopic resection and metachronous cancer after endoscopic resection for adenocarcinoma of the esophagogastric junction in Japan. Gastrointest Endosc. 2019;89:1120-1128. [PMID: 30576649 DOI: 10.1016/j.gie.2018.12.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
328 Mital S, Nguyen HV. Response to Jirapinyo et al. Am J Gastroenterol 2020;115:482-3. [PMID: 32039979 DOI: 10.14309/ajg.0000000000000541] [Reference Citation Analysis]
329 Trindade AJ, Pleskow DK, Sengupta N, Kothari S, Inamdar S, Berkowitz J, Kaul V. Efficacy of liquid nitrogen cryotherapy for Barrett's esophagus after endoscopic resection of intramucosal cancer: A multicenter study. J Gastroenterol Hepatol 2018;33:461-5. [PMID: 28770555 DOI: 10.1111/jgh.13909] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
330 Iqbal U, Siddique O, Ovalle A, Anwar H, Moss SF. Safety and efficacy of a minimally invasive cell sampling device ('Cytosponge') in the diagnosis of esophageal pathology: a systematic review. Eur J Gastroenterol Hepatol 2018;30:1261-9. [PMID: 30044236 DOI: 10.1097/MEG.0000000000001210] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
331 Yin F, Hernandez Gonzalo D, Lai J, Liu X. Histopathology of Barrett’s Esophagus and Early-Stage Esophageal Adenocarcinoma: An Updated Review. GastrointestDisord 2018;1:147-63. [DOI: 10.3390/gidisord1010011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
332 Stier MW, Lodhia N, Jacobs J, Nozicka D, Kavitt R, Siddiqui U, Waxman I, Konda VJ. Perceptions of risk and therapy among patients with Barrett's esophagus: a patient survey study. Diseases of the Esophagus 2017;31. [DOI: 10.1093/dote/dox109] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
333 Elias PS, Castell DO. The Role of Acid Suppression in Barrett's Esophagus. Am J Med 2017;130:525-9. [PMID: 28159599 DOI: 10.1016/j.amjmed.2016.12.032] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
334 Mkarimi M, Mashimo H. Advanced Imaging for Barrett's Esophagus and Early Neoplasia: Surface and Subsurface Imaging for Diagnosis and Management. Curr Gastroenterol Rep 2018;20:54. [PMID: 30302571 DOI: 10.1007/s11894-018-0661-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
335 Britton J, Hamdy S, McLaughlin J, Horne M, Ang Y. Barrett's oesophagus: A qualitative study of patient burden, care delivery experience and follow-up needs. Health Expect 2019;22:21-33. [PMID: 30430714 DOI: 10.1111/hex.12817] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
336 Shaheen NJ, Smith MS, Odze RD. Progression of Barrett's esophagus, crypt dysplasia, and low-grade dysplasia diagnosed by wide-area transepithelial sampling with 3-dimensional computer-assisted analysis: a retrospective analysis. Gastrointest Endosc 2021:S0016-5107(21)01645-X. [PMID: 34537193 DOI: 10.1016/j.gie.2021.09.014] [Reference Citation Analysis]
337 Blevins CH, Egginton JS, Shah ND, Johnson ML, Iyer PG. Comparative Assessment of Patient Preferences and Tolerability in Barrett Esophagus Screening: Results From a Randomized Trial. J Clin Gastroenterol. 2018;52:880-884. [PMID: 29369237 DOI: 10.1097/mcg.0000000000000991] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
338 Overwater A, van der Meulen KE, Künzli HT, Schoon EJ, Bergman JJ, Mihaela Raicu G, Seldenrijk KC, Weusten BL. Optimizing histopathologic evaluation of EMR specimens of Barrett’s esophagus–related neoplasia: a randomized study of 3 specimen handling methods. Gastrointestinal Endoscopy 2019;90:384-392.e5. [DOI: 10.1016/j.gie.2019.03.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
339 Sawas T, Manrique GC, Iyer PG, Wang KK, Katzka DA. Young Adults With Esophageal Adenocarcinoma Present With More Advanced Stage Tumors and Have Shorter Survival Times. Clin Gastroenterol Hepatol 2019;17:1756-62. [PMID: 30267861 DOI: 10.1016/j.cgh.2018.09.031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
340 Riley CA, Marino MJ, Hsieh MC, Wu EL, Wu XC, McCoul ED. Detection of laryngeal carcinoma in the U.S. elderly population with gastroesophageal reflux disease. Head Neck 2019;41:1434-40. [PMID: 30681216 DOI: 10.1002/hed.25600] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
341 Sepulveda JL, Komissarova EV, Kongkarnka S, Friedman RA, Davison JM, Levy B, Bryk D, Jobanputra V, Del Portillo A, Falk GW, Sonett JR, Lightdale CJ, Abrams JA, Wang TC, Sepulveda AR. High-resolution genomic alterations in Barrett's metaplasia of patients who progress to esophageal dysplasia and adenocarcinoma. Int J Cancer 2019;145:2754-66. [PMID: 31001805 DOI: 10.1002/ijc.32351] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
342 Ko MS, Fung KZ, Shi Y, Espaldon R, Shergill A, Walter LC. Barrett's Esophagus Commonly Diagnosed in Elderly Men with Limited Life Expectancy. J Am Geriatr Soc 2016;64:e109-11. [PMID: 27685424 DOI: 10.1111/jgs.14409] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
343 Frederiks CN, Canto MI, Weusten BLAM. Updates in Cryotherapy for Barrett's Esophagus. Gastrointest Endosc Clin N Am 2021;31:155-70. [PMID: 33213793 DOI: 10.1016/j.giec.2020.09.005] [Reference Citation Analysis]
344 Kunzmann AT, Coleman HG, Johnston BT, Turkington RC, McManus D, Anderson LA, Thrift AP. Does Risk of Progression from Barrett's Esophagus to Esophageal Adenocarcinoma Change Based on the Number of Non-dysplastic Endoscopies? Dig Dis Sci 2021;66:1965-73. [PMID: 32734400 DOI: 10.1007/s10620-020-06483-0] [Reference Citation Analysis]
345 Gupta N, Siddiqui U, Waxman I, Chapman C, Koons A, Valuckaite V, Xiao SY, Setia N, Hart J, Konda V. Use of volumetric laser endomicroscopy for dysplasia detection at the gastroesophageal junction and gastric cardia. World J Gastrointest Endosc 2017; 9(7): 319-326 [PMID: 28744344 DOI: 10.4253/wjge.v9.i7.319] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
346 Visrodia K, Zakko L, Wang KK. Mucosal Ablation in Patients with Barrett's Esophagus: Fry or Freeze? Dig Dis Sci 2018;63:2129-35. [PMID: 29777441 DOI: 10.1007/s10620-018-5064-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
347 Lordick F, Mariette C, Haustermans K, Obermannová R, Arnold D; ESMO Guidelines Committee. Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2016;27:v50-7. [PMID: 27664261 DOI: 10.1093/annonc/mdw329] [Cited by in Crossref: 372] [Cited by in F6Publishing: 350] [Article Influence: 62.0] [Reference Citation Analysis]
348 Jansson-knodell CL, Codipilly DC, Leggett CL. Making Dysphagia Easier to Swallow. Mayo Clinic Proceedings 2017;92:965-72. [DOI: 10.1016/j.mayocp.2017.03.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
349 Whiteman DC, Kendall BJ. Barrett's oesophagus: epidemiology, diagnosis and clinical management. Medical Journal of Australia 2016;205:317-24. [DOI: 10.5694/mja16.00796] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
350 Mousa H, Krishnan U, Hassan M, Dall'Oglio L, Rosen R, Gottrand F, Faure C. How to Care for Patients with EA-TEF: The Known and the Unknown. Curr Gastroenterol Rep 2017;19:65. [PMID: 29177550 DOI: 10.1007/s11894-017-0605-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.2] [Reference Citation Analysis]
351 Thota PN, Arora Z, Benjamin T, Pagadala M, Lopez R, Sanaka MR. Influence of body mass index on the prevalence and progression of dysplasia in Barrett's esophagus: a retrospective analysis (.). Scand J Gastroenterol 2016;51:1288-93. [PMID: 27460942 DOI: 10.1080/00365521.2016.1208271] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
352 Ten Kate CA, van Hal ARL, Erler NS, Doukas M, Nikkessen S, Vlot J, IJsselstijn H, Wijnhoven BPL, Wijnen RMH, Spaander MCW. Recommendations for endoscopic surveillance after esophageal atresia repair in adults. Dis Esophagus 2022:doab095. [PMID: 35034110 DOI: 10.1093/dote/doab095] [Reference Citation Analysis]
353 Moulla Y, Lyros O, Mehdorn M, Lange U, Hamade H, Thieme R, Hoffmeister A, Feisthammel J, Blüher M, Jansen-winkeln B, Gockel I, Dietrich A. Preoperative Upper-GI Endoscopy Prior to Bariatric Surgery: Essential or Optional? OBES SURG 2020;30:2076-84. [DOI: 10.1007/s11695-020-04485-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
354 Sawhney MS, Bilal M, Pohl H, Kushnir VM, Khashab MA, Schulman AR, Berzin TM, Chahal P, Muthusamy VR, Varadarajulu S, Banerjee S, Ginsberg GG, Raju GS, Feuerstein JD. Triaging advanced GI endoscopy procedures during the COVID-19 pandemic: consensus recommendations using the Delphi method. Gastrointest Endosc 2020;92:535-42. [PMID: 32425235 DOI: 10.1016/j.gie.2020.05.014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
355 Montgomery E, Arnold CA, Lam-Himlin D, Salimian K, Waters K. Some observations on Barrett esophagus and associated dysplasia. Ann Diagn Pathol 2018;37:75-82. [PMID: 30312881 DOI: 10.1016/j.anndiagpath.2018.09.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
356 Delman AM, Ammann AM, Turner KM, Vaysburg DM, Van Haren RM. A narrative review of socioeconomic disparities in the treatment of esophageal cancer. J Thorac Dis 2021;13:3801-8. [PMID: 34277070 DOI: 10.21037/jtd-20-3095] [Reference Citation Analysis]
357 Rubenstein JH, Raghunathan T, Doan C, Schneider J, Zhao W, Metko V, Nofz K, Khodadost M, Corley DA. Validation of Tools for Predicting Incident Adenocarcinoma of the Esophagus or Esophagogastric Junction. Am J Gastroenterol 2021;116:949-57. [PMID: 33852454 DOI: 10.14309/ajg.0000000000001255] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
358 Reed CC, Shaheen NJ. Endoscopic Treatment of High-Grade Dysplasia and Intramucosal Esophageal Adenocarcinoma. J Laparoendosc Adv Surg Tech A 2016;26:768-72. [PMID: 27541732 DOI: 10.1089/lap.2016.29012.ccr] [Reference Citation Analysis]
359 Ireland CJ, Thrift AP, Esterman A. Risk Prediction Models for Barrett's Esophagus Discriminate Well and Are Generalizable in an External Validation Study. Dig Dis Sci 2020;65:2992-9. [PMID: 31897894 DOI: 10.1007/s10620-019-06018-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
360 Mocker L, Hildenbrand R, Oyama T, Sido B, Yahagi N, Dumoulin FL. Implementation of endoscopic submucosal dissection for early upper gastrointestinal tract cancer after primary experience in colorectal endoscopic submucosal dissection. Endosc Int Open 2019;7:E446-51. [PMID: 30931376 DOI: 10.1055/a-0854-3610] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
361 Hasan Y, Murali AR, Gerke H. Endoscopic mucosal resection for early esophageal carcinoma is effective and safe but necessitates continued surveillance. Indian J Gastroenterol 2020;39:487-94. [PMID: 33201442 DOI: 10.1007/s12664-020-01084-1] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
362 Louie BE, Hofstetter W, Triadafilopoulos G, Weusten BL. Evaluation of a novel cryoballoon swipe ablation system in bench, porcine, and human esophagus models. Dis Esophagus 2018;31. [PMID: 29481581 DOI: 10.1093/dote/dox155] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
363 Kamboj AK, Katzka DA, Iyer PG. Endoscopic Screening for Barrett's Esophagus and Esophageal Adenocarcinoma: Rationale, Candidates, and Challenges. Gastrointest Endosc Clin N Am 2021;31:27-41. [PMID: 33213798 DOI: 10.1016/j.giec.2020.08.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
364 Aziz M, Fatima R. Future of diagnosing neoplasia in Barrett's esophagus: volumetric laser endomicroscopy. Clin J Gastroenterol 2018;11:179-83. [PMID: 29680981 DOI: 10.1007/s12328-018-0863-3] [Reference Citation Analysis]
365 Tan ND, Lin YQ, Ye ZY, Zhang N, Chen SF, Zhang MY, Cui Y, Chen MH, Xiao YL. White-light endoscopy is insufficient to distinguish between types of esophageal white lesions. J Dig Dis 2021. [PMID: 34390179 DOI: 10.1111/1751-2980.13039] [Reference Citation Analysis]
366 Baldwin-Hunter BL, Knotts RM, Leeds SD, Rubenstein JH, Lightdale CJ, Abrams JA. Use of the Electronic Health Record to Target Patients for Non-endoscopic Barrett's Esophagus Screening. Dig Dis Sci 2019;64:3463-70. [PMID: 31273597 DOI: 10.1007/s10620-019-05707-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
367 Eells AC, Mackintosh C, Marks L, Marino MJ. Gastroesophageal reflux disease and head and neck cancers: A systematic review and meta-analysis. Am J Otolaryngol 2020;41:102653. [PMID: 32841763 DOI: 10.1016/j.amjoto.2020.102653] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
368 Rouphael C, Anil Kumar M, Sanaka MR, Thota PN. Indications, contraindications and limitations of endoscopic therapy for Barrett's esophagus and early esophageal adenocarcinoma. Therap Adv Gastroenterol 2020;13:1756284820924209. [PMID: 32523628 DOI: 10.1177/1756284820924209] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
369 Henn AJ, Song KY, Gravely AA, Mesa H, Sultan S, Shaheen NJ, Shaukat A, Hanson BJ. Persistent indefinite for dysplasia in Barrett's esophagus is a risk factor for dysplastic progression to low-grade dysplasia. Dis Esophagus 2020;33:doaa015. [PMID: 32399569 DOI: 10.1093/dote/doaa015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
370 Rizvi QU, Balachandran A, Koay D, Sharma P, Singh R. Endoscopic Management of Early Esophagogastric Cancer. Surg Oncol Clin N Am 2017;26:179-91. [PMID: 28279463 DOI: 10.1016/j.soc.2016.10.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
371 Scarpignato C, Gatta L. Acid Suppression for Management of Gastroesophageal Reflux Disease: Benefits and Risks. In: Morice AH, Dettmar PW, editors. Reflux Aspiration and Lung Disease. Cham: Springer International Publishing; 2018. pp. 269-91. [DOI: 10.1007/978-3-319-90525-9_23] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
372 Dellon ES, Liacouras CA, Molina-Infante J, Furuta GT, Spergel JM, Zevit N, Spechler SJ, Attwood SE, Straumann A, Aceves SS, Alexander JA, Atkins D, Arva NC, Blanchard C, Bonis PA, Book WM, Capocelli KE, Chehade M, Cheng E, Collins MH, Davis CM, Dias JA, Di Lorenzo C, Dohil R, Dupont C, Falk GW, Ferreira CT, Fox A, Gonsalves NP, Gupta SK, Katzka DA, Kinoshita Y, Menard-Katcher C, Kodroff E, Metz DC, Miehlke S, Muir AB, Mukkada VA, Murch S, Nurko S, Ohtsuka Y, Orel R, Papadopoulou A, Peterson KA, Philpott H, Putnam PE, Richter JE, Rosen R, Rothenberg ME, Schoepfer A, Scott MM, Shah N, Sheikh J, Souza RF, Strobel MJ, Talley NJ, Vaezi MF, Vandenplas Y, Vieira MC, Walker MM, Wechsler JB, Wershil BK, Wen T, Yang GY, Hirano I, Bredenoord AJ. Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference. Gastroenterology. 2018;155:1022-1033.e10. [PMID: 30009819 DOI: 10.1053/j.gastro.2018.07.009] [Cited by in Crossref: 306] [Cited by in F6Publishing: 258] [Article Influence: 76.5] [Reference Citation Analysis]
373 Bajaj J, Brenner D, Cai Q, Cash B, Crowell M, Dibaise J, Gallegos-orozco J, Gardner T, Gyawali C, Ha C, Holtmann G, Jamil L, Kaplan G, Karsan H, Kinoshita Y, Lebwohl B, Leontiadis G, Lichtenstein G, Longstreth G, Muthusamy V, Oxentenko A, Pimentel M, Pisegna J, Rubenstein J, Russo M, Saini S, Samadder N, Shaukat A, Simren M, Stevens T, Valdovinos M, Vargas H, Spiegel B, Lacy B. Major Trends in Gastroenterology and Hepatology Between 2010 and 2019: An Overview of Advances From the Past Decade Selected by the Editorial Board of The American Journal of Gastroenterology. Am J Gastroenterol 2020;115:1007-18. [DOI: 10.14309/ajg.0000000000000709] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
374 Campos GM, Mazzini GS, Altieri MS, Docimo S Jr, DeMaria EJ, Rogers AM; Clinical Issues Committee of the American Society for Metabolic and Bariatric Surgery. ASMBS position statement on the rationale for performance of upper gastrointestinal endoscopy before and after metabolic and bariatric surgery. Surg Obes Relat Dis 2021;17:837-47. [PMID: 33875361 DOI: 10.1016/j.soard.2021.03.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
375 Fedorova E, Watson TJ. Antireflux and Endoscopic Therapies for Barrett Esophagus and Superficial Esophageal Neoplasia. Surg Clin North Am 2021;101:391-403. [PMID: 34048760 DOI: 10.1016/j.suc.2021.03.002] [Reference Citation Analysis]
376 Cook MB, Thrift AP. Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma: Implications for Screening and Surveillance. Gastrointest Endosc Clin N Am 2021;31:1-26. [PMID: 33213789 DOI: 10.1016/j.giec.2020.08.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
377 Blevins CH, Iyer PG. Who Deserves Endoscopic Screening for Esophageal Neoplasia? Gastrointest Endosc Clin N Am. 2017;27:365-378. [PMID: 28577762 DOI: 10.1016/j.giec.2017.02.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
378 Laine L, Nagar A. Long-Term PPI Use: Balancing Potential Harms and Documented Benefits. Am J Gastroenterol 2016;111:913-5. [PMID: 27113114 DOI: 10.1038/ajg.2016.156] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
379 Nguyen TH, Thrift AP, Rugge M, El-Serag HB. Prevalence of Barrett's esophagus and performance of societal screening guidelines in an unreferred primary care population of U.S. veterans. Gastrointest Endosc 2021;93:409-419.e1. [PMID: 32565183 DOI: 10.1016/j.gie.2020.06.032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
380 Song KY, Henn AJ, Gravely AA, Mesa H, Sultan S, Shaheen NJ, Shaukat A, Hanson BJ. Persistent confirmed low-grade dysplasia in Barrett's esophagus is a risk factor for progression to high-grade dysplasia and adenocarcinoma in a US Veterans cohort. Dis Esophagus 2020;33:doz061. [PMID: 31274147 DOI: 10.1093/dote/doz061] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
381 Tan J, Li L, Huang X, Yang C, Liang X, Zhao Y, Xie J, Chen R, Wang D, Xie S. Associations between gastro-oesophageal reflux disease and a range of diseases: an umbrella review of systematic reviews and meta-analyses. BMJ Open 2020;10:e038450. [PMID: 33380477 DOI: 10.1136/bmjopen-2020-038450] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
382 Newberry C, Lynch K. Can We Use Diet to Effectively Treat Esophageal Disease? A Review of the Current Literature. Curr Gastroenterol Rep 2017;19:38. [PMID: 28730507 DOI: 10.1007/s11894-017-0578-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
383 Killcoyne S, Yusuf A, Fitzgerald RC. Genomic instability signals offer diagnostic possibility in early cancer detection. Trends Genet 2021:S0168-9525(21)00165-7. [PMID: 34218956 DOI: 10.1016/j.tig.2021.06.009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
384 Schlottmann F, Andolfi C, Herbella FA, Rebecchi F, Allaix ME, Patti MG. GERD: Presence and Size of Hiatal Hernia Influence Clinical Presentation, Esophageal Function, Reflux Profile, and Degree of Mucosal Injury. The American Surgeon 2018;84:978-82. [DOI: 10.1177/000313481808400651] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 3.8] [Reference Citation Analysis]
385 Snyder P, Dunbar K, Cipher DJ, Souza RF, Spechler SJ, Konda VJA. Aberrant p53 Immunostaining in Barrett's Esophagus Predicts Neoplastic Progression: Systematic Review and Meta-Analyses. Dig Dis Sci 2019;64:1089-97. [PMID: 30911864 DOI: 10.1007/s10620-019-05586-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
386 Singh T, Sanghi V, Thota PN. Current management of Barrett esophagus and esophageal adenocarcinoma. Cleve Clin J Med 2019;86:724-32. [PMID: 31710585 DOI: 10.3949/ccjm.86a.18106] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
387 McIntyre CA, Allen PJ. How Long Should Patients with Cystic Lesions of the Pancreas Be Followed? Adv Surg 2018;52:223-33. [PMID: 30098614 DOI: 10.1016/j.yasu.2018.03.014] [Reference Citation Analysis]
388 Eluri S, Shaheen NJ. IMportance of an Irregular Z Line: Is Barrett’s in the Eye of the Beholder? Dig Dis Sci 2018;63:1378-80. [DOI: 10.1007/s10620-018-4998-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
389 Fonollà R, Scheeve T, Struyvenberg MR, Curvers WL, de Groof AJ, van der Sommen F, Schoon EJ, Bergman JJ, de With PH. Ensemble of Deep Convolutional Neural Networks for Classification of Early Barrett’s Neoplasia Using Volumetric Laser Endomicroscopy. Applied Sciences 2019;9:2183. [DOI: 10.3390/app9112183] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
390 Snider EJ, Kaz AM, Inadomi JM, Grady WM. Chemoprevention of esophageal adenocarcinoma. Gastroenterol Rep (Oxf) 2020;8:253-60. [PMID: 32843972 DOI: 10.1093/gastro/goaa040] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
391 Scarpignato C, Hunt RH. The potential role of potassium-competitive acid blockers in the treatment of gastroesophageal reflux disease. Current Opinion in Gastroenterology 2019;35:344-55. [DOI: 10.1097/mog.0000000000000543] [Cited by in Crossref: 12] [Article Influence: 4.0] [Reference Citation Analysis]
392 Bellizzi AM, Hafezi‐bakhtiari S, Westerhoff M, Marginean EC, Riddell RH. Gastrointestinal pathologists’ perspective on managing risk in the distal esophagus: convergence on a pragmatic approach. Ann N Y Acad Sci 2018;1434:35-45. [DOI: 10.1111/nyas.13680] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
393 Oda M, Kalloo A, Mizukami K, Murakami K, Sawa A. Endoscopy and Barrett's Esophagus: Current Perspectives in the US and Japan. Intern Med 2021;60:327-35. [PMID: 32863360 DOI: 10.2169/internalmedicine.4400-19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
394 Redston M, Noffsinger A, Kim A, Akarca FG, Rara M, Stapleton D, Nowden L, Lash R, Bass AJ, Stachler MD. Abnormal TP53 predicts risk of progression in patients with Barrett's esophagus regardless of a diagnosis of dysplasia. Gastroenterology 2021:S0016-5085(21)03710-0. [PMID: 34757142 DOI: 10.1053/j.gastro.2021.10.038] [Reference Citation Analysis]
395 Otaki F, Ma GK, Krigel A, Dierkhising RA, Lewis JT, Blevins CH, Gopalakrishnan NP, Ravindran A, Johnson ML, Leggett CL, Wigle D, Wang KK, Falk GW, Abrams JA, Nakagawa H, Rustgi AK, Wang TC, Lightdale CJ, Ginsberg GG, Iyer PG. Outcomes of patients with submucosal (T1b) esophageal adenocarcinoma: a multicenter cohort study. Gastrointest Endosc 2020;92:31-39.e1. [PMID: 31953189 DOI: 10.1016/j.gie.2020.01.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
396 Peters Y, Siersema PD. Public Preferences and Predicted Uptake for Esophageal Cancer Screening Strategies: A Labeled Discrete Choice Experiment. Clin Transl Gastroenterol 2020;11:e00260. [PMID: 33105164 DOI: 10.14309/ctg.0000000000000260] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
397 Solfisburg QS, Sami SS, Gabre J, Soroush A, Dhaliwal L, Beveridge C, Jin Z, Poneros JM, Falk GW, Ginsberg GG, Wang KK, Lightdale CJ, Iyer PG, Abrams JA. Clinical significance of recurrent gastroesophageal junction intestinal metaplasia after endoscopic eradication of Barrett's esophagus. Gastrointest Endosc 2021;93:1250-1257.e3. [PMID: 33144238 DOI: 10.1016/j.gie.2020.10.027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
398 Chen J, Zhou J, Gao Z, Li X, Wang F, Duan X, Li G, Joshi BP, Kuick R, Appelman HD, Wang TD. Multiplexed Targeting of Barrett's Neoplasia with a Heterobivalent Ligand: Imaging Study on Mouse Xenograft in Vivo and Human Specimens ex Vivo. J Med Chem 2018;61:5323-31. [PMID: 29870260 DOI: 10.1021/acs.jmedchem.8b00405] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
399 Shah SC, Dai Q, Zhu X, Peek RM Jr, Roumie C, Shrubsole MJ. Associations between calcium and magnesium intake and the risk of incident oesophageal cancer: an analysis of the NIH-AARP Diet and Health Study prospective cohort. Br J Cancer 2020;122:1857-64. [PMID: 32242097 DOI: 10.1038/s41416-020-0818-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
400 Loughrey MB, Shepherd NA. The indications for biopsy in routine upper gastrointestinal endoscopy. Histopathology 2021;78:215-27. [PMID: 33382487 DOI: 10.1111/his.14213] [Reference Citation Analysis]
401 Iyer PG. Dysplasia detection in Barrett's esophagus: Is the glass half full or half empty? Gastrointestinal Endoscopy 2019;90:742-4. [DOI: 10.1016/j.gie.2019.06.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
402 Lottrup C, Khan A, Rangan V, Clarke JO. Esophageal physiology-an overview of esophageal disorders from a pathophysiological point of view. Ann N Y Acad Sci 2020;1481:182-97. [PMID: 32648992 DOI: 10.1111/nyas.14417] [Reference Citation Analysis]
403 Jung HK, Tae CH, Song KH, Kang SJ, Park JK, Gong EJ, Shin JE, Lim HC, Lee SK, Jung DH, Choi YJ, Seo SI, Kim JS, Lee JM, Kim BJ, Kang SH, Park CH, Choi SC, Kwon JG, Park KS, Park MI, Lee TH, Kim SY, Cho YS, Lee HH, Jung KW, Kim DH, Moon HS, Miwa H, Chen CL, Gonlachanvit S, Ghoshal UC, Wu JCY, Siah KTH, Hou X, Oshima T, Choi MY, Lee KJ; Korean Society of Neurogastroenterology and Motility. 2020 Seoul Consensus on the Diagnosis and Management of Gastroesophageal Reflux Disease. J Neurogastroenterol Motil 2021;27:453-81. [PMID: 34642267 DOI: 10.5056/jnm21077] [Reference Citation Analysis]
404 Badgery H, Chong L, Iich E, Huang Q, Georgy SR, Wang DH, Read M. Recent insights into the biology of Barrett's esophagus. Ann N Y Acad Sci 2020;1481:198-209. [PMID: 32681541 DOI: 10.1111/nyas.14432] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
405 Clermont M, Falk GW. Clinical Guidelines Update on the Diagnosis and Management of Barrett’s Esophagus. Dig Dis Sci 2018;63:2122-8. [DOI: 10.1007/s10620-018-5070-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 5.8] [Reference Citation Analysis]
406 Spechler SJ. Cardiac Metaplasia: Follow, Treat, or Ignore? Dig Dis Sci 2018;63:2052-8. [PMID: 29671160 DOI: 10.1007/s10620-018-5063-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
407 Rajaram R, Hofstetter WL. Mucosal Ablation Techniques for Barrett's Esophagus and Early Esophageal Cancer. Thorac Surg Clin 2018;28:473-80. [PMID: 30268293 DOI: 10.1016/j.thorsurg.2018.07.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
408 Eluri S, Klaver E, Duits LC, Jackson SA, Bergman JJ, Shaheen NJ. Validation of a biomarker panel in Barrett's esophagus to predict progression to esophageal adenocarcinoma. Dis Esophagus 2018;31. [PMID: 29635420 DOI: 10.1093/dote/doy026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
409 Fujii-Lau LL, Cinnor B, Shaheen N, Gaddam S, Komanduri S, Muthusamy VR, Das A, Wilson R, Simon VC, Kushnir V, Mullady D, Edmundowicz SA, Early DS, Wani S. Recurrence of intestinal metaplasia and early neoplasia after endoscopic eradication therapy for Barrett's esophagus: a systematic review and meta-analysis. Endosc Int Open 2017;5:E430-49. [PMID: 28573176 DOI: 10.1055/s-0043-106578] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
410 Houston T, Sharma P. Volumetric laser endomicroscopy in Barrett's esophagus: ready for primetime. Transl Gastroenterol Hepatol. 2020;5:27. [PMID: 32258531 DOI: 10.21037/tgh.2019.11.16] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
411 van Munster SN, Nieuwenhuis EA, Weusten BLAM, Herrero LA, Bogte A, Alkhalaf A, Schenk BE, Schoon EJ, Curvers W, Koch AD, van de Ven SEM, de Jonge PJF, Tang T, Nagengast WB, Peters FTM, Westerhof J, Houben MHMG, Bergman JJGHM, Pouw RE; Dutch Barrett Expert Centers. Endoscopic Resection Without Subsequent Ablation Therapy for Early Barrett's Neoplasia: Endoscopic Findings and Long-Term Mortality. J Gastrointest Surg 2021;25:67-76. [PMID: 33140322 DOI: 10.1007/s11605-020-04836-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
412 Lee SW, Lien HC, Chang CS, Lin MX, Chang CH, Ko CW. Benefits of the Seattle biopsy protocol in the diagnosis of Barrett’s esophagus in a Chinese population. World J Clin Cases 2018; 6(14): 753-758 [PMID: 30510939 DOI: 10.12998/wjcc.v6.i14.753] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
413 Qumseya BJ, Bartel MJ, Gendy S, Bain P, Qumseya A, Wolfsen H. High rate of over-staging of Barrett's neoplasia with endoscopic ultrasound: Systemic review and meta-analysis. Dig Liver Dis. 2018;50:438-445. [PMID: 29573963 DOI: 10.1016/j.dld.2018.02.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
414 Triadafilopoulos G, Zikos T, Regalia K, Sonu I, Fernandez-becker NQ, Nguyen L, Nandwani MCR, Clarke JO. Use of Esophageal pH Monitoring to Minimize Proton-Pump Inhibitor Utilization in Patients with Gastroesophageal Reflux Symptoms. Dig Dis Sci 2018;63:2673-80. [DOI: 10.1007/s10620-018-5183-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
415 Zhang LY, Kalloo AN, Ngamruengphong S. Therapeutic Endoscopy and the Esophagus: State of the Art and Future Directions. Gastroenterol Clin North Am 2021;50:935-58. [PMID: 34717880 DOI: 10.1016/j.gtc.2021.08.007] [Reference Citation Analysis]
416 Wani S, Williams JL, Komanduri S, Muthusamy VR, Shaheen NJ. Over-Utilization of Repeat Upper Endoscopy in Patients with Non-dysplastic Barrett's Esophagus: A Quality Registry Study. Am J Gastroenterol 2019;114:1256-64. [DOI: 10.14309/ajg.0000000000000184] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
417 Okereke IC, Westra J, Tyler D, Klimberg S, Jupiter D, Venkatesan R, Brooks K, Kuo YF. Disparities in esophageal cancer care based on race: a National Cancer Database analysis. Dis Esophagus 2021:doab083. [PMID: 34918057 DOI: 10.1093/dote/doab083] [Reference Citation Analysis]
418 Wiens E, Kovaltchouk U, Koomson A, Targownik LE. The Clinician's Guide to Proton-Pump Inhibitor Discontinuation. J Clin Gastroenterol 2019;53:553-9. [PMID: 31356559 DOI: 10.1097/MCG.0000000000001243] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
419 Magee CG, Graham D, Gordon C, Dunn J, Penman I, Willert R, Smart H, Ortiz-Fernandez-Sordo J, Ragunath K, Everson M, Alzoubaidi D, Banks M, Morris D, Sami S, Morris AJ, Bhandari P, Narayanasamy R, Di Pietro M, Lovat LB, Haidry R. Radiofrequency ablation for Barrett's oesophagus related neoplasia with the 360 Express catheter: initial experience from the United Kingdom and Ireland-preliminary results. Surg Endosc 2021. [PMID: 33547491 DOI: 10.1007/s00464-021-08325-0] [Reference Citation Analysis]
420 Mejri F, Ben Khoud H, Njim L, Baati T, Selmi S, Martins A, Serralheiro ML, Rauter AP, Hosni K. In vitro and in vivo biological properties of pea pods (Pisum sativum L.). Food Bioscience 2019;32:100482. [DOI: 10.1016/j.fbio.2019.100482] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
421 Lee SW, Lien HC, Peng YC, Lin MX, Ko CW, Chang CS. The incidence of esophageal cancer and dysplasia in a Chinese population with nondysplastic Barrett's esophagus. JGH Open 2018;2:214-6. [PMID: 30483592 DOI: 10.1002/jgh3.12075] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
422 Omidvari A, Roumans CA, Naber SK, Kroep S, Wijnhoven BP, Gaast AVD, de Jonge P, Spaander MC, Lansdorp-vogelaar I. The Impact of the Policy-Practice Gap on Costs and Benefits of Barrett's Esophagus Management. Am J Gastroenterol 2020;115:1026-35. [DOI: 10.14309/ajg.0000000000000578] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
423 Nusrat S, Syed T, Nusrat S, Chen S, Chen WJ, Bielefeldt K. Assessment of Pharmaceutical Company and Device Manufacturer Payments to Gastroenterologists and Their Participation in Clinical Practice Guideline Panels. JAMA Netw Open 2018;1:e186343. [PMID: 30646328 DOI: 10.1001/jamanetworkopen.2018.6343] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
424 Eluri S, Earasi AG, Moist SE, Dellon ES, Shaheen NJ. Prevalence and Incidence of Intestinal Metaplasia and Dysplasia of Gastric Cardia in Patients With Barrett's Esophagus After Endoscopic Therapy. Clin Gastroenterol Hepatol 2020;18:82-88.e1. [PMID: 31077822 DOI: 10.1016/j.cgh.2019.04.065] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
425 Zakko L, Visrodia K, Wang KK, Iyer PG. Editorial: The Effect of Bias on Estimation of Improved Survival After Diagnosis of Barrett's Esophagus. Am J Gastroenterol 2017;112:1265-6. [PMID: 28766563 DOI: 10.1038/ajg.2017.185] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
426 Kaul V, Gross S, Corbett FS, Malik Z, Smith MS, Tofani C, Infantolino A. Clinical utility of wide-area transepithelial sampling with three-dimensional computer-assisted analysis (WATS3D) in identifying Barrett's esophagus and associated neoplasia. Dis Esophagus 2020;33:doaa069. [PMID: 32607543 DOI: 10.1093/dote/doaa069] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
427 Thota PN, Arora Z, Dumot JA, Falk G, Benjamin T, Goldblum J, Jang S, Lopez R, Vargo JJ. Cryotherapy and Radiofrequency Ablation for Eradication of Barrett's Esophagus with Dysplasia or Intramucosal Cancer. Dig Dis Sci. 2018;63:1311-1319. [PMID: 29524114 DOI: 10.1007/s10620-018-5009-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
428 Faqih A, Broman KK, Huang LC, Phillips SE, Holzman MD, Pierce RA, Poulose BK, Yachimski PS. Frequency of endoscopic surveillance for Barrett's esophagus is influenced by health insurance status: results from a population-based analysis. Dis Esophagus 2017;30:1-8. [PMID: 28881902 DOI: 10.1093/dote/dox080] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
429 Triantafyllou T, Wijnhoven BPL. Current status of esophageal cancer treatment. Chin J Cancer Res 2020;32:271-86. [PMID: 32694894 DOI: 10.21147/j.issn.1000-9604.2020.03.01] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
430 Chiu PWY, Uedo N, Singh R, Gotoda T, Ng EKW, Yao K, Ang TL, Ho SH, Kikuchi D, Yao F, Pittayanon R, Goda K, Lau JYW, Tajiri H, Inoue H. An Asian consensus on standards of diagnostic upper endoscopy for neoplasia. Gut. 2019;68:186-197. [PMID: 30420400 DOI: 10.1136/gutjnl-2018-317111] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 9.0] [Reference Citation Analysis]
431 Edwards P, Davidson M, Calamai V, Cunningham D, Starling N. Third line treatment of advanced oesophagogastric cancer: A critical review of current evidence and evolving trends. Cancer Treat Rev 2018;71:32-8. [PMID: 30343173 DOI: 10.1016/j.ctrv.2018.10.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
432 Duits LC, Lao-Sirieix P, Wolf WA, O'Donovan M, Galeano-Dalmau N, Meijer SL, Offerhaus GJA, Redman J, Crawte J, Zeki S, Pouw RE, Chak A, Shaheen NJ, Bergman JJGHM, Fitzgerald RC. A biomarker panel predicts progression of Barrett's esophagus to esophageal adenocarcinoma. Dis Esophagus. 2019;32. [PMID: 30496496 DOI: 10.1093/dote/doy102] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
433 Genere JR, Priyan H, Sawas T, Hanada Y, Visrodia K, Zakko L, Iyer PG, Wong Kee Song LM, Wang KK. Safety and histologic outcomes of endoscopic submucosal dissection with a novel articulating knife for esophageal neoplasia. Gastrointestinal Endoscopy 2020;91:797-805. [DOI: 10.1016/j.gie.2019.12.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
434 Swager AF, Tearney GJ, Leggett CL, van Oijen MGH, Meijer SL, Weusten BL, Curvers WL, Bergman JJGHM. Identification of volumetric laser endomicroscopy features predictive for early neoplasia in Barrett's esophagus using high-quality histological correlation. Gastrointest Endosc 2017;85:918-926.e7. [PMID: 27658906 DOI: 10.1016/j.gie.2016.09.012] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 8.2] [Reference Citation Analysis]
435 Levink IJ, Tearney GJ, Erler NS, Wolfsen HC, Siersema PD, Wallace MB. Barrett’s Epithelial Thickness, Assessed by Volumetric Laser Endomicroscopy, Is Associated With Response to Radiofrequency Ablation. Clinical Gastroenterology and Hepatology 2021;19:1160-1169.e2. [DOI: 10.1016/j.cgh.2020.05.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
436 Tokuyama M, Geisler D, Deitrick C, Fasanella KE, Chennat JS, McGrath KM, Pai RK, Davison JM. Use of p53 immunohistochemistry in conjunction with routine histology improves risk stratification of patients with Barrett's oesophagus during routine clinical care. Histopathology 2020;77:481-91. [PMID: 32431062 DOI: 10.1111/his.14143] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
437 Trindade AJ, Inamdar S, Smith MS, Chang KJ, Leggett CL, Lightdale CJ, Pleskow DK, Sejpal DV, Tearney GJ, Thomas RM, Wallace MB. Volumetric laser endomicroscopy in Barrett's esophagus: interobserver agreement for interpretation of Barrett's esophagus and associated neoplasia among high-frequency users. Gastrointest Endosc. 2017;86:133-139. [PMID: 27899321 DOI: 10.1016/j.gie.2016.11.026] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
438 Shaheen NJ, Komanduri S, Muthusamy VR, Wani S, O'Donovan M, Kaushal R, Haydek JM. Acceptability and Adequacy of a Non-endoscopic Cell Collection Device for Diagnosis of Barrett's Esophagus: Lessons Learned. Dig Dis Sci 2021. [PMID: 33532971 DOI: 10.1007/s10620-021-06833-6] [Reference Citation Analysis]
439 Davison JM, Shah MB, Deitrick C, Chennat J, Fasanella KE, Mcgrath K. Low-grade dysplasia diagnosis ratio and progression metrics identify variable Barrett’s esophagus risk stratification proficiency in independent pathology practices. Gastrointestinal Endoscopy 2018;88:807-815.e2. [DOI: 10.1016/j.gie.2018.06.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
440 Scarpignato C, Sloan JA, Wang DH, Hunt RH. Gastrointestinal pharmacology: practical tips for the esophagologist. Ann N Y Acad Sci 2020;1481:90-107. [PMID: 32822080 DOI: 10.1111/nyas.14447] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
441 Hamade N, Kamboj AK, Krishnamoorthi R, Singh S, Hassett LC, Katzka DA, Kahi CJ, Fatima H, Iyer PG. Systematic review with meta-analysis: neoplasia detection rate and post-endoscopy Barrett's neoplasia in Barrett's oesophagus. Aliment Pharmacol Ther 2021;54:546-59. [PMID: 34275161 DOI: 10.1111/apt.16531] [Reference Citation Analysis]
442 Kaz AM, Grady WM. Novel Barrett's esophagus screening assays based on swallowable devices: will they change the game? Transl Gastroenterol Hepatol 2019;4:25. [PMID: 31143846 DOI: 10.21037/tgh.2019.04.01] [Reference Citation Analysis]
443 Antony A, Pohanka C, Keogh S, Klein R, Alshelleh M, Lee C, Trindade AJ. Adherence to quality indicators in endoscopic surveillance of Barrett's esophagus and correlation to dysplasia detection rates. Clinics and Research in Hepatology and Gastroenterology 2018;42:591-6. [DOI: 10.1016/j.clinre.2018.06.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
444 Soifer L, Tawil J, Remes-Troche JM, M A Valdovinos, Schmulson M; grupo de colaboración de ERGE de la Sociedad Latinoamericana de Neurogastroenterología. Degree of concordance on the management of patients with gastroesophageal reflux disease. A study among specialists that are members of the Sociedad Latinoamericana de Neurogastroenterología (SLNG). Rev Gastroenterol Mex 2021:S0375-0906(21)00060-4. [PMID: 34294483 DOI: 10.1016/j.rgmx.2021.02.006] [Reference Citation Analysis]
445 Wronska E, Polkowski M, Orlowska J, Mroz A, Wieszczy P, Regula J. Argon plasma coagulation for Barrett's esophagus with low-grade dysplasia: a randomized trial with long-term follow-up on the impact of power setting and proton pump inhibitor dose. Endoscopy 2021;53:123-32. [PMID: 32650347 DOI: 10.1055/a-1203-5930] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
446 Barret M, Prat F. Diagnosis and treatment of superficial esophageal cancer. Ann Gastroenterol. 2018;31:256-265. [PMID: 29720850 DOI: 10.20524/aog.2018.0252] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
447 Pickens A. Racial Disparities in Esophageal Cancer. Thorac Surg Clin 2022;32:57-65. [PMID: 34801196 DOI: 10.1016/j.thorsurg.2021.09.004] [Reference Citation Analysis]
448 Thota PN, Hajifathalian K, Benjamin T, Runkana A, Lopez R, Sanaka MR. Lack of incremental effect of histamine receptor antagonists over proton pump inhibitors on the risk of neoplastic progression in patients with Barrett's esophagus: a cohort study. J Dig Dis 2017;18:143-50. [PMID: 28188977 DOI: 10.1111/1751-2980.12457] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
449 Martínek J, Akiyama JI, Vacková Z, Furnari M, Savarino E, Weijs TJ, Valitova E, van der Horst S, Ruurda JP, Goense L, Triadafilopoulos G. Current treatment options for esophageal diseases. Ann N Y Acad Sci 2016;1381:139-51. [PMID: 27391867 DOI: 10.1111/nyas.13146] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
450 Marabotto E, Pellegatta G, Sheijani AD, Ziola S, Zentilin P, De Marzo MG, Giannini EG, Ghisa M, Barberio B, Scarpa M, Angriman I, Fassan M, Savarino V, Savarino E. Prevention Strategies for Esophageal Cancer-An Expert Review. Cancers (Basel) 2021;13:2183. [PMID: 34062788 DOI: 10.3390/cancers13092183] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
451 Curtius K, Wright NA, Graham TA. An evolutionary perspective on field cancerization. Nat Rev Cancer 2018;18:19-32. [PMID: 29217838 DOI: 10.1038/nrc.2017.102] [Cited by in Crossref: 157] [Cited by in F6Publishing: 157] [Article Influence: 31.4] [Reference Citation Analysis]
452 van Munster SN, Overwater A, Haidry R, Bisschops R, Bergman JJGHM, Weusten BLAM. Focal cryoballoon versus radiofrequency ablation of dysplastic Barrett's esophagus: impact on treatment response and postprocedural pain. Gastrointest Endosc 2018;88:795-803.e2. [PMID: 29928869 DOI: 10.1016/j.gie.2018.06.015] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
453 Desai M, Lieberman DA, Kennedy KF, Hamade N, Thota P, Parasa S, Gorrepati VS, Bansal A, Gupta N, Gaddam S, Young PE, Mathur S, Moawad FJ, Cash BD, Sampliner R, Vargo JJ, Falk GW, Sharma P. Increasing prevalence of high-grade dysplasia and adenocarcinoma on index endoscopy in Barrett's esophagus over the past 2 decades: data from a multicenter U.S. consortium. Gastrointest Endosc 2019;89:257-263.e3. [PMID: 30342028 DOI: 10.1016/j.gie.2018.09.041] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
454 Zhang M, Cui M, Zuo Q, Wang L, Wang J, Zhu L, Yan R, Lu N, Yan H, Zhang L. Construction and evaluation of prognostic models for esophageal cancer patients with distant and non-distant metastases: providing a reference process for clinical diagnosis and treatment. J Gastrointest Oncol 2021;12:1241-54. [PMID: 34532084 DOI: 10.21037/jgo-21-429] [Reference Citation Analysis]
455 Duprée A, Ehlken H, Rösch T, Lüken M, Reeh M, Werner YB, de Heer J, Schachschal G, Clauditz TS, Mann O, Izbicki JR, Groth S. Laparoscopic lymph node sampling: a new concept for patients with high-risk early esophagogastric junction cancer resected endoscopically. Gastrointest Endosc 2021;94:282-90. [PMID: 33639136 DOI: 10.1016/j.gie.2021.02.014] [Reference Citation Analysis]
456 Overwater A, van Munster SN, Nagengast WB, Pouw RE, Bergman JJGHM, Schoon EJ, Weusten BLAM. Novel cryoballoon 180° ablation system for treatment of Barrett's esophagus-related neoplasia: a first-in-human study. Endoscopy 2021. [PMID: 33662991 DOI: 10.1055/a-1381-7562] [Reference Citation Analysis]
457 Konda VJA, Souza RF. Biomarkers of Barrett's Esophagus: From the Laboratory to Clinical Practice. Dig Dis Sci. 2018;63:2070-2080. [PMID: 29713984 DOI: 10.1007/s10620-018-5088-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
458 van der Wel MJ, Coleman HG, Bergman JJGHM, Jansen M, Meijer SL; BOLERO working group. Histopathologist features predictive of diagnostic concordance at expert level among a large international sample of pathologists diagnosing Barrett's dysplasia using digital pathology. Gut 2020;69:811-22. [PMID: 31852770 DOI: 10.1136/gutjnl-2019-318985] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
459 Desai M, Sharma P. What Quality Metrics Should We Apply in Barrett's Esophagus? Am J Gastroenterol 2019;114:1197-8. [PMID: 31306150 DOI: 10.14309/ajg.0000000000000316] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
460 Brosnan C, Hannan E, Duggan W, Harding T, Maguire D, Stafford AT. Diagnostic Inaccuracies of Barrett's Oesophagus on Gastroscopy: Are We Performing Unnecessary Surveillance? Cureus 2020;12:e9850. [PMID: 32953357 DOI: 10.7759/cureus.9850] [Reference Citation Analysis]
461 Michopoulos S. Critical appraisal of guidelines for screening and surveillance of Barrett's esophagus. Ann Transl Med 2018;6:259. [PMID: 30094245 DOI: 10.21037/atm.2018.05.09] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
462 Soroush A, Poneros JM, Lightdale CJ, Abrams JA. Shorter time to achieve endoscopic eradication is not associated with improved long-term outcomes in Barrett's esophagus. Diseases of the Esophagus 2019;32:doz026. [DOI: 10.1093/dote/doz026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
463 Marques de Sá I, Pereira AD, Sharma P, Dinis-Ribeiro M. Systematic review of the published guidelines on Barrett's esophagus: should we stress the consensus or the differences? Dis Esophagus 2020:doaa115. [PMID: 33249488 DOI: 10.1093/dote/doaa115] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
464 Parasa S, Vennalaganti S, Gaddam S, Vennalaganti P, Young P, Gupta N, Thota P, Cash B, Mathur S, Sampliner R, Moawad F, Lieberman D, Bansal A, Kennedy KF, Vargo J, Falk G, Spaander M, Bruno M, Sharma P. Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia. Gastroenterology. 2018;154:1282-1289.e2. [PMID: 29273452 DOI: 10.1053/j.gastro.2017.12.009] [Cited by in Crossref: 52] [Cited by in F6Publishing: 40] [Article Influence: 10.4] [Reference Citation Analysis]
465 Struyvenberg MR, van der Sommen F, Swager AF, de Groof AJ, Rikos A, Schoon EJ, Bergman JJ, de With PHN, Curvers WL. Improved Barrett's neoplasia detection using computer-assisted multiframe analysis of volumetric laser endomicroscopy. Dis Esophagus. 2020;33. [PMID: 31364700 DOI: 10.1093/dote/doz065] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
466 Naveed M, Kubiliun N. Endoscopic Treatment of Early-Stage Esophageal Cancer. Curr Oncol Rep. 2018;20:71. [PMID: 30058019 DOI: 10.1007/s11912-018-0713-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
467 Hatta W, Tong D, Lee YY, Ichihara S, Uedo N, Gotoda T. Different time trend and management of esophagogastric junction adenocarcinoma in three Asian countries. Dig Endosc 2017;29 Suppl 2:18-25. [PMID: 28425657 DOI: 10.1111/den.12808] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 5.8] [Reference Citation Analysis]
468 Januszewicz W, Kaminski MF. Quality indicators in diagnostic upper gastrointestinal endoscopy. Therap Adv Gastroenterol 2020;13:1756284820916693. [PMID: 32477426 DOI: 10.1177/1756284820916693] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
469 Wirsching A, Boshier PR, Krishnamoorthi R, Larsen MC, Irani S, Ross AS, Low DE. Endoscopic therapy and surveillance versus esophagectomy for early esophageal adenocarcinoma: A review of early outcomes and cost analysis. Am J Surg. 2019;218:164-169. [PMID: 30635212 DOI: 10.1016/j.amjsurg.2018.12.058] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
470 Mönig S, Chevallay M, Niclauss N, Zilli T, Fang W, Bansal A, Hoeppner J. Early esophageal cancer: the significance of surgery, endoscopy, and chemoradiation. Ann N Y Acad Sci 2018;1434:115-23. [PMID: 30138532 DOI: 10.1111/nyas.13955] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
471 Walker MJ, Crews NR, El-Halabi M, Fayad NF. Educational Intervention Improves Proton Pump Inhibitor Stewardship in Outpatient Gastroenterology Clinics. Gastroenterology Res 2019;12:305-11. [PMID: 31803310 DOI: 10.14740/gr1238] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
472 Krishnamoorthi R, Hargraves I, Gopalakrishnan N, Blevins CH, Priyan H, Johnson ML, Maixner KA, Wang KK, Katzka DA, Talwalkar JA, LeBlanc A, Iyer PG. Development and Pilot Testing of Decision Aid for Shared Decision Making in Barrett's Esophagus With Low-Grade Dysplasia. J Clin Gastroenterol 2021;55:36-42. [PMID: 32040049 DOI: 10.1097/MCG.0000000000001319] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
473 Zullo A, Fiorini G, Bassotti G, Bachetti F, Monica F, Macor D, Paoluzi OA, Scaccianoce G, Portincasa P, De Francesco V, Lorenzetti R, Saracino IM, Pavoni M, Vaira D. Upper Endoscopy in Patients with Extra-Oesophageal Reflux Symptoms: A Multicentre Study. GE Port J Gastroenterol 2020;27:312-7. [PMID: 32999903 DOI: 10.1159/000505581] [Reference Citation Analysis]
474 Garg S, Xie J, Inamdar S, Thomas SL, Trindade AJ. Spatial distribution of dysplasia in Barrett's esophagus segments before and after endoscopic ablation therapy: a meta-analysis. Endoscopy 2021;53:6-14. [PMID: 32503057 DOI: 10.1055/a-1195-1000] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
475 Xavier S, Magalhães J, Cotter J. Proton Pump Inhibitors: Are They a Real Threat to the Patient? GE Port J Gastroenterol 2018;25:243-52. [PMID: 30320163 DOI: 10.1159/000487154] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
476 Yamamoto K, Ohnishi S, Mizushima T, Kodaira J, Ono M, Hatanaka Y, Hatanaka KC, Kuriki Y, Kamiya M, Ehira N, Shinada K, Takahashi H, Shimizu Y, Urano Y, Sakamoto N. Detection of early adenocarcinoma of the esophagogastric junction by spraying an enzyme-activatable fluorescent probe targeting Dipeptidyl peptidase-IV. BMC Cancer 2020;20:64. [PMID: 31992267 DOI: 10.1186/s12885-020-6537-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
477 Odze RD, Goldblum J, Kaul V. Role of Wide-Area Transepithelial Sampling With 3D Computer-Assisted Analysis in the Diagnosis and Management of Barrett's Esophagus. Clin Transl Gastroenterol 2021;12:e00422. [PMID: 34874019 DOI: 10.14309/ctg.0000000000000422] [Reference Citation Analysis]
478 Jeong S, Bak J, Kim SM, Kang HW. Feasibility study of endoscopic thermal coagulation with circumferential laser irradiation for treating esophageal tissue. Lasers Med Sci 2020;35:893-900. [PMID: 31641966 DOI: 10.1007/s10103-019-02877-3] [Reference Citation Analysis]
479 Wani S, Yadlapati R, Singh S, Sawas T, Katzka DA; Post-Endoscopy Esophageal Neoplasia Expert Consensus Panel. Post-endoscopy Esophageal Neoplasia in Barrett's Esophagus: Consensus Statements From an International Expert Panel. Gastroenterology 2021:S0016-5085(21)03620-9. [PMID: 34655571 DOI: 10.1053/j.gastro.2021.09.067] [Reference Citation Analysis]
480 Szymański M, Marek I, Wilczyński M, Janczy A, Bigda J, Kaska Ł, Proczko-stepaniak M. Evaluation of esophageal pathology in a group of patients 2 years after one-anastomosis gastric bypass (OAGB) — Cohort study. Obesity Research & Clinical Practice 2021. [DOI: 10.1016/j.orcp.2021.12.001] [Reference Citation Analysis]
481 Sharma N, Srivastava S, Kern F, Xian W, Yeoh KG, Ming T, McKeon F, Ho KY. CEACAM 6, a novel marker for the diagnosis of Barrett's esophagus. Dis Esophagus 2017;30:1-5. [PMID: 28475729 DOI: 10.1093/dote/dox026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
482 Offman J, Fitzgerald RC. Alternatives to Traditional Per-Oral Endoscopy for Screening. Gastrointest Endosc Clin N Am 2017;27:379-96. [PMID: 28577763 DOI: 10.1016/j.giec.2017.02.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
483 Oumrani S, Barret M, Beuvon F, Leblanc S, Chaussade S, Prat F. Salvage endoscopic submucosal dissection for esophageal adenocarcinoma arising during radiofrequency ablation. Ann Gastroenterol 2018;31:522-4. [PMID: 29991901 DOI: 10.20524/aog.2018.0261] [Reference Citation Analysis]
484 Peters Y, van Grinsven E, Siersema PD. Systematic review with meta-analysis: the effects of family history on the risk of Barrett's oesophagus and oesophageal adenocarcinoma. Aliment Pharmacol Ther 2021;54:868-79. [PMID: 34383966 DOI: 10.1111/apt.16558] [Reference Citation Analysis]
485 Januszewicz W, Tan WK, Lehovsky K, Debiram-Beecham I, Nuckcheddy T, Moist S, Kadri S, di Pietro M, Boussioutas A, Shaheen NJ, Katzka DA, Dellon ES, Fitzgerald RC; BEST1 and BEST2 study investigators. Safety and Acceptability of Esophageal Cytosponge Cell Collection Device in a Pooled Analysis of Data From Individual Patients. Clin Gastroenterol Hepatol. 2019;17:647-656.e1. [PMID: 30099104 DOI: 10.1016/j.cgh.2018.07.043] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 7.3] [Reference Citation Analysis]
486 Yang H, Hu B. Recent advances in early esophageal cancer: diagnosis and treatment based on endoscopy. Postgrad Med 2021;133:665-73. [PMID: 34030580 DOI: 10.1080/00325481.2021.1934495] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
487 Monardo A, McCullough J. Incidence of Dysplasia in Obese vs Nonobese Patients With Nondysplastic Barrett Esophagus. Ochsner J 2019;19:347-52. [PMID: 31903058 DOI: 10.31486/toj.19.0038] [Reference Citation Analysis]
488 Docimo S Jr, Al-Mansour M, Tsuda S. SAGES TAVAC safety and efficacy analysis WATS3D (CDx Diagnostics, Suffern, NY). Surg Endosc 2020;34:3743-7. [PMID: 32162125 DOI: 10.1007/s00464-020-07503-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
489 Aihara H, Kushnir V, Anand GS, Cassani L, Chahal P, Dacha S, Duloy A, Ghassemi S, Huang C, Kowalski TE, Qayed E, Sheth SG, Simons-Linares CR, Taylor JR, Umar SB, Vela SAF, Walsh CM, Williams RL, Wagh MS; ASGE Training Committee. Core curriculum for endoscopic ablative techniques. Gastrointest Endosc 2021;93:305-8. [PMID: 32854937 DOI: 10.1016/j.gie.2020.06.055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
490 Ventre S, Shahid H. Endoscopic therapies for Barrett's esophagus. Transl Gastroenterol Hepatol 2021;6:62. [PMID: 34805584 DOI: 10.21037/tgh.2020.02.04] [Reference Citation Analysis]
491 Barbeiro S, Libânio D, Castro R, Dinis-Ribeiro M, Pimentel-Nunes P. Narrow-Band Imaging: Clinical Application in Gastrointestinal Endoscopy. GE Port J Gastroenterol 2018;26:40-53. [PMID: 30675503 DOI: 10.1159/000487470] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
492 Yamasaki A, Shimizu T, Kawachi H, Yamamoto N, Yoshimizu S, Horiuchi Y, Ishiyama A, Yoshio T, Hirasawa T, Tsuchida T, Sasaki Y, Fujisaki J. Endoscopic features of esophageal adenocarcinoma derived from short-segment versus long-segment Barrett's esophagus. J Gastroenterol Hepatol 2020;35:211-7. [PMID: 31396997 DOI: 10.1111/jgh.14827] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
493 Marques de Sá I, Marcos P, Sharma P, Dinis-Ribeiro M. The global prevalence of Barrett's esophagus: A systematic review of the published literature. United European Gastroenterol J 2020;8:1086-105. [PMID: 32631176 DOI: 10.1177/2050640620939376] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
494 Diehl DL, Khara HS, Akhtar N, Critchley-Thorne RJ. TissueCypher Barrett's esophagus assay impacts clinical decisions in the management of patients with Barrett's esophagus. Endosc Int Open 2021;9:E348-55. [PMID: 33655033 DOI: 10.1055/a-1326-1533] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
495 Gorrepati VS, Sharma P. How Should We Report Endoscopic Results in Patient's with Barrett's Esophagus? Dig Dis Sci 2018;63:2115-21. [PMID: 29675664 DOI: 10.1007/s10620-018-5067-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
496 Kolb JM, Wani S. Barrett's esophagus: current standards in advanced imaging. Transl Gastroenterol Hepatol 2021;6:14. [PMID: 33409408 DOI: 10.21037/tgh.2020.02.10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
497 Braden B, Jones-Morris E. How to get the most out of costly Barrett's oesophagus surveillance. Dig Liver Dis 2018;50:871-7. [PMID: 29730158 DOI: 10.1016/j.dld.2018.04.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
498 Jacobson RA, Munding E, Hayden DM, Levy M, Kuzel TM, Pappas SG, Masood A. Evolving Clinical Utility of Liquid Biopsy in Gastrointestinal Cancers. Cancers (Basel) 2019;11:E1164. [PMID: 31412682 DOI: 10.3390/cancers11081164] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
499 Ahmed O, Ajani JA, Lee JH. Endoscopic management of esophageal cancer. World J Gastrointest Oncol 2019; 11(10): 830-841 [PMID: 31662822 DOI: 10.4251/wjgo.v11.i10.830] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
500 van der Wel MJ, Duits LC, Pouw RE, Seldenrijk CA, Offerhaus GJA, Visser M, Ten Kate FJ, Biermann K, Brosens LAA, Doukas M, Huysentruyt C, Karrenbeld A, Kats-Ugurlu G, van der Laan JS, van Lijnschoten GI, Moll FCP, Ooms AHAG, van der Valk H, Tijssen JG, Bergman JJ, Meijer SL. Improved diagnostic stratification of digitised Barrett's oesophagus biopsies by p53 immunohistochemical staining. Histopathology 2018;72:1015-23. [PMID: 29314176 DOI: 10.1111/his.13462] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
501 Ahmadi N, Mbuagbaw L, Hanna WC, Finley C, Agzarian J, Wen CK, Coret M, Schieman C, Shargall Y. Development of a clinical score to distinguish malignant from benign esophageal disease in an undiagnosed patient population referred to an esophageal diagnostic assessment program. J Thorac Dis 2020;12:191-8. [PMID: 32274084 DOI: 10.21037/jtd.2020.02.07] [Reference Citation Analysis]
502 Frei NF, Konte K, Bossart EA, Stebbins K, Zhang Y, Pouw RE, Critchley-Thorne RJ, Bergman JJGHM. Independent Validation of a Tissue Systems Pathology Assay to Predict Future Progression in Nondysplastic Barrett's Esophagus: A Spatial-Temporal Analysis. Clin Transl Gastroenterol 2020;11:e00244. [PMID: 33108124 DOI: 10.14309/ctg.0000000000000244] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
503 Hamel C, Ahmadzai N, Beck A, Thuku M, Skidmore B, Pussegoda K, Bjerre L, Chatterjee A, Dennis K, Ferri L, Maziak DE, Shea BJ, Hutton B, Little J, Moher D, Stevens A. Screening for esophageal adenocarcinoma and precancerous conditions (dysplasia and Barrett's esophagus) in patients with chronic gastroesophageal reflux disease with or without other risk factors: two systematic reviews and one overview of reviews to inform a guideline of the Canadian Task Force on Preventive Health Care (CTFPHC). Syst Rev 2020;9:20. [PMID: 31996261 DOI: 10.1186/s13643-020-1275-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
504 Adachi K, Mishiro T, Tanaka S, Kinoshita Y. Circumferential Locations of Different Shapes of Short-segment Barrett's Esophagus. Intern Med 2017;56:1937-42. [PMID: 28768960 DOI: 10.2169/internalmedicine.56.8260] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
505 Pratap A, McCarter MD, Watson TJ. Surgical Management of Barrett's-Related Neoplasia. Gastrointest Endosc Clin N Am 2021;31:205-18. [PMID: 33213796 DOI: 10.1016/j.giec.2020.09.003] [Reference Citation Analysis]
506 Correia ACP, Calpe S, Mostafavi N, Hoefnagel SJM, Sancho-Serra MDC, de Koning PS, Krishnadath KK. Detection of circulating BMP5 as a risk factor for Barrett's esophagus. Sci Rep 2020;10:15579. [PMID: 32968094 DOI: 10.1038/s41598-020-70760-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
507 Komanduri S, Muthusamy VR, Wani S. Controversies in Endoscopic Eradication Therapy for Barrett’s Esophagus. Gastroenterology 2018;154:1861-1875.e1. [DOI: 10.1053/j.gastro.2017.12.045] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
508 Ten Kate FJC, Nieboer D, Ten Kate FJW, Doukas M, Bruno MJ, Spaander MCW, Looijenga LHJ, Biermann K; ProBar study group and Palga Group. Improved Progression Prediction in Barrett's Esophagus With Low-grade Dysplasia Using Specific Histologic Criteria. Am J Surg Pathol 2018;42:918-26. [PMID: 29697438 DOI: 10.1097/PAS.0000000000001066] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
509 Jaruvongvanich V, Osman K, Matar R, Baroud S, Hanada Y, Chesta FNU, Maselli DB, Mahmoud T, Wang KK, Abu Dayyeh BK. Impact of bariatric surgery on surveillance and treatment outcomes of Barrett's esophagus: A stage-matched cohort study. Surg Obes Relat Dis 2021;17:1457-64. [PMID: 34083137 DOI: 10.1016/j.soard.2021.04.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
510 Souza RF, Spechler SJ. Advances in Biomarkers for Risk Stratification in Barrett's Esophagus. Gastrointest Endosc Clin N Am 2021;31:105-15. [PMID: 33213790 DOI: 10.1016/j.giec.2020.08.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
511 Wani S, Gyawali CP, Katzka DA. AGA Clinical Practice Update on Reducing Rates of Post-Endoscopy Esophageal Adenocarcinoma: Commentary. Gastroenterology 2020;159:1533-7. [DOI: 10.1053/j.gastro.2020.06.089] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
512 Srivastava A, Appelman H, Goldsmith JD, Davison JM, Hart J, Krasinskas AM. The Use of Ancillary Stains in the Diagnosis of Barrett Esophagus and Barrett Esophagus–associated Dysplasia: Recommendations From the Rodger C. Haggitt Gastrointestinal Pathology Society. American Journal of Surgical Pathology 2017;41:e8-e21. [DOI: 10.1097/pas.0000000000000819] [Cited by in Crossref: 23] [Cited by in F6Publishing: 5] [Article Influence: 4.6] [Reference Citation Analysis]
513 Itskoviz D, Levi Z, Boltin D, Vilkin A, Snir Y, Gingold-belfer R, Niv Y, Dotan I, Dickman R. Risk of Neoplastic Progression Among Patients with an Irregular Z Line on Long-Term Follow-Up. Dig Dis Sci 2018;63:1513-7. [DOI: 10.1007/s10620-018-4910-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
514 Le Bras GF, Farooq MH, Falk GW, Andl CD. Esophageal cancer: The latest on chemoprevention and state of the art therapies. Pharmacol Res 2016;113:236-44. [PMID: 27565381 DOI: 10.1016/j.phrs.2016.08.021] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
515 Arora Z, Garber A, Thota PN. Risk factors for Barrett's esophagus. J Dig Dis 2016;17:215-21. [PMID: 26929263 DOI: 10.1111/1751-2980.12332] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
516 Jin Z, Zhang D, Zhang Q, Lai J, Akki A, Esnakula A, Kresak J, Gonzalo DH, Draganov PV, Xie H, Liu X. Desmoplasia and Detached Papillae in Early Esophageal Adenocarcinoma: A Histologic Study on Endoscopic Submucosal Dissection Specimens. Gastroenterology Res 2019;12:72-7. [PMID: 31019616 DOI: 10.14740/gr1154] [Reference Citation Analysis]
517 Parasa S, Sharma P. Barrett’s Esophagus With Low-Grade Dysplasia: Ablate or Wait? American Journal of Gastroenterology 2017;112:195-6. [DOI: 10.1038/ajg.2016.605] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
518 Gould JC, Wendling MR, Oeschlager BK, Mittal SK, Komanduri S, Perry KA, Cleary S, Galandiuk S, Scott DJ, Fisichella PM, Shaheen NJ, Haisley KR, Hunter JG. Advances in the Diagnosis and Treatment of Barrett's Esophagus and Early Esophageal Cancer; Summary of the Kelly and Carlos Pellegrini SSAT/SAGES Luncheon Symposium. J Gastrointest Surg 2017;21:1342-9. [PMID: 28243981 DOI: 10.1007/s11605-017-3390-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
519 Dong J, Grant C, Vuong B, Nishioka N, Gao AH, Beatty M, Baldwin G, Baillargeon A, Bablouzian A, Grahmann P, Bhat N, Ryan E, Barrios A, Giddings S, Ford T, Beaulieu-Ouellet E, Hosseiny SH, Lerman I, Trasischker W, Reddy R, Singh K, Gora M, Hyun D, Quénéhervé L, Wallace M, Wolfsen H, Sharma P, Wang KK, Leggett CL, Poneros J, Abrams JA, Lightdale C, Leeds S, Rosenberg M, Tearney GJ. Feasibility and Safety of Tethered Capsule Endomicroscopy in Patients With Barrett's Esophagus in a Multi-Center Study. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00109-9. [PMID: 33549871 DOI: 10.1016/j.cgh.2021.02.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
520 Bulamu NB, Chen G, Bright T, Ratcliffe J, Chung A, Fraser RJL, Törnqvist B, Watson DI. Preferences for Surveillance of Barrett's Oesophagus: a Discrete Choice Experiment. J Gastrointest Surg 2019;23:1309-17. [PMID: 30478530 DOI: 10.1007/s11605-018-4049-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
521 Visrodia K, Zakko L, Singh S, Leggett CL, Iyer PG, Wang KK. Cryotherapy for persistent Barrett's esophagus after radiofrequency ablation: a systematic review and meta-analysis. Gastrointest Endosc 2018;87:1396-1404.e1. [PMID: 29476849 DOI: 10.1016/j.gie.2018.02.021] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
522 Leggett CL, Wolfsen HC. A new aim for targeted biopsies in Barrett's esophagus. Gastrointest Endosc 2017;86:473-5. [PMID: 28826548 DOI: 10.1016/j.gie.2017.03.1517] [Reference Citation Analysis]
523 Codipilly DC, Krishna Chandar A, Wang KK, Katzka DA, Goldblum JR, Thota PN, Falk GW, Chak A, Iyer PG. Wide-area transepithelial sampling for dysplasia detection in Barrett's esophagus: a systematic review and meta-analysis. Gastrointest Endosc 2021:S0016-5107(21)01646-1. [PMID: 34543648 DOI: 10.1016/j.gie.2021.09.015] [Reference Citation Analysis]
524 Hosono I, Miyahara R, Furukawa K, Funasaka K, Sawada T, Maeda K, Yamamura T, Ishikawa T, Ohno E, Nakamura M, Kawashima H, Yokoi T, Tsukamoto T, Hirooka Y, Fujishiro M. Use of Immunostaining for the diagnosis of Lymphovascular invasion in superficial Barrett's esophageal adenocarcinoma. BMC Gastroenterol 2020;20:175. [PMID: 32503448 DOI: 10.1186/s12876-020-01319-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
525 Jones B, Williams JL, Komanduri S, Muthusamy VR, Shaheen NJ, Wani S. Racial Disparities in Adherence to Quality Indicators in Barrett's Esophagus: An Analysis Using the GIQuIC National Benchmarking Registry. Am J Gastroenterol 2021;116:1201-10. [DOI: 10.14309/ajg.0000000000001230] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
526 Mastracci L, Grillo F, Parente P, Unti E, Battista S, Spaggiari P, Campora M, Scaglione G, Fassan M, Fiocca R. Gastro-esophageal reflux disease and Barrett's esophagus: an overview with an histologic diagnostic approach. Pathologica 2020;112:117-27. [PMID: 33179616 DOI: 10.32074/1591-951X-162] [Reference Citation Analysis]
527 Iyer PG, Taylor WR, Johnson ML, Lansing RL, Maixner KA, Yab TC, Simonson JA, Devens ME, Slettedahl SW, Mahoney DW, Berger CK, Foote PH, Smyrk TC, Wang KK, Wolfsen HC, Ahlquist DA. Highly Discriminant Methylated DNA Markers for the Non-endoscopic Detection of Barrett's Esophagus. Am J Gastroenterol 2018;113:1156-66. [PMID: 29891853 DOI: 10.1038/s41395-018-0107-7] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 7.3] [Reference Citation Analysis]
528 Crous-Bou M, Jovani M, De Vivo I, Jacobson BC. Gene-Environment Interactions and the Risk of Barrett's Esophagus in Three US Cohorts. Am J Gastroenterol 2019;114:893-9. [PMID: 30950840 DOI: 10.14309/ajg.0000000000000219] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
529 Tomizawa Y, Konda VJ, Coronel E, Chapman CG, Siddiqui UD. Efficacy, Durability, and Safety of Complete Endoscopic Mucosal Resection of Barrett Esophagus: A Systematic Review and Meta-Analysis. Journal of Clinical Gastroenterology 2018;52:210-6. [DOI: 10.1097/mcg.0000000000000800] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
530 Nieto T, Tomlinson CL, Dretzke J, Bayliss S, Dilworth M, Beggs AD, Tucker O. Epigenetic biomarkers in progression from non-dysplastic Barrett's oesophagus to oesophageal adenocarcinoma: a systematic review protocol. BMJ Open 2016;6:e013361. [PMID: 27927666 DOI: 10.1136/bmjopen-2016-013361] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
531 Saxena N, Inadomi JM. Effectiveness and Cost-Effectiveness of Endoscopic Screening and Surveillance. Gastrointestinal Endoscopy Clinics of North America 2017;27:397-421. [DOI: 10.1016/j.giec.2017.02.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
532 Rogers BD, Gyawali CP. Why differences between New York and New Delhi matter in approach to gastroesophageal reflux disease. Indian J Gastroenterol 2019;38:371-7. [DOI: 10.1007/s12664-019-00987-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
533 Singh H, Ha K, Hornick JL, Madha S, Cejas P, Jajoo K, Singh P, Polak P, Lee H, Shivdasani RA. Hybrid Stomach-Intestinal Chromatin States Underlie Human Barrett's Metaplasia. Gastroenterology 2021;161:924-939.e11. [PMID: 34090884 DOI: 10.1053/j.gastro.2021.05.057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
534 Rosmolen WD, Phoa NKYN, Nieuwkerk PT, Pouw RE, Weusten BLAM, Bisschops R, Schoon EJ, Sprangers MAG, Bergman JJGHM. Impact of ablation of Barrett's esophagus with low-grade dysplasia on patients' illness perception and quality of life: a multicenter randomized trial. Gastrointest Endosc 2019;90:215-21. [PMID: 31026438 DOI: 10.1016/j.gie.2019.04.226] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
535 Voltaggio L, Montgomery EA. Diagnosis and Management of Barrett-Related Neoplasia in the Modern Era. Surg Pathol Clin 2017;10:781-800. [PMID: 29103533 DOI: 10.1016/j.path.2017.07.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
536 Jones B, Wani S. Endoscopic Eradication Therapy for Barrett's Neoplasia: Where Do We Stand a Decade Later? Curr Gastroenterol Rep 2020;22:61. [PMID: 33277663 DOI: 10.1007/s11894-020-00799-7] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
537 Trindade AJ, Raphael KL, Inamdar S, Stewart M, Berkowitz J, Vegesna A, McKinley MJ, Benias PC, Kahn A, Leggett CL, Lee C, Sejpal DV, Rishi A. Volumetric laser endomicroscopy features of dysplasia at the gastric cardia in Barrett's oesophagus: results from an observational cohort study. BMJ Open Gastroenterol 2019;6:e000340. [PMID: 31749979 DOI: 10.1136/bmjgast-2019-000340] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
538 Condon A, Muthusamy VR. The evolution of endoscopic therapy for Barrett's esophagus. Ther Adv Gastrointest Endosc 2021;14:26317745211051834. [PMID: 34708204 DOI: 10.1177/26317745211051834] [Reference Citation Analysis]
539 Amano Y, Nakahara R, Yuki T, Murakami D, Ujihara T, Tomoyuki I, Sagami R, Suehiro S, Katsuyama Y, Hayasaka K, Harada H, Tada Y, Miyaoka Y, Fujishiro H. Relationship between Barrett's esophagus and colonic diseases: a role for colonoscopy in Barrett's surveillance. J Gastroenterol 2019;54:984-93. [PMID: 31240437 DOI: 10.1007/s00535-019-01600-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
540 Chiam KH, Shin SH, Choi KC, Leiria F, Militz M, Singh R. Current Status of Mucosal Imaging with Narrow-Band Imaging in the Esophagus. Gut Liver 2021;15:492-9. [PMID: 32307976 DOI: 10.5009/gnl20031] [Reference Citation Analysis]
541 Omar M, Thaker AM, Wani S, Simon V, Ezekwe E, Boniface M, Edmundowicz S, Obuch J, Cinnor B, Brauer BC, Wood M, Early DS, Lang GD, Mullady D, Hollander T, Kushnir V, Komanduri S, Muthusamy VR. Anatomic location of Barrett's esophagus recurrence after endoscopic eradication therapy: development of a simplified surveillance biopsy strategy. Gastrointest Endosc 2019;90:395-403. [PMID: 31004598 DOI: 10.1016/j.gie.2019.04.216] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
542 Singh T, Sanaka MR, Thota PN. Endoscopic therapy for Barrett’s esophagus and early esophageal cancer: Where do we go from here? World J Gastrointest Endosc 2018; 10(9): 165-174 [PMID: 30283599 DOI: 10.4253/wjge.v10.i9.165] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
543 Mahawar KK, Carr WRJ, Borg CM, Aminian A. Does Sleeve Gastrectomy Cause Barrett's Oesophagus? Obes Surg 2018;28:4049-50. [PMID: 30280332 DOI: 10.1007/s11695-018-3541-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
544 Nie Z, Yeh SA, LePalud M, Badr F, Tse F, Armstrong D, Liu LWC, Deen MJ, Fang Q. Optical Biopsy of the Upper GI Tract Using Fluorescence Lifetime and Spectra. Front Physiol 2020;11:339. [PMID: 32477151 DOI: 10.3389/fphys.2020.00339] [Reference Citation Analysis]
545 Sharma N, Hui T, Wong HC, Srivastava S, Teh M, Yeoh KG, Ho KY. Risk stratifying the screening of Barrett's esophagus: An Asian perspective. JGH Open 2017;1:68-73. [PMID: 30483537 DOI: 10.1002/jgh3.12013] [Reference Citation Analysis]
546 Solanky D, Krishnamoorthi R, Crews N, Johnson M, Wang K, Wolfsen H, Fleischer D, Ramirez FC, Katzka D, Buttar N, Iyer PG. Barrett Esophagus Length, Nodularity, and Low-grade Dysplasia are Predictive of Progression to Esophageal Adenocarcinoma. J Clin Gastroenterol 2019;53:361-5. [PMID: 29608452 DOI: 10.1097/MCG.0000000000001027] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
547 Siddiki HA, Lam-himlin DM, Kahn A, Bandres MV, Burdick GE, Crowell MD, Pannala R, Ramirez FC, Vela MF, Fleischer DE. Intestinal metaplasia of the gastric cardia: findings in patients with versus without Barrett’s esophagus. Gastrointestinal Endoscopy 2019;89:759-68. [DOI: 10.1016/j.gie.2018.10.048] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
548 Baik D, Sheng J, Schlaffer K, Friedenberg FK, Smith MS, Ehrlich AC. Abdominal diameter index is a stronger predictor of prevalent Barrett's esophagus than BMI or waist-to-hip ratio. Dis Esophagus 2017;30:1-6. [PMID: 28859359 DOI: 10.1093/dote/dox056] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
549 Qin Y, Iyer PG. Predicting Progression in Barrett's Esophagus: Is the Holy Grail Within Reach? Am J Gastroenterol 2020;115:841-2. [PMID: 32287139 DOI: 10.14309/ajg.0000000000000635] [Reference Citation Analysis]
550 Barret M, Bordaçahar B, Beuvon F, Terris B, Camus M, Coriat R, Chaussade S, Batteux F, Prat F. Self-assembling peptide matrix for the prevention of esophageal stricture after endoscopic resection: a randomized controlled trial in a porcine model. Diseases of the Esophagus 2017;30:1-7. [DOI: 10.1093/dote/dow015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
551 Kahn A, Shaheen NJ, Iyer PG. Approach to the Post-Ablation Barrett's Esophagus Patient. Am J Gastroenterol 2020;115:823-31. [PMID: 31899706 DOI: 10.14309/ajg.0000000000000514] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
552 Qumseya BJ, Wolfsen HC. The Role of Endoscopic Ultrasound in the Management of Patients with Barrett's Esophagus and Superficial Neoplasia. Gastrointestinal Endoscopy Clinics of North America 2017;27:471-80. [DOI: 10.1016/j.giec.2017.03.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
553 Riley CA, Wu EL, Hsieh MC, Marino MJ, Wu XC, McCoul ED. Association of Gastroesophageal Reflux With Malignancy of the Upper Aerodigestive Tract in Elderly Patients. JAMA Otolaryngol Head Neck Surg 2018;144:140-8. [PMID: 29270624 DOI: 10.1001/jamaoto.2017.2561] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
554 Canto MI, Trindade AJ, Abrams J, Rosenblum M, Dumot J, Chak A, Iyer P, Diehl D, Khara HS, Corbett FS, McKinley M, Shin EJ, Waxman I, Infantolino A, Tofani C, Samarasena J, Chang K, Wang B, Goldblum J, Voltaggio L, Montgomery E, Lightdale CJ, Shaheen NJ. Multifocal Cryoballoon Ablation for Eradication of Barrett's Esophagus-Related Neoplasia: A Prospective Multicenter Clinical Trial. Am J Gastroenterol 2020;115:1879-90. [PMID: 33156107 DOI: 10.14309/ajg.0000000000000822] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
555 Inayat F, Weissman S, Malik A, Munir B, Iqbal S. Endoscopic Submucosal Tunnel Dissection as a Novel Therapeutic Technique in Patients With Barrett's Esophagus. J Investig Med High Impact Case Rep 2020;8:2324709620941318. [PMID: 32666847 DOI: 10.1177/2324709620941318] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
556 Schlottmann F, Patti MG, Shaheen NJ. From Heartburn to Barrett's Esophagus, and Beyond. World J Surg 2017;41:1698-704. [PMID: 28258457 DOI: 10.1007/s00268-017-3957-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
557 Zagari RM, Eusebi LH, Galloro G, Rabitti S, Neri M, Pasquale L, Bazzoli F. Attending Training Courses on Barrett's Esophagus Improves Adherence to Guidelines: A Survey from the Italian Society of Digestive Endoscopy. Dig Dis Sci 2021;66:2888-96. [PMID: 32984930 DOI: 10.1007/s10620-020-06615-6] [Reference Citation Analysis]
558 Westerveld D, Khullar V, Mramba L, Ayoub F, Brar T, Agarwal M, Forde J, Chakraborty J, Riverso M, Perbtani YB, Gupte A, Forsmark CE, Draganov P, Yang D. Adherence to quality indicators and surveillance guidelines in the management of Barrett's esophagus: a retrospective analysis. Endosc Int Open 2018;6:E300-7. [PMID: 29507870 DOI: 10.1055/s-0044-101351] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
559 Gabre J, Chak A, Rustgi A. Familial Barrett’s Esophagus and Esophageal Adenocarcinoma. Curr Treat Options Gastro 2020;18:616-22. [DOI: 10.1007/s11938-020-00313-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
560 Omidvari AH, Hazelton WD, Lauren BN, Naber SK, Lee M, Ali A, Seguin C, Kong CY, Richmond E, Rubenstein JH, Luebeck GE, Inadomi JM, Hur C, Lansdorp-Vogelaar I. The Optimal Age to Stop Endoscopic Surveillance of Patients With Barrett's Esophagus Based on Sex and Comorbidity: A Comparative Cost-Effectiveness Analysis. Gastroenterology 2021;161:487-494.e4. [PMID: 33974935 DOI: 10.1053/j.gastro.2021.05.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
561 Overwater A, Brosens LAA, Offerhaus GJA, Weusten BLAM. Single-Step Treatment with Limited Endoscopic Resection and Cryoballoon Ablation Is Feasible and Safe in an Esophageal Porcine Model. Dig Dis Sci 2020;65:3175-83. [PMID: 31970611 DOI: 10.1007/s10620-020-06054-3] [Reference Citation Analysis]
562 Smyth EC, Lagergren J, Fitzgerald RC, Lordick F, Shah MA, Lagergren P, Cunningham D. Oesophageal cancer. Nat Rev Dis Primers. 2017;3:17048. [PMID: 28748917 DOI: 10.1038/nrdp.2017.48] [Cited by in Crossref: 249] [Cited by in F6Publishing: 246] [Article Influence: 49.8] [Reference Citation Analysis]
563 Nieto T, Tomlinson CL, Dretzke J, Bayliss S, Price MJ, Dilworth M, Beggs AD, Tucker O. A systematic review of epigenetic biomarkers in progression from non-dysplastic Barrett's oesophagus to oesophageal adenocarcinoma. BMJ Open 2018;8:e020427. [PMID: 29961009 DOI: 10.1136/bmjopen-2017-020427] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
564 Sharma P, Allen JE, Gorrepati VS, Gupta N. Improving quality of care in patients with Barrett's esophagus by measuring and improving neoplasia detection rates. Gastrointest Endosc 2018;87:1195-7. [PMID: 29655434 DOI: 10.1016/j.gie.2018.01.033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
565 Hiremath G, Locke A, Sivakumar A, Thomas G, Mahadevan-Jansen A. Clinical translational application of Raman spectroscopy to advance Benchside biochemical characterization to bedside diagnosis of esophageal diseases. J Gastroenterol Hepatol 2019;34:1911-21. [PMID: 31124184 DOI: 10.1111/jgh.14738] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
566 Hadjinicolaou AV, van Munster SN, Achilleos A, Santiago Garcia J, Killcoyne S, Ragunath K, Bergman JJGHM, Fitzgerald RC, di Pietro M. Aneuploidy in targeted endoscopic biopsies outperforms other tissue biomarkers in the prediction of histologic progression of Barrett's oesophagus: A multi-centre prospective cohort study. EBioMedicine 2020;56:102765. [PMID: 32460165 DOI: 10.1016/j.ebiom.2020.102765] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
567 Katzka DA, Kahrilas PJ. Advances in the diagnosis and management of gastroesophageal reflux disease. BMJ. [DOI: 10.1136/bmj.m3786] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
568 Gomez G. The Evaluation and Management of Suspicious Gastric Lesions Following Bariatric Surgery. Surg Clin North Am 2017;97:467-74. [PMID: 28325198 DOI: 10.1016/j.suc.2016.12.003] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
569 Levert-Mignon A, Bourke MJ, Lord SJ, Taylor AC, Wettstein AR, Edwards M, Botelho NK, Sonson R, Jayasekera C, Fisher OM, Thomas ML, Macrae F, Hussey DJ, Watson DI, Lord RV. Changes in gene expression of neo-squamous mucosa after endoscopic treatment for dysplastic Barrett's esophagus and intramucosal adenocarcinoma. United European Gastroenterol J 2017;5:13-20. [PMID: 28405317 DOI: 10.1177/2050640616650794] [Reference Citation Analysis]
570 Watts AE, Cotton CC, Shaheen NJ. Radiofrequency Ablation of Barrett's Esophagus: Have We Gone Too Far, or Not Far Enough? Curr Gastroenterol Rep 2020;22:29. [PMID: 32383077 DOI: 10.1007/s11894-020-00766-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
571 Rocha-Filho DR, Peixoto RD, Weschenfelder RF, Rego JFM, Riechelmann R, Coutinho AK, Fernandes GS, Jacome AA, Andrade AC, Murad AM, Mello CAL, Miguel DSCG, Gomes DBD, Racy DJ, Moraes ED, Akaishi EH, Carvalho ES, Mello ES, Filho FM, Coimbra FJF, Capareli FC, Arruda FF, Vieira FMAC, Takeda FR, Cotti GCC, Pereira GLS, Paulo GA, Ribeiro HSC, Lourenco LG, Crosara M, Toneto MG, Oliveira MB, de Lourdes Oliveira M, Begnami MD, Forones NM, Yagi O, Ashton-Prolla P, Aguillar PB, Amaral PCG, Hoff PM, Araujo RLC, Di Paula Filho RP, Gansl RC, Gil RA, Pfiffer TEF, Souza T, Ribeiro U Jr, Jesus VHF, Costa WL Jr, Prolla G. Brazilian Group of Gastrointestinal Tumours' consensus guidelines for the management of oesophageal cancer. Ecancermedicalscience 2021;15:1195. [PMID: 33889204 DOI: 10.3332/ecancer.2021.1195] [Reference Citation Analysis]
572 Demkowicz R, Thota PN, Benjamin T, Lopez R, Lu H, Patil DT, Downs-Kelly E, Jeung JA, Lai KK, Lapinski J, Savage EC, Goldblum JR, Gordon IO. Allaying uncertainty in diagnosing buried Barrett's esophagus. Ann Diagn Pathol 2021;51:151672. [PMID: 33418428 DOI: 10.1016/j.anndiagpath.2020.151672] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
573 Trindade AJ, Navaneethan U, Aslanian HR, Bhutani MS, Krishnan K, Lichtenstein DR, Melson J, Pannala R, Parsi MA, Schulman AR, Sethi A, Trikudanathan G, Watson RR, Maple JT. Advances in the diagnosis and surveillance of Barrett’s esophagus (with videos). Gastrointestinal Endoscopy 2019;90:325-34. [DOI: 10.1016/j.gie.2019.05.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
574 Davison JM, Goldblum J, Grewal US, McGrath K, Fasanella K, Deitrick C, DeWard AD, Bossart EA, Hayward SL, Zhang Y, Critchley-Thorne RJ, Thota PN. Independent Blinded Validation of a Tissue Systems Pathology Test to Predict Progression in Patients With Barrett's Esophagus. Am J Gastroenterol 2020;115:843-52. [PMID: 32079863 DOI: 10.14309/ajg.0000000000000556] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
575 Vajravelu RK, Kolb JM, Thanawala SU, Scott FI, Han S, Singal AG, Falk GW, Katzka DA, Wani S. Characterization of Prevalent, Post-Endoscopy, and Incident Esophageal Cancer in the United States: A Large Retrospective Cohort Study. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00106-3. [PMID: 33549872 DOI: 10.1016/j.cgh.2021.02.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
576 Epstein JA, Cosby H, Falk GW, Khashab MA, Kiesslich R, Montgomery EA, Wang JS, Canto MI. Columnar islands in Barrett's esophagus: Do they impact Prague C&M criteria and dysplasia grade?: Columnar Islands in Barrett's Esophagus. Journal of Gastroenterology and Hepatology 2017;32:1598-603. [DOI: 10.1111/jgh.13744] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
577 Hadi YB, Khan AA, Naqvi SFZ, Kupec JT. Independent association of obstructive sleep apnea with Barrett's esophagus. J Gastroenterol Hepatol 2020;35:408-11. [PMID: 31290178 DOI: 10.1111/jgh.14779] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
578 Hao J, Critchley-Thorne R, Diehl DL, Snyder SR. A Cost-Effectiveness Analysis Of An Adenocarcinoma Risk Prediction Multi-Biomarker Assay For Patients With Barrett's Esophagus. Clinicoecon Outcomes Res 2019;11:623-35. [PMID: 31749626 DOI: 10.2147/CEOR.S221741] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.7] [Reference Citation Analysis]
579 Wahking RA, Steele RL, Hanners RE, Lockwood SM, Davis KW. Outcomes From a Pharmacist - led Proton Pump Inhibitor Stewardship Program at a Single Institution. Hosp Pharm 2018;53:59-67. [PMID: 29434389 DOI: 10.1177/0018578717747192] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
580 Newberry C, Lynch K. Using Diet to Treat Diseases of Esophagus: Back to the Basics. Gastroenterol Clin North Am 2021;50:959-72. [PMID: 34717881 DOI: 10.1016/j.gtc.2021.08.008] [Reference Citation Analysis]
581 Trindade AJ, McKinley MJ, Alshelleh M, Levi G, Stewart M, Quinn KJ, Thomas RM. Mutational load may predict risk of progression in patients with Barrett's oesophagus and indefinite for dysplasia: a pilot study. BMJ Open Gastroenterol 2019;6:e000268. [PMID: 30815274 DOI: 10.1136/bmjgast-2018-000268] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
582 Garman KS. Drivers of Esophageal Adenocarcinoma and Opportunities for Cancer Interception. Cell Mol Gastroenterol Hepatol 2021;12:787-8. [PMID: 34029533 DOI: 10.1016/j.jcmgh.2021.04.018] [Reference Citation Analysis]
583 Kolb JM, Wani S. Endoscopic eradication therapy for Barrett's oesophagus: state of the art. Curr Opin Gastroenterol 2020;36:351-8. [PMID: 32487852 DOI: 10.1097/MOG.0000000000000650] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
584 Bansal R, Khan R, Scaffidi MA, Gimpaya N, Genis S, Bukhari A, Dhillon J, Dao K, Bonneau C, Grover SC. Undisclosed payments by pharmaceutical and medical device manufacturers to authors of endoscopy guidelines in the United States. Gastrointest Endosc 2020;91:266-73. [PMID: 31738925 DOI: 10.1016/j.gie.2019.11.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
585 Codipilly DC, Gavrilova RH, Tangalos EG. De novo 2p16.1 microdeletion with metastatic esophageal adenocarcinoma. BMJ Case Rep 2017;2017:bcr2016218016. [PMID: 28108439 DOI: 10.1136/bcr-2016-218016] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
586 Zakko L, Lutzke L, Wang KK. Screening and Preventive Strategies in Esophagogastric Cancer. Surg Oncol Clin N Am 2017;26:163-78. [PMID: 28279462 DOI: 10.1016/j.soc.2016.10.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
587 Kandel P, Wallace MB. The Role of Adjunct Imaging in Endoscopic Detection of Dysplasia in Barrett's Esophagus. Gastrointest Endosc Clin N Am. 2017;27:423-446. [PMID: 28577765 DOI: 10.1016/j.giec.2017.02.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
588 Spechler SJ, Katzka DA, Fitzgerald RC. New Screening Techniques in Barrett’s Esophagus: Great Ideas or Great Practice? Gastroenterology 2018;154:1594-601. [DOI: 10.1053/j.gastro.2018.03.031] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 6.5] [Reference Citation Analysis]
589 Groulx S, Limburg H, Doull M, Klarenbach S, Singh H, Wilson BJ, Thombs B; Canadian Task Force on Preventive Health Care. Guideline on screening for esophageal adenocarcinoma in patients with chronic gastroesophageal reflux disease. CMAJ 2020;192:E768-77. [PMID: 32631908 DOI: 10.1503/cmaj.190814] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
590 Trindade AJ, Smith MS, Pleskow DK. The new kid on the block for advanced imaging in Barrett's esophagus: a review of volumetric laser endomicroscopy. Therap Adv Gastroenterol 2016;9:408-16. [PMID: 27134668 DOI: 10.1177/1756283X16639003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
591 Peters Y, van Grinsven E, van de Haterd M, van Lankveld D, Verbakel J, Siersema PD. Individuals’ Preferences for Esophageal Cancer Screening: A Discrete Choice Experiment. Value in Health 2020;23:1087-95. [DOI: 10.1016/j.jval.2020.03.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
592 Sawas T, Majzoub AM, Haddad J, Tielleman T, Nayfeh T, Yadlapati R, Singh S, Kolb J, Vajravelu RK, Katzka DA, Wani S; Post-Endoscopy Esophageal Adenocarcinoma Consensus Panel. Magnitude and Time-Trend Analysis of Post-Endoscopy Esophageal Adenocarcinoma: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00466-3. [PMID: 33901662 DOI: 10.1016/j.cgh.2021.04.032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
593 Laszkowska M, Oh A, Hur C. Screening for Upper Gastrointestinal Malignancies in the United States-Which Immigrant Groups Should Be Considered High-Risk? Gastroenterology 2020;158:4-8. [PMID: 31614125 DOI: 10.1053/j.gastro.2019.09.047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
594 Biswas Roy S, Banks P, Kunz M, Ipsen TR, Masuda T, Mittal SK, Smith MA, Bremner RM. Prevalence and Natural History of Barrett's Esophagus in Lung Transplant: A Single-Center Experience. Ann Thorac Surg 2019;107:1017-23. [PMID: 30481513 DOI: 10.1016/j.athoracsur.2018.10.041] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
595 Shaheen NJ, Fennerty MB, Bergman JJ. Less Is More: A Minimalist Approach to Endoscopy. Gastroenterology 2018;154:1993-2003. [PMID: 29454789 DOI: 10.1053/j.gastro.2017.12.044] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
596 Farina DA, Condon A, Komanduri S, Muthusamy VR. A Practical Approach to Refractory and Recurrent Barrett's Esophagus. Gastrointest Endosc Clin N Am 2021;31:183-203. [PMID: 33213795 DOI: 10.1016/j.giec.2020.09.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
597 Thota PN, Kistangari G, Esnakula AK, Gonzalo DH, Liu XL. Clinical significance and management of Barrett’s esophagus with epithelial changes indefinite for dysplasia. World J Gastrointest Pharmacol Ther 2016; 7(3): 406-411 [PMID: 27602241 DOI: 10.4292/wjgpt.v7.i3.406] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
598 McGoran JJ, Ragunath K. Endoscopic management of Barrett's esophagus: Western perspective of current status and future prospects. Dig Endosc 2021;33:720-9. [PMID: 32790886 DOI: 10.1111/den.13812] [Reference Citation Analysis]
599 Cotton CC, Wolf WA, Overholt BF, Li N, Lightdale CJ, Wolfsen HC, Pasricha S, Wang KK, Shaheen NJ; AIM Dysplasia Trial Group. Late Recurrence of Barrett's Esophagus After Complete Eradication of Intestinal Metaplasia is Rare: Final Report From Ablation in Intestinal Metaplasia Containing Dysplasia Trial. Gastroenterology 2017;153:681-688.e2. [PMID: 28579538 DOI: 10.1053/j.gastro.2017.05.044] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 10.4] [Reference Citation Analysis]
600 Tan WK, di Pietro M, Fitzgerald RC. Past, present and future of Barrett's oesophagus. Eur J Surg Oncol 2017;43:1148-60. [PMID: 28256346 DOI: 10.1016/j.ejso.2017.02.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
601 Watson TJ. Esophagectomy for Superficial Esophageal Neoplasia. Gastrointest Endosc Clin N Am 2017;27:531-46. [PMID: 28577773 DOI: 10.1016/j.giec.2017.02.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
602 Muñoz-Largacha JA, Litle VR. Endoscopic mucosal ablation and resection of Barrett's esophagus and related diseases. J Vis Surg 2017;3:128. [PMID: 29078688 DOI: 10.21037/jovs.2017.07.10] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
603 Lawrence SA, Attiyeh MA, Seier K, Gönen M, Schattner M, Haviland DL, Balachandran VP, Kingham TP, D'Angelica MI, DeMatteo RP, Brennan MF, Jarnagin WR, Allen PJ. Should Patients With Cystic Lesions of the Pancreas Undergo Long-term Radiographic Surveillance?: Results of 3024 Patients Evaluated at a Single Institution. Ann Surg 2017;266:536-44. [PMID: 28657939 DOI: 10.1097/SLA.0000000000002371] [Cited by in Crossref: 34] [Cited by in F6Publishing: 11] [Article Influence: 6.8] [Reference Citation Analysis]
604 Peters Y, Al-kaabi A, Shaheen NJ, Chak A, Blum A, Souza RF, Di Pietro M, Iyer PG, Pech O, Fitzgerald RC, Siersema PD. Barrett oesophagus. Nat Rev Dis Primers 2019;5. [DOI: 10.1038/s41572-019-0086-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
605 Visrodia K, Singh S, Krishnamoorthi R, Ahlquist DA, Wang KK, Iyer PG, Katzka DA. Magnitude of Missed Esophageal Adenocarcinoma After Barrett's Esophagus Diagnosis: A Systematic Review and Meta-analysis. Gastroenterology. 2016;150:599-607.e7; quiz e14-5. [PMID: 26619962 DOI: 10.1053/j.gastro.2015.11.040] [Cited by in Crossref: 72] [Cited by in F6Publishing: 63] [Article Influence: 10.3] [Reference Citation Analysis]
606 Frei NF, Khoshiwal AM, Konte K, Bossart EA, Stebbins K, Zhang Y, Pouw RE, Ten Kate FJW, Seldenrijk KA, Meijer SL, Critchley-Thorne RJ, Bergman JJGHM. Tissue Systems Pathology Test Objectively Risk Stratifies Barrett's Esophagus Patients With Low-Grade Dysplasia. Am J Gastroenterol 2021;116:675-82. [PMID: 33982936 DOI: 10.14309/ajg.0000000000001037] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
607 Dimaio CJ. Current Guideline Controversies in the Management of Pancreatic Cystic Neoplasms. Gastrointestinal Endoscopy Clinics of North America 2018;28:529-47. [DOI: 10.1016/j.giec.2018.05.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
608 Triggs JR, Falk GW. Best Practices in Surveillance for Barrett's Esophagus. Gastrointest Endosc Clin N Am 2021;31:59-75. [PMID: 33213800 DOI: 10.1016/j.giec.2020.08.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
609 Vogt JS, Larsen AC, Sommer T, Ejstrud P. Quality of endoscopic surveillance of Barrett’s esophagus. Scandinavian Journal of Gastroenterology 2018;53:256-9. [DOI: 10.1080/00365521.2018.1430251] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
610 Inadomi J, Alastal H, Bonavina L, Gross S, Hunt RH, Mashimo H, di Pietro M, Rhee H, Shah M, Tolone S, Wang DH, Xie SH. Recent advances in Barrett's esophagus. Ann N Y Acad Sci 2018;1434:227-38. [PMID: 29974975 DOI: 10.1111/nyas.13909] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
611 Thota PN, Vennalaganti P, Vennelaganti S, Young P, Gaddam S, Gupta N, Lieberman D, Sampliner R, Falk GW, Mathur S, Kennedy K, Cash BD, Moawad F, Bansal A, Spaander MC, Bruno MJ, Vargo J, Sharma P. Low Risk of High-Grade Dysplasia or Esophageal Adenocarcinoma Among Patients With Barrett's Esophagus Less Than 1 cm (Irregular Z Line) Within 5 Years of Index Endoscopy. Gastroenterology 2017;152:987-92. [PMID: 27988383 DOI: 10.1053/j.gastro.2016.12.005] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
612 Komanduri S, Kahrilas PJ, Krishnan K, McGorisk T, Bidari K, Grande D, Keefer L, Pandolfino J. Recurrence of Barrett's Esophagus is Rare Following Endoscopic Eradication Therapy Coupled With Effective Reflux Control. Am J Gastroenterol. 2017;112:556-566. [PMID: 28195178 DOI: 10.1038/ajg.2017.13] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 7.4] [Reference Citation Analysis]
613 Hamade N, Vennelaganti S, Parasa S, Vennalaganti P, Gaddam S, Spaander MCW, van Olphen SH, Thota PN, Kennedy KF, Bruno MJ, Vargo JJ, Mathur S, Cash BD, Sampliner R, Gupta N, Falk GW, Bansal A, Young PE, Lieberman DA, Sharma P. Lower Annual Rate of Progression of Short-Segment vs Long-Segment Barrett's Esophagus to Esophageal Adenocarcinoma. Clin Gastroenterol Hepatol 2019;17:864-8. [PMID: 30012433 DOI: 10.1016/j.cgh.2018.07.008] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
614 Amadi C, Gatenby P. Barrett’s oesophagus: Current controversies. World J Gastroenterol 2017; 23(28): 5051-5067 [PMID: 28811703 DOI: 10.3748/wjg.v23.i28.5051] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
615 Quach DT, Pham QTT, Tran TLT, Vu NTH, Le QD, Nguyen DTN, Dang NLB, Le HM, Le NQ, Sharma P, Ho KY. Prevalence, clinical characteristics, and risk factors of Barrett esophagus in Vietnamese patients with upper gastrointestinal symptoms. Medicine (Baltimore) 2020;99:e21791. [PMID: 32846811 DOI: 10.1097/MD.0000000000021791] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
616 Ramay FH, Vareedayah AA, Visrodia K, Iyer PG, Wang KK, Eluri S, Shaheen NJ, Reddy R, Martin LW, Greenwald BD, Edwards MA. What Constitutes Optimal Management of T1N0 Esophageal Adenocarcinoma? Ann Surg Oncol 2019;26:714-31. [DOI: 10.1245/s10434-018-07118-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
617 Otaki F, Shaheen NJ. Stratifying Risk in Barrett’s Esophagus With Low-grade Dysplasia: Making the Best of a (Not So) Bad Situation. Clinical Gastroenterology and Hepatology 2016;14:963-5. [DOI: 10.1016/j.cgh.2016.03.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
618 Freedberg DE, Kim LS, Yang YX. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association. Gastroenterology. 2017;152:706-715. [PMID: 28257716 DOI: 10.1053/j.gastro.2017.01.031] [Cited by in Crossref: 322] [Cited by in F6Publishing: 270] [Article Influence: 64.4] [Reference Citation Analysis]
619 Wani S, Williams JL, Falk GW, Komanduri S, Muthusamy VR, Shaheen NJ. An Analysis of the GIQuIC Nationwide Quality Registry Reveals Unnecessary Surveillance Endoscopies in Patients With Normal and Irregular Z-Lines. Am J Gastroenterol 2020;115:1869-78. [PMID: 33156106 DOI: 10.14309/ajg.0000000000000960] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
620 Ge PS, Muthusamy VR. Endoscopic Mucosal Resection for Barrett's Esophagus. J Laparoendosc Adv Surg Tech A 2017;27:404-11. [PMID: 27901624 DOI: 10.1089/lap.2016.0532] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
621 Alkhayyat M, Sanghi V, Qapaja T, Butler R, Rouphael C, McMichael J, Goldblum J, Sanaka MR, Thota PN. Pyloroplasty and the risk of Barrett's esophagus in patients with gastroparesis. Dis Esophagus 2020;33:doaa049. [PMID: 32556104 DOI: 10.1093/dote/doaa049] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
622 Qu J, Wang Z, Qin J, Zhang H, Zhao Y, Lu Y, Yan X, Zhang S, Wang S, Kamel IR, Li H. MRI features in differentiating mucosal high-grade neoplasia from early invasive squamous cell cancer of the esophagus. Eur Radiol 2020;30:3455-61. [PMID: 32086576 DOI: 10.1007/s00330-020-06716-w] [Reference Citation Analysis]
623 Zhang L, Sun B, Zhou X, Wei Q, Liang S, Luo G, Li T, Lü M. Barrett's Esophagus and Intestinal Metaplasia. Front Oncol 2021;11:630837. [PMID: 34221959 DOI: 10.3389/fonc.2021.630837] [Reference Citation Analysis]
624 Maslyonkina KS, Konyukova AK, Alexeeva DY, Sinelnikov MY, Mikhaleva LM. Barrett's esophagus: The pathomorphological and molecular genetic keystones of neoplastic progression. Cancer Med 2021. [PMID: 34870375 DOI: 10.1002/cam4.4447] [Reference Citation Analysis]
625 Guccione C, Yadlapati R, Shah S, Knight R, Curtius K. Challenges in Determining the Role of Microbiome Evolution in Barrett's Esophagus and Progression to Esophageal Adenocarcinoma. Microorganisms 2021;9:2003. [PMID: 34683324 DOI: 10.3390/microorganisms9102003] [Reference Citation Analysis]
626 Schlottmann F, Molena D, Patti MG. Gastroesophageal reflux and Barrett’s esophagus: a pathway to esophageal adenocarcinoma. Updates Surg 2018;70:339-42. [DOI: 10.1007/s13304-018-0564-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
627 Wenker TN, Tan MC, Liu Y, El-Serag HB, Thrift AP. Prior Diagnosis of Barrett's Esophagus Is Infrequent, but Associated with Improved Esophageal Adenocarcinoma Survival. Dig Dis Sci 2018;63:3112-9. [PMID: 30109579 DOI: 10.1007/s10620-018-5241-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
628 Sreenarasimhaiah J. Endoscopic applications of cryospray ablation therapy-from Barrett’s esophagus and beyond. World J Gastrointest Endosc 2016; 8(16): 546-552 [PMID: 27621766 DOI: 10.4253/wjge.v8.i16.546] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
629 Sami SS, Ravindran A, Kahn A, Snyder D, Santiago J, Ortiz-Fernandez-Sordo J, Tan WK, Dierkhising RA, Crook JE, Heckman MG, Johnson ML, Lansing R, Ragunath K, di Pietro M, Wolfsen H, Ramirez F, Fleischer D, Wang KK, Leggett CL, Katzka DA, Iyer PG. Timeline and location of recurrence following successful ablation in Barrett's oesophagus: an international multicentre study. Gut 2019;68:1379-85. [PMID: 30635408 DOI: 10.1136/gutjnl-2018-317513] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 11.7] [Reference Citation Analysis]
630 Stachler MD, Camarda ND, Deitrick C, Kim A, Agoston AT, Odze RD, Hornick JL, Nag A, Thorner AR, Ducar M, Noffsinger A, Lash RH, Redston M, Carter SL, Davison JM, Bass AJ. Detection of Mutations in Barrett's Esophagus Before Progression to High-Grade Dysplasia or Adenocarcinoma. Gastroenterology 2018;155:156-67. [PMID: 29608884 DOI: 10.1053/j.gastro.2018.03.047] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 13.5] [Reference Citation Analysis]
631 Otaki F, Iyer PG. Best of foregut: esophagus, stomach, and duodenum. Gastrointest Endosc 2017;85:48-54. [PMID: 27746170 DOI: 10.1016/j.gie.2016.10.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
632 Hammad TA, Thrift AP, El-Serag HB, Husain NS. Missed Opportunities for Screening and Surveillance of Barrett's Esophagus in Veterans with Esophageal Adenocarcinoma. Dig Dis Sci 2019;64:367-72. [PMID: 30370493 DOI: 10.1007/s10620-018-5336-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
633 Moriarty JP, Shah ND, Rubenstein JH, Blevins CH, Johnson M, Katzka DA, Wang KK, Wongkeesong LM, Ahlquist DA, Iyer PG. Costs associated with Barrett's esophagus screening in the community: an economic analysis of a prospective randomized controlled trial of sedated versus hospital unsedated versus mobile community unsedated endoscopy. Gastrointest Endosc. 2018;87:88-94.e2. [PMID: 28455158 DOI: 10.1016/j.gie.2017.04.019] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 4.2] [Reference Citation Analysis]
634 Han S, Wani S. Quality Indicators in Endoscopic Ablation for Barrett's Esophagus. Curr Treat Options Gastroenterol 2017;15:241-55. [PMID: 28421454 DOI: 10.1007/s11938-017-0136-0] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
635 Tan WK, Rattan A, O'Donovan M, Nuckcheddy T, Alias B, Sujendran V, di Pietro M. Comparative outcomes of radiofrequency ablation for Barrett's oesophagus with different baseline histology. United European Gastroenterol J 2018;6:662-8. [PMID: 30083327 DOI: 10.1177/2050640617752183] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
636 Mendes JJ, Silva MJ, Miguel LS, Gonçalves MA, Oliveira MJ, Oliveira CDL, Gouveia J. Sociedade Portuguesa de Cuidados Intensivos guidelines for stress ulcer prophylaxis in the intensive care unit. Rev Bras Ter Intensiva 2019;31:5-14. [PMID: 30843949 DOI: 10.5935/0103-507X.20190002] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
637 Siddiki H, Fukami N. Endoscopic submucosal dissection for Barrett's neoplasia: decade of experience, little progress. Is ESD thE-BEST for complex Barrett's neoplasia? Gastrointest Endosc 2017;86:619-22. [PMID: 28917341 DOI: 10.1016/j.gie.2017.06.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
638 Tavakkoli A, Appelman HD, Beer DG, Madiyal C, Khodadost M, Nofz K, Metko V, Elta G, Wang T, Rubenstein JH. Use of Appropriate Surveillance for Patients With Nondysplastic Barrett's Esophagus. Clin Gastroenterol Hepatol 2018; 16: 862-869. e3. [PMID: 29432922 DOI: 10.1016/j.cgh.2018.01.052] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
639 Killcoyne S, Fitzgerald RC. Evolution and progression of Barrett's oesophagus to oesophageal cancer. Nat Rev Cancer 2021;21:731-41. [PMID: 34545238 DOI: 10.1038/s41568-021-00400-x] [Reference Citation Analysis]
640 Desai M, Hamade N, Sharma P. Screening for Barrett's esophagus: challenges in identifying the population at risk. Gastrointest Endosc 2021;93:420-1. [PMID: 33478664 DOI: 10.1016/j.gie.2020.11.002] [Reference Citation Analysis]
641 Knotts RM, Solfisburg QS, Keating C, DiMango E, Lightdale CJ, Abrams JA. Cystic fibrosis is associated with an increased risk of Barrett's esophagus. J Cyst Fibros. 2019;18:425-429. [PMID: 30473189 DOI: 10.1016/j.jcf.2018.11.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
642 Codipilly DC, Chandar AK, Singh S, Wani S, Shaheen NJ, Inadomi JM, Chak A, Iyer PG. The Effect of Endoscopic Surveillance in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis. Gastroenterology 2018;154:2068-2086.e5. [PMID: 29458154 DOI: 10.1053/j.gastro.2018.02.022] [Cited by in Crossref: 61] [Cited by in F6Publishing: 53] [Article Influence: 15.3] [Reference Citation Analysis]
643 Cummings LC, Kou TD, Chak A, Schluchter MD, Margevicius S, Cooper GS. Receipt of Serial Endoscopy Procedures Prior to Esophageal Adenocarcinoma Diagnosis Is Associated with Better Survival. Dig Dis Sci 2021. [PMID: 33881677 DOI: 10.1007/s10620-021-06927-1] [Reference Citation Analysis]
644 Tullie L, Kelay A, Bethell GS, Major C, Hall NJ. Barrett's oesophagus and oesophageal cancer following oesophageal atresia repair: a systematic review. BJS Open 2021;5:zrab069. [PMID: 34370830 DOI: 10.1093/bjsopen/zrab069] [Reference Citation Analysis]
645 Chis R, Hew S, Hopman W, Hookey L, Bechara R. Taking the Next Steps in Endoscopic Visual Assessment of Barrett's Esophagus: A Pilot Study. Clin Exp Gastroenterol 2021;14:113-22. [PMID: 33911891 DOI: 10.2147/CEG.S293477] [Reference Citation Analysis]
646 Herrera Elizondo JL, Monreal Robles R, García Compean D, González Moreno EI, Borjas Almaguer OD, Maldonado Garza HJ, González González JA. Prevalence of Barrett's esophagus: An observational study from a gastroenterology clinic. Rev Gastroenterol Mex 2017;82:296-300. [PMID: 28687434 DOI: 10.1016/j.rgmx.2017.01.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
647 Levine MS, Carucci LR, Disantis DJ, Einstein DM, Hawn MT, Martin-harris B, Katzka DA, Morgan DE, Rubesin SE, Scholz FJ, Turner MA, Wolf EL, Canon CL. Consensus Statement of Society of Abdominal Radiology Disease-Focused Panel on Barium Esophagography in Gastroesophageal Reflux Disease. American Journal of Roentgenology 2016;207:1009-15. [DOI: 10.2214/ajr.16.16323] [Cited by in Crossref: 26] [Cited by in F6Publishing: 2] [Article Influence: 4.3] [Reference Citation Analysis]
648 Wu PC, Chen YH, Wu FZ, Lin KH, Hsu CL, Chen CS, Chen YH, Lin PH, Mar GY, Yu HC. Risk factors for Barrett's esophagus in young adults who underwent upper gastrointestinal endoscopy in a health examination center. Therap Adv Gastroenterol 2019;12:1756284819853115. [PMID: 31210784 DOI: 10.1177/1756284819853115] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
649 Kumar P, Thota PN. Barrett's Esophagus in Rubinstein-Taybi Syndrome. Cureus 2020;12:e11709. [PMID: 33391942 DOI: 10.7759/cureus.11709] [Reference Citation Analysis]
650 Liu X, Cheng Y, Abraham JM, Wang Z, Wang Z, Ke X, Yan R, Shin EJ, Ngamruengphong S, Khashab MA, Zhang G, McNamara G, Ewald AJ, Lin D, Liu Z, Meltzer SJ. Modeling Wnt signaling by CRISPR-Cas9 genome editing recapitulates neoplasia in human Barrett epithelial organoids. Cancer Lett 2018;436:109-18. [PMID: 30144514 DOI: 10.1016/j.canlet.2018.08.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
651 Diaz LI, Mony S, Klapman J. Narrative review of the role of gastroenterologist in the diagnosis, treatment and palliation in gastric and gastroesophageal cancer. Ann Transl Med 2020;8:1106. [PMID: 33145325 DOI: 10.21037/atm-20-4143] [Reference Citation Analysis]
652 Wani S, Williams JL, Komanduri S, Muthusamy VR, Shaheen NJ. Endoscopists systematically undersample patients with long-segment Barrett’s esophagus: an analysis of biopsy sampling practices from a quality improvement registry. Gastrointestinal Endoscopy 2019;90:732-741.e3. [DOI: 10.1016/j.gie.2019.04.250] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]
653 Mansour NM, El-Serag HB, Anandasabapathy S. Barrett's esophagus: best practices for treatment and post-treatment surveillance. Ann Cardiothorac Surg 2017;6:75-87. [PMID: 28446996 DOI: 10.21037/acs.2017.03.05] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
654 Vosko S, Gupta S, Shahidi N, Hourigan LF, van Hattem WA, Bar-Yishay I, Schoeman S, Sidhu M, Burgess NG, Lee EYT, Bourke MJ. Snare-tip soft coagulation is effective and efficient as a first-line modality for treating intraprocedural bleeding during Barrett's mucosectomy. Endoscopy 2021;53:511-6. [PMID: 32659800 DOI: 10.1055/a-1218-6089] [Reference Citation Analysis]
655 Cotton CC, Shaheen NJ. Overutilization of Endoscopic Surveillance in Barrett's Esophagus: The Perils of Too Much of a Good Thing. Am J Gastroenterol 2020;115:1019-21. [PMID: 32618650 DOI: 10.14309/ajg.0000000000000650] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
656 Chan MQ, Blum AE, Chandar AK, Emmons AMLK, Shindo Y, Brock W, Falk GW, Canto MI, Wang JS, Iyer PG, Shaheen NJ, Grady WM, Abrams JA, Thota PN, Guda KK, Chak A. Association of sporadic and familial Barrett's esophagus with breast cancer. Dis Esophagus 2018;31. [PMID: 29528378 DOI: 10.1093/dote/doy007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
657 Sawas T, Visrodia KH, Zakko L, Lutzke LS, Leggett CL, Wang KK. Clutch cutter is a safe device for performing endoscopic submucosal dissection of superficial esophageal neoplasms: a western experience. Diseases of the Esophagus 2018;31. [DOI: 10.1093/dote/doy054] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
658 Patel A, Gyawali CP. Screening for Barrett's Esophagus: Balancing Clinical Value and Cost-effectiveness. J Neurogastroenterol Motil 2019;25:181-8. [PMID: 30827080 DOI: 10.5056/jnm18156] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
659 Britton J, Keld R, Prasad N, Hamdy S, McLaughlin J, Ang Y. Effect of diagnosis, surveillance, and treatment of Barrett's oesophagus on health-related quality of life. Lancet Gastroenterol Hepatol 2018;3:57-65. [PMID: 28970029 DOI: 10.1016/S2468-1253(17)30213-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
660 Kuipers EJ, Spaander MC. Natural History of Barrett's Esophagus. Dig Dis Sci 2018;63:1997-2004. [PMID: 29905908 DOI: 10.1007/s10620-018-5161-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
661 Krishnamoorthi R, Mohan BP, Jayaraj M, Wang KK, Katzka DA, Ross A, Adler DG, Iyer PG. Risk of progression in Barrett’s esophagus indefinite for dysplasia: a systematic review and meta-analysis. Gastrointestinal Endoscopy 2020;91:3-10.e3. [DOI: 10.1016/j.gie.2019.07.037] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
662 Dunbar KB, Souza RF. Beyond Dysplasia Grade: The Role of Biomarkers in Stratifying Risk. Gastrointest Endosc Clin N Am 2017;27:447-59. [PMID: 28577766 DOI: 10.1016/j.giec.2017.02.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
663 Putra J, Arva NC, Tan SY, Melin-Aldana H, Bass LM, Mitchell PD, Fox VL, Goldsmith JD. Barrett Esophagus and Intestinal Metaplasia of the Gastroesophageal Junction in Children: A Clinicopathologic Study. J Pediatr Gastroenterol Nutr 2020;70:562-7. [PMID: 31977949 DOI: 10.1097/MPG.0000000000002640] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
664 Cheung KS, Leung WK. Long-term use of proton-pump inhibitors and risk of gastric cancer: A review of the current evidence. Therap Adv Gastroenterol. 2019;12:1756284819834511. [PMID: 30886648 DOI: 10.1177/1756284819834511] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 13.0] [Reference Citation Analysis]
665 Sami SS, Moriarty JP, Rosedahl JK, Borah BJ, Katzka DA, Wang KK, Kisiel JB, Ragunath K, Rubenstein JH, Iyer PG. Comparative Cost Effectiveness of Reflux-Based and Reflux-Independent Strategies for Barrett's Esophagus Screening. Am J Gastroenterol 2021. [PMID: 34131096 DOI: 10.14309/ajg.0000000000001336] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
666 Salimian KJ, Waters KM, Eze O, Pezhouh MK, Tarabishy Y, Shin EJ, Canto MI, Voltaggio L, Montgomery EA. Definition of Barrett Esophagus in the United States: Support for Retention of a Requirement for Goblet Cells. Am J Surg Pathol 2018;42:264-8. [PMID: 29016405 DOI: 10.1097/PAS.0000000000000971] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 4.7] [Reference Citation Analysis]
667 Axley P, Mitchell R, Council L, Patel C, Tracht J, Collingwood R, Harrison D, Redden D, Beasely M, Kabir Baig KKR, Al Diffalha S, Peter S. Videoconference microscopy is a reliable alternative to conventional microscopy in the evaluation of Barrett's esophagus: Zooming into a new era. Dis Esophagus 2021:doab064. [PMID: 34553220 DOI: 10.1093/dote/doab064] [Reference Citation Analysis]
668 Busslinger GA, de Barbanson B, Oka R, Weusten BLA, de Maat M, van Hillegersberg R, Brosens LAA, van Boxtel R, van Oudenaarden A, Clevers H. Molecular characterization of Barrett's esophagus at single-cell resolution. Proc Natl Acad Sci U S A 2021;118:e2113061118. [PMID: 34795059 DOI: 10.1073/pnas.2113061118] [Reference Citation Analysis]
669 Barret M. Pediatric Barrett's Esophagus: A Fifth Column? Dig Dis Sci 2021;66:2143-4. [PMID: 32945985 DOI: 10.1007/s10620-020-06595-7] [Reference Citation Analysis]
670 LaMasters T. Comment on: Esophageal adenocarcinoma after sleeve gastrectomy: actual or potential threat? Italian series and literature review. Surg Obes Relat Dis 2021;17:854-6. [PMID: 33676873 DOI: 10.1016/j.soard.2021.01.015] [Reference Citation Analysis]
671 Çelik F, Aypak C, Özdemir A, Görpelioğlu S. Inappropriate Prescribing of Proton Pump Inhibitors in Outpatient Clinics. Gastroenterol Nurs 2021;44:84-91. [PMID: 33795619 DOI: 10.1097/SGA.0000000000000500] [Reference Citation Analysis]
672 Machicado JD, Han S, Yadlapati RH, Simon VC, Qumseya BJ, Sultan S, Kushnir VM, Komanduri S, Rastogi A, Muthusamy VR, Haidry R, Ragunath K, Singh R, Hammad HT, Shaheen NJ, Wani S. A Survey of Expert Practice and Attitudes Regarding Advanced Imaging Modalities in Surveillance of Barrett's Esophagus. Dig Dis Sci 2018;63:3262-71. [PMID: 30178283 DOI: 10.1007/s10620-018-5257-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
673 Bar N, Schwartz N, Nissim M, Fliss-Isacov N, Zelber-Sagi S, Kariv R. Barrett’s esophagus with high grade dysplasia is associated with non-esophageal cancer. World J Gastroenterol 2018; 24(39): 4472-4481 [PMID: 30356981 DOI: 10.3748/wjg.v24.i39.4472] [Reference Citation Analysis]
674 Eluri S, Shaheen NJ. Barrett's esophagus: diagnosis and management. Gastrointest Endosc. 2017;85:889-903. [PMID: 28109913 DOI: 10.1016/j.gie.2017.01.007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
675 Wang X, Cao Y, Zhang S, Chen Z, Fan L, Shen X, Zhou S, Chen D. Stem cell autocrine CXCL12/CXCR4 stimulates invasion and metastasis of esophageal cancer. Oncotarget 2017;8:36149-60. [PMID: 28193907 DOI: 10.18632/oncotarget.15254] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
676 Shimamura Y, Iwaya Y, Goda K, Teshima CW. Endoscopic treatment of Barrett's esophagus: What can we learn from the Western perspective? Digestive Endoscopy 2018;30:182-91. [DOI: 10.1111/den.12950] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
677 Liu Y. Artificial intelligence-assisted endoscopic detection of esophageal neoplasia in early stage: The next step? World J Gastroenterol 2021; 27(14): 1392-1405 [PMID: 33911463 DOI: 10.3748/wjg.v27.i14.1392] [Reference Citation Analysis]
678 ASGE Standards of Practice Committee, Qumseya B, Sultan S, Bain P, Jamil L, Jacobson B, Anandasabapathy S, Agrawal D, Buxbaum JL, Fishman DS, Gurudu SR, Jue TL, Kripalani S, Lee JK, Khashab MA, Naveed M, Thosani NC, Yang J, DeWitt J, Wani S; ASGE Standards of Practice Committee Chair. ASGE guideline on screening and surveillance of Barrett's esophagus. Gastrointest Endosc. 2019;90:335-359.e2. [PMID: 31439127 DOI: 10.1016/j.gie.2019.05.012] [Cited by in Crossref: 77] [Cited by in F6Publishing: 63] [Article Influence: 38.5] [Reference Citation Analysis]
679 Badgery H, Read M, Winter NN, Taylor ACF, Hii MW. The role of esophagectomy in the management of Barrett's esophagus with high-grade dysplasia. Ann N Y Acad Sci 2020;1481:72-89. [PMID: 32812261 DOI: 10.1111/nyas.14439] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
680 Huang RJ, Ende AR, Singla A, Higa JT, Choi AY, Lee AB, Whang SG, Gravelle K, D'Andrea S, Bang SJ, Schmidt RA, Yeh MM, Hwang JH. Prevalence, risk factors, and surveillance patterns for gastric intestinal metaplasia among patients undergoing upper endoscopy with biopsy. Gastrointest Endosc 2020;91:70-77.e1. [PMID: 31425693 DOI: 10.1016/j.gie.2019.07.038] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
681 Zhou Z, Kalatskaya I, Russell D, Marcon N, Cirocco M, Krzyzanowski PM, Streutker C, Liang H, Litle VR, Godfrey TE, Stein L. Combined EsophaCap cytology and MUC2 immunohistochemistry for screening of intestinal metaplasia, dysplasia and carcinoma. Clin Exp Gastroenterol 2019;12:219-29. [PMID: 31190949 DOI: 10.2147/CEG.S186958] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
682 Moayyedi P, El-Serag HB. Current Status of Chemoprevention in Barrett's Esophagus. Gastrointest Endosc Clin N Am 2021;31:117-30. [PMID: 33213791 DOI: 10.1016/j.giec.2020.08.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
683 Alderson D, Wijnhoven BP. Interventions for Barrett's oesophagus and early cancer. Br J Surg 2016;103:475-6. [PMID: 26898858 DOI: 10.1002/bjs.10135] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
684 Meyer C, Hejazi R, Bansal A. How extent of Barrett's metaplasia influences the risk of esophageal adenocarcinoma. Curr Opin Gastroenterol 2021;37:378-83. [PMID: 33883421 DOI: 10.1097/MOG.0000000000000743] [Reference Citation Analysis]
685 Gyawali CP, Fass R. Management of Gastroesophageal Reflux Disease. Gastroenterology. 2018;154:302-318. [PMID: 28827081 DOI: 10.1053/j.gastro.2017.07.049] [Cited by in Crossref: 109] [Cited by in F6Publishing: 75] [Article Influence: 21.8] [Reference Citation Analysis]
686 Wang Z, Lee H, Ahsen O, Liang K, Figueiredo M, Huang Q, Fujimoto J, Mashimo H. Computer-Aided Analysis of Gland-Like Subsurface Hyposcattering Structures in Barrett’s Esophagus Using Optical Coherence Tomography. Applied Sciences 2018;8:2420. [DOI: 10.3390/app8122420] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
687 Suzuki H, Yoshitaka T, Yoshio T, Tada T. Artificial intelligence for cancer detection of the upper gastrointestinal tract. Dig Endosc 2021;33:254-62. [PMID: 33222330 DOI: 10.1111/den.13897] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
688 Peters Y, Huibertse LJ, Schrauwen RWM, Tan AC, van der Post RS, Siersema PD. Increased risk of Barrett's oesophagus and related neoplasia in individuals with a positive family history. Eur J Cancer 2021;155:116-26. [PMID: 34375895 DOI: 10.1016/j.ejca.2021.07.007] [Reference Citation Analysis]
689 Rubenstein JH, Jiang L, Kurlander JE, Chen J, Metko V, Khodadost M, Nofz K, Raghunathan T. Incomplete Response of Gastroesophageal Reflux Symptoms Poorly Predicts Erosive Esophagitis or Barrett's Esophagus. Clin Gastroenterol Hepatol 2020:S1542-3565(20)31153-8. [PMID: 32835843 DOI: 10.1016/j.cgh.2020.08.044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
690 Thrift AP, Vaughan TL, Anderson LA, Whiteman DC, El-Serag HB. External Validation of the Michigan Barrett's Esophagus Prediction Tool. Clin Gastroenterol Hepatol 2017;15:1124-6. [PMID: 28300685 DOI: 10.1016/j.cgh.2017.03.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
691 Barrie J, Yanni F, Sherif M, Dube AK, Tamhankar AP. Length of Barrett's esophagus in the presence of low-grade dysplasia, high-grade dysplasia, and adenocarcinoma. Surg Endosc 2021;35:4756-62. [PMID: 32880012 DOI: 10.1007/s00464-020-07950-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
692 Isseh M, Mueller L, Abunafeesa H, Imam Z, Shakaroun D, Abu Ghanimeh M, Isseh N, Miller J, Jafri SM, Lenhart A. An Urban Center Experience Exploring Barriers to Adherence to Endoscopic Surveillance for Non-Dysplastic Barrett's Esophagus. Cureus 2021;13:e13030. [PMID: 33665052 DOI: 10.7759/cureus.13030] [Reference Citation Analysis]
693 Ireland CJ, Gordon AL, Thompson SK, Watson DI, Whiteman DC, Reed RL, Esterman A. Validation of a risk prediction model for Barrett's esophagus in an Australian population. Clin Exp Gastroenterol 2018;11:135-42. [PMID: 29628770 DOI: 10.2147/CEG.S158627] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
694 Trindade AJ. How Much Post-Ablation Surveillance Is Too Much for Patients With Barrett's Esophagus? Clin Gastroenterol Hepatol 2020;18:2435-6. [PMID: 32200084 DOI: 10.1016/j.cgh.2020.03.030] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
695 Zhao Z, Yin Z, Zhang C. Lifestyle interventions can reduce the risk of Barrett's esophagus: a systematic review and meta-analysis of 62 studies involving 250,157 participants. Cancer Med 2021;10:5297-320. [PMID: 34128354 DOI: 10.1002/cam4.4061] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
696 Draganov PV, Wang AY, Othman MO, Fukami N. AGA Institute Clinical Practice Update: Endoscopic Submucosal Dissection in the United States. Clin Gastroenterol Hepatol. 2019;17:16-25.e1. [PMID: 30077787 DOI: 10.1016/j.cgh.2018.07.041] [Cited by in Crossref: 108] [Cited by in F6Publishing: 86] [Article Influence: 27.0] [Reference Citation Analysis]
697 Januszewicz W, Fitzgerald RC. Early detection and therapeutics. Mol Oncol. 2019;13:599-613. [PMID: 30677217 DOI: 10.1002/1878-0261.12458] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
698 Karamchandani DM, Zhang Q, Liao XY, Xu JH, Liu XL. Inflammatory bowel disease- and Barrett's esophagus-associated neoplasia: the old, the new, and the persistent struggles. Gastroenterol Rep (Oxf) 2019;7:379-95. [PMID: 31857901 DOI: 10.1093/gastro/goz032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
699 Codipilly DC, Iyer PG. One Size May Not Fit All as We Inch Closer to Personalized Management Strategies for Barrett's Esophagus. Clin Gastroenterol Hepatol 2020;18:1930-2. [PMID: 31996325 DOI: 10.1016/j.cgh.2020.01.027] [Reference Citation Analysis]
700 Uedo N, Yoshio T, Yoshinaga S, Takeuchi M, Hatta W, Yano T, Tanuma T, Goto O, Takahashi A, Tong D, Lee YY, Nakayama Y, Ichihara S, Gotoda T. Endoscopic gastric mucosal atrophy distinguishes the characteristics of superficial esophagogastric junction adenocarcinoma. Digestive Endoscopy 2017;29:26-36. [DOI: 10.1111/den.12849] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
701 Baffy G, Fisichella PM. Gastrointestinal Surgery and Endoscopy: Recent Trends in Competition and Collaboration. Clin Gastroenterol Hepatol 2017;15:799-803. [PMID: 28235574 DOI: 10.1016/j.cgh.2017.02.014] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
702 Rodriguez MAC, de Moura DTH, Ribeiro IB, Bernardo WM, Morita FHA, Marques SB, Sakai P, de Moura EGH. Volumetric laser endomicroscopy and optical coherence tomography in Barrett's esophagus: a systematic review and meta-analysis.Endosc Int Open. 2019;7:E1078-E1091. [PMID: 31475224 DOI: 10.1055/a-0965-6487] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
703 Bartel MJ, Srivastava A, Gordon S, Rothstein RI, Pohl H. Subsquamous intestinal metaplasia is common in treatment-naïve Barrett’s esophagus. Gastrointestinal Endoscopy 2018;87:67-74. [DOI: 10.1016/j.gie.2017.06.024] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
704 Qumseya BJ, Wani S, Gendy S, Harnke B, Bergman JJ, Wolfsen H. Disease Progression in Barrett's Low-Grade Dysplasia With Radiofrequency Ablation Compared With Surveillance: Systematic Review and Meta-Analysis. Am J Gastroenterol. 2017;112:849-865. [PMID: 28374819 DOI: 10.1038/ajg.2017.70] [Cited by in Crossref: 45] [Cited by in F6Publishing: 30] [Article Influence: 9.0] [Reference Citation Analysis]
705 Griffin-Sobel JP. Gastrointestinal Cancers: Screening and Early Detection. Semin Oncol Nurs 2017;33:165-71. [PMID: 28343837 DOI: 10.1016/j.soncn.2017.02.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
706 Ishihara R, Arima M, Iizuka T, Oyama T, Katada C, Kato M, Goda K, Goto O, Tanaka K, Yano T, Yoshinaga S, Muto M, Kawakubo H, Fujishiro M, Yoshida M, Fujimoto K, Tajiri H, Inoue H; Japan Gastroenterological Endoscopy Society Guidelines Committee of ESD/EMR for Esophageal Cancer. Endoscopic submucosal dissection/endoscopic mucosal resection guidelines for esophageal cancer. Dig Endosc 2020;32:452-93. [PMID: 32072683 DOI: 10.1111/den.13654] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 26.0] [Reference Citation Analysis]